OSEHRA ZGO Export: ONCO AJCC STAGING CHAPTERS
ZWR
^ONCO(165.8,0)="ONCO AJCC STAGING CHAPTERS^165.8I^107^107"
^ONCO(165.8,1,0)="6^Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck"
^ONCO(165.8,1,1,0)="^165.82IA^1^1"
^ONCO(165.8,1,1,1,0)="T0"
^ONCO(165.8,1,1,1,1)="No evidence of primary tumor"
^ONCO(165.8,1,1,"B","T0",1)=""
^ONCO(165.8,1,2,0)="^165.83IA^10^10"
^ONCO(165.8,1,2,1,0)="NX"
^ONCO(165.8,1,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,1,2,2,0)="N0"
^ONCO(165.8,1,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,1,2,3,0)="N1"
^ONCO(165.8,1,2,3,1)="Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(-)"
^ONCO(165.8,1,2,4,0)="N2"
^ONCO(165.8,1,2,4,1)="Metastasis in a single ipsilateral node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); or in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension, ENE(-)"
^ONCO(165.8,1,2,5,0)="N2a"
^ONCO(165.8,1,2,5,1)="Metastasis in a single ipsilateral node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-)"
^ONCO(165.8,1,2,6,0)="N2b"
^ONCO(165.8,1,2,6,1)="Metastasis in multiple ipsilateral nodes, none larger than 6 cm in greatest dimension and ENE(-)"
^ONCO(165.8,1,2,7,0)="N2c"
^ONCO(165.8,1,2,7,1)="Metastasis in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-)"
^ONCO(165.8,1,2,8,0)="N3"
^ONCO(165.8,1,2,8,1)="Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); 2 or metastasis in any node(s) with clinically overt ENE(+) (ENEc)"
^ONCO(165.8,1,2,9,0)="N3a"
^ONCO(165.8,1,2,9,1)="Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-)"
^ONCO(165.8,1,2,10,0)="N3b"
^ONCO(165.8,1,2,10,1)="Metastasis in any node(s) with clinically overt ENE(+) (ENEc)"
^ONCO(165.8,1,2,"B","N0",2)=""
^ONCO(165.8,1,2,"B","N1",3)=""
^ONCO(165.8,1,2,"B","N2",4)=""
^ONCO(165.8,1,2,"B","N2a",5)=""
^ONCO(165.8,1,2,"B","N2b",6)=""
^ONCO(165.8,1,2,"B","N2c",7)=""
^ONCO(165.8,1,2,"B","N3",8)=""
^ONCO(165.8,1,2,"B","N3a",9)=""
^ONCO(165.8,1,2,"B","N3b",10)=""
^ONCO(165.8,1,2,"B","NX",1)=""
^ONCO(165.8,1,3,0)="^165.84IA^3^3"
^ONCO(165.8,1,3,1,0)="cM0"
^ONCO(165.8,1,3,1,1)="No distant metastasis"
^ONCO(165.8,1,3,2,0)="cM1"
^ONCO(165.8,1,3,2,1)="Distant metastasis"
^ONCO(165.8,1,3,3,0)="pM1"
^ONCO(165.8,1,3,3,1)="Distant metastasis, microscopically confirmed"
^ONCO(165.8,1,3,"B","cM0",1)=""
^ONCO(165.8,1,3,"B","cM1",2)=""
^ONCO(165.8,1,3,"B","pM1",3)=""
^ONCO(165.8,1,4,0)="^165.85I^1^1"
^ONCO(165.8,1,4,1,0)="(m)^Select if synchronous primary tumors are found in single organ"
^ONCO(165.8,1,4,"B","(m)",1)=""
^ONCO(165.8,1,5,0)="^165.86I^4^4"
^ONCO(165.8,1,5,1,0)="(sn)^Select if regional lymph node metastasis identified by SLN biopsy only"
^ONCO(165.8,1,5,2,0)="(f)^Select if regional lymph node metastasis identified by FNA or core needle biopsy only"
^ONCO(165.8,1,5,3,0)="U^Metastasis above the lower border of the cricoid"
^ONCO(165.8,1,5,4,0)="L^Metastasis below the lower border of the cricoid"
^ONCO(165.8,1,5,"B","(f)",2)=""
^ONCO(165.8,1,5,"B","(sn)",1)=""
^ONCO(165.8,1,5,"B","L",4)=""
^ONCO(165.8,1,5,"B","U",3)=""
^ONCO(165.8,1,7,0)="^165.88AI^10^10"
^ONCO(165.8,1,7,1,0)="NX"
^ONCO(165.8,1,7,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,1,7,2,0)="N0"
^ONCO(165.8,1,7,2,1)="No regional lymph node metastasis"
^ONCO(165.8,1,7,3,0)="N1"
^ONCO(165.8,1,7,3,1)="Metastasis in a single ipsilateral lymph node, 3cm or smaller in greatest dimension and ENE(-)"
^ONCO(165.8,1,7,4,0)="N2"
^ONCO(165.8,1,7,4,1)="Metastasis in a single ipsilateral LN, 3cm or < in greatest dimension and ENE(+); or > than 3cm but not > than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none > than 6cm in greatest dimension and ENE(-)"
^ONCO(165.8,1,7,5,0)="N2a"
^ONCO(165.8,1,7,5,1)="Metastasis in a single ipsilateral node 3cm or less in greatest dimension and ENE(+); or a single ipsilateral node larger than 3cm but not larger than 6cm in greatest dimension and ENE(-)"
^ONCO(165.8,1,7,6,0)="N2b"
^ONCO(165.8,1,7,6,1)="Metastasis in multiple ipsilateral nodes, none larger than 6 cm in greatest dimension and ENE(-)"
^ONCO(165.8,1,7,7,0)="N2c"
^ONCO(165.8,1,7,7,1)="Metastasis in bilateral or contralateral lymph node(s), none larger than 6 cm in greatest dimension and ENE(-)"
^ONCO(165.8,1,7,8,0)="N3"
^ONCO(165.8,1,7,8,1)="Metastasis in a lymph node larger than 6cm in greatest dimension and ENE(-); or metastasis in a single ipsilateral node larger than 3cm in greatest dimension and ENE(+); or multiple ipsilateral, contralateral, or bilateral nodes and size and ENE(+) in any node"
^ONCO(165.8,1,7,9,0)="N3a"
^ONCO(165.8,1,7,9,1)="Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-)"
^ONCO(165.8,1,7,10,0)="N3b"
^ONCO(165.8,1,7,10,1)="Metastasis in a single ipsilateral node larger than 3cm in greatest dimension and ENE(+); or multiple ipsilateral, contralateral, or bilateral nodes any size and ENE(+) in any node; or a single contralateral node of any size and ENE(+)"
^ONCO(165.8,1,7,"B","N0",2)=""
^ONCO(165.8,1,7,"B","N1",3)=""
^ONCO(165.8,1,7,"B","N2",4)=""
^ONCO(165.8,1,7,"B","N2a",5)=""
^ONCO(165.8,1,7,"B","N2b",6)=""
^ONCO(165.8,1,7,"B","N2c",7)=""
^ONCO(165.8,1,7,"B","N3",8)=""
^ONCO(165.8,1,7,"B","N3a",9)=""
^ONCO(165.8,1,7,"B","N3b",10)=""
^ONCO(165.8,1,7,"B","NX",1)=""
^ONCO(165.8,2,0)="7^Oral Cavity^^6^6"
^ONCO(165.8,2,1,0)="^165.82IA^8^8"
^ONCO(165.8,2,1,1,0)="TX"
^ONCO(165.8,2,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,2,1,2,0)="Tis"
^ONCO(165.8,2,1,2,1)="Carcinoma in situ"
^ONCO(165.8,2,1,3,0)="T1"
^ONCO(165.8,2,1,3,1)="Tumor<=2cm, with <=5mm depth of invasion (DOI). DOI is depth of invasion and not tumor thickness"
^ONCO(165.8,2,1,4,0)="T2"
^ONCO(165.8,2,1,4,1)="Tumor<=2cm, DOI>5mm or tumor>2cm and <=4cm, and DOI<=10mm"
^ONCO(165.8,2,1,5,0)="T3"
^ONCO(165.8,2,1,5,1)="Tumor>2cm and <=4cm with DOI>10mm or tumor>4cm with DOI<=10mm"
^ONCO(165.8,2,1,6,0)="T4"
^ONCO(165.8,2,1,6,1)="Moderately advanced or very advanced local disease"
^ONCO(165.8,2,1,7,0)="T4a"
^ONCO(165.8,2,1,7,1)="Moderately advanced local disease"
^ONCO(165.8,2,1,8,0)="T4b"
^ONCO(165.8,2,1,8,1)="Very advanced local disease"
^ONCO(165.8,2,1,"B","T1",3)=""
^ONCO(165.8,2,1,"B","T2",4)=""
^ONCO(165.8,2,1,"B","T3",5)=""
^ONCO(165.8,2,1,"B","T4",6)=""
^ONCO(165.8,2,1,"B","T4a",7)=""
^ONCO(165.8,2,1,"B","T4b",8)=""
^ONCO(165.8,2,1,"B","TX",1)=""
^ONCO(165.8,2,1,"B","Tis",2)=""
^ONCO(165.8,3,0)="8^Major Salivary Glands^^6^6"
^ONCO(165.8,3,1,0)="^165.82IA^9^9"
^ONCO(165.8,3,1,1,0)="TX"
^ONCO(165.8,3,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,3,1,2,0)="T0"
^ONCO(165.8,3,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,3,1,3,0)="Tis"
^ONCO(165.8,3,1,3,1)="Carcinoma in situ"
^ONCO(165.8,3,1,4,0)="T1"
^ONCO(165.8,3,1,4,1)="Tumor 2cm or smaller in greatest dimension without extraparenchymal extension"
^ONCO(165.8,3,1,5,0)="T2"
^ONCO(165.8,3,1,5,1)="Tumor larger than 2 cm but not larger than 4 cm in greatest dimension without extraparenchymal extension"
^ONCO(165.8,3,1,6,0)="T3"
^ONCO(165.8,3,1,6,1)="Tumor larger than 4 cm and/or tumor having extraparenchymal extension"
^ONCO(165.8,3,1,7,0)="T4"
^ONCO(165.8,3,1,7,1)="Moderately advanced or very advanced disease"
^ONCO(165.8,3,1,8,0)="T4a"
^ONCO(165.8,3,1,8,1)="Moderately advanced disease; Tumor invades skin, mandible, ear canal and/or facial nerve"
^ONCO(165.8,3,1,9,0)="T4b"
^ONCO(165.8,3,1,9,1)="Very advanced disease; Tumor invades skull base and/or pterygold plates and/or encases carotid artery"
^ONCO(165.8,3,1,"B","T0",2)=""
^ONCO(165.8,3,1,"B","T1",4)=""
^ONCO(165.8,3,1,"B","T2",5)=""
^ONCO(165.8,3,1,"B","T3",6)=""
^ONCO(165.8,3,1,"B","T4",7)=""
^ONCO(165.8,3,1,"B","T4a",8)=""
^ONCO(165.8,3,1,"B","T4b",9)=""
^ONCO(165.8,3,1,"B","TX",1)=""
^ONCO(165.8,3,1,"B","Tis",3)=""
^ONCO(165.8,4,0)="9^Nasopharynx^^^6"
^ONCO(165.8,4,1,0)="^165.82IA^7^7"
^ONCO(165.8,4,1,1,0)="TX"
^ONCO(165.8,4,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,4,1,2,0)="T0"
^ONCO(165.8,4,1,2,1)="No tumor identified, but EBV-positive cervical node(s) involvement"
^ONCO(165.8,4,1,3,0)="Tis"
^ONCO(165.8,4,1,3,1)="Tumor in situ"
^ONCO(165.8,4,1,4,0)="T1"
^ONCO(165.8,4,1,4,1)="Tumor confined to nasopharynx, or extension to oropharynx and/or nasal cavity without parapharyngeal involvement"
^ONCO(165.8,4,1,5,0)="T2"
^ONCO(165.8,4,1,5,1)="Tumor with extension to parapharyngeal space, and/or adjacent soft tissue involvement (medial pterygoid, lateral pterygoid, prevertebral muscles)"
^ONCO(165.8,4,1,6,0)="T3"
^ONCO(165.8,4,1,6,1)="Tumor with infiltration of bony structures at skull base, cervical vertebra, pterygoid structures, and/or paranasal sinuses"
^ONCO(165.8,4,1,7,0)="T4"
^ONCO(165.8,4,1,7,1)="Tumor with intracranial extension, involvement of cranial nerves, hypopharynx, orbit, parotid gland, and/or extensive soft tissue infiltration beyond the lateral surface of the lateral pterygoid muscle"
^ONCO(165.8,4,1,"B","T0",2)=""
^ONCO(165.8,4,1,"B","T1",4)=""
^ONCO(165.8,4,1,"B","T2",5)=""
^ONCO(165.8,4,1,"B","T3",6)=""
^ONCO(165.8,4,1,"B","T4",7)=""
^ONCO(165.8,4,1,"B","TX",1)=""
^ONCO(165.8,4,1,"B","Tis",3)=""
^ONCO(165.8,4,2,0)="^165.83IA^5^5"
^ONCO(165.8,4,2,1,0)="NX"
^ONCO(165.8,4,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,4,2,2,0)="N0"
^ONCO(165.8,4,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,4,2,3,0)="N1"
^ONCO(165.8,4,2,3,1)="Unilateral metastasis in cervical lymph node(s) and/or unilateral or bilateral metastasis in retropharyngeal lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage"
^ONCO(165.8,4,2,4,0)="N2"
^ONCO(165.8,4,2,4,1)="Bilateral metastasis in cervical lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage"
^ONCO(165.8,4,2,5,0)="N3"
^ONCO(165.8,4,2,5,1)="Unilateral or bilateral metastasis in cervical lymph node(s), larger than 6 cm in greatest dimension, and/or extension below the caudal border of cricoid cartilage"
^ONCO(165.8,4,2,"B","N0",2)=""
^ONCO(165.8,4,2,"B","N1",3)=""
^ONCO(165.8,4,2,"B","N2",4)=""
^ONCO(165.8,4,2,"B","N3",5)=""
^ONCO(165.8,4,2,"B","NX",1)=""
^ONCO(165.8,4,5,0)="^165.86I^2^2"
^ONCO(165.8,4,5,1,0)="(sn)^Select if regional lymph node metastasis identified by SLN biopsy only"
^ONCO(165.8,4,5,2,0)="(f)^Select if regional lymph node metastasis identified by FNA or core needle biopsy only"
^ONCO(165.8,4,5,"B","(f)",2)=""
^ONCO(165.8,4,5,"B","(sn)",1)=""
^ONCO(165.8,5,0)="10^HPV-Mediated (p16+) Oropharyngeal Cancer^^^6"
^ONCO(165.8,5,1,0)="^165.82IA^5^5"
^ONCO(165.8,5,1,1,0)="T0"
^ONCO(165.8,5,1,1,1)="No primary identified"
^ONCO(165.8,5,1,2,0)="T1"
^ONCO(165.8,5,1,2,1)="Tumor 2cm or smaller in greatest dimension"
^ONCO(165.8,5,1,3,0)="T2"
^ONCO(165.8,5,1,3,1)="Tumor larger than 2cm but not larger than 4cm in greatest dimension"
^ONCO(165.8,5,1,4,0)="T3"
^ONCO(165.8,5,1,4,1)="Tumor larger than 4 cm in greatest dimension or extension to lingual surface of epiglottis"
^ONCO(165.8,5,1,5,0)="T4"
^ONCO(165.8,5,1,5,1)="Moderately advanced local disease; Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible or beyond"
^ONCO(165.8,5,1,"B","T0",1)=""
^ONCO(165.8,5,1,"B","T1",2)=""
^ONCO(165.8,5,1,"B","T2",3)=""
^ONCO(165.8,5,1,"B","T3",4)=""
^ONCO(165.8,5,1,"B","T4",5)=""
^ONCO(165.8,5,2,0)="^165.83IA^5^5"
^ONCO(165.8,5,2,1,0)="NX"
^ONCO(165.8,5,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,5,2,2,0)="N0"
^ONCO(165.8,5,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,5,2,3,0)="N1"
^ONCO(165.8,5,2,3,1)="One or more ipsilateral lymph nodes, none larger than 6 cm"
^ONCO(165.8,5,2,4,0)="N2"
^ONCO(165.8,5,2,4,1)="Contralateral or bilateral lymph nodes, none larger than 6 cm"
^ONCO(165.8,5,2,5,0)="N3"
^ONCO(165.8,5,2,5,1)="Lymph node(s) larger than 6 cm"
^ONCO(165.8,5,2,"B","N0",2)=""
^ONCO(165.8,5,2,"B","N1",3)=""
^ONCO(165.8,5,2,"B","N2",4)=""
^ONCO(165.8,5,2,"B","N3",5)=""
^ONCO(165.8,5,2,"B","NX",1)=""
^ONCO(165.8,5,7,0)="^165.88AI^4^4"
^ONCO(165.8,5,7,1,0)="NX"
^ONCO(165.8,5,7,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,5,7,2,0)="N0"
^ONCO(165.8,5,7,2,1)="No regional lymph node metastasis"
^ONCO(165.8,5,7,3,0)="N1"
^ONCO(165.8,5,7,3,1)="Metastasis in 4 or fewer lymph nodes"
^ONCO(165.8,5,7,4,0)="N2"
^ONCO(165.8,5,7,4,1)="Metastasis in more than 4 lymph nodes"
^ONCO(165.8,5,7,"B","N0",2)=""
^ONCO(165.8,5,7,"B","N1",3)=""
^ONCO(165.8,5,7,"B","N2",4)=""
^ONCO(165.8,5,7,"B","NX",1)=""
^ONCO(165.8,6,0)="11.1^Oropharynx (p16-)^^6^6"
^ONCO(165.8,6,1,0)="^165.82IA^8^8"
^ONCO(165.8,6,1,1,0)="TX"
^ONCO(165.8,6,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,6,1,2,0)="Tis"
^ONCO(165.8,6,1,2,1)="Carcinoma in situ"
^ONCO(165.8,6,1,3,0)="T1"
^ONCO(165.8,6,1,3,1)="Tumor 2cm or smaller in greatest dimension"
^ONCO(165.8,6,1,4,0)="T2"
^ONCO(165.8,6,1,4,1)="Tumor larger than 2cm but not larger than 4cm in greatest dimension"
^ONCO(165.8,6,1,5,0)="T3"
^ONCO(165.8,6,1,5,1)="Tumor larger than 4 cm in greatest dimension or extension to lingual surface of epiglottis"
^ONCO(165.8,6,1,6,0)="T4"
^ONCO(165.8,6,1,6,1)="Moderately advanced or very advanced local disease"
^ONCO(165.8,6,1,7,0)="T4a"
^ONCO(165.8,6,1,7,1)="Moderately advanced local disease; Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible"
^ONCO(165.8,6,1,8,0)="T4b"
^ONCO(165.8,6,1,8,1)="Very advanced local disease; Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery"
^ONCO(165.8,6,1,"B","T1",3)=""
^ONCO(165.8,6,1,"B","T2",4)=""
^ONCO(165.8,6,1,"B","T3",5)=""
^ONCO(165.8,6,1,"B","T4",6)=""
^ONCO(165.8,6,1,"B","T4a",7)=""
^ONCO(165.8,6,1,"B","T4b",8)=""
^ONCO(165.8,6,1,"B","TX",1)=""
^ONCO(165.8,6,1,"B","Tis",2)=""
^ONCO(165.8,6,7,0)="^165.88AI^10^10"
^ONCO(165.8,6,7,1,0)="NX"
^ONCO(165.8,6,7,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,6,7,2,0)="N0"
^ONCO(165.8,6,7,2,1)="No regional lymph node metastasis"
^ONCO(165.8,6,7,3,0)="N1"
^ONCO(165.8,6,7,3,1)="Metastasis in a single ipsilateral lymph node, 3cm or smaller in greatest dimension and ENE(-)"
^ONCO(165.8,6,7,4,0)="N2"
^ONCO(165.8,6,7,4,1)="Metastasis in a single ipsilateral lymph node, 3cm or < in greatest dimension and ENE(+); or > than 3cm but < than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none  > 6cm in greatest dimension and ENE(-); or in bilateral or contralateral LN, none > 6cm in greatest dimension and ENE(-)"
^ONCO(165.8,6,7,5,0)="N2a"
^ONCO(165.8,6,7,5,1)="Metastasis in single ipsilateral node 3cm or smaller in greatest dimension and ENE(+); or a single ipsilateral node larger than 3cm but not larger than 6cm in greatest dimension and ENE(-)"
^ONCO(165.8,6,7,6,0)="N2b"
^ONCO(165.8,6,7,6,1)="Metastasis in multiple ipsilateral nodes, none larger than 6 cm in greatest dimension and ENE(-)"
^ONCO(165.8,6,7,7,0)="N2c"
^ONCO(165.8,6,7,7,1)="Metastasis in bilateral or contralateral lymph node(s), none larger than 6 cm in greatest dimension and ENE(-)"
^ONCO(165.8,6,7,8,0)="N3"
^ONCO(165.8,6,7,8,1)="Metastasis in a lymph node larger than 6cm in greatest dimension and ENE(-); or in a single ipsilateral node larger than 3 cm in greatest dimension and ENE(+); or multiple ipsilateral, contralateral or bilateral nodes, any with ENE(+); or a single contralateral node of any size and ENE(+)"
^ONCO(165.8,6,7,9,0)="N3a"
^ONCO(165.8,6,7,9,1)="Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-)"
^ONCO(165.8,6,7,10,0)="N3b"
^ONCO(165.8,6,7,10,1)="Metastasis in a single ipsilateral node larger than 3cm in greatest dimension and ENE(+); or multiple ipsilateral, contralateral or bilateral nodes, any with ENE(+); or a single contralateral node of any size and ENE(+)"
^ONCO(165.8,6,7,"B","N0",2)=""
^ONCO(165.8,6,7,"B","N1",3)=""
^ONCO(165.8,6,7,"B","N2",4)=""
^ONCO(165.8,6,7,"B","N2a",5)=""
^ONCO(165.8,6,7,"B","N2b",6)=""
^ONCO(165.8,6,7,"B","N2c",7)=""
^ONCO(165.8,6,7,"B","N3",8)=""
^ONCO(165.8,6,7,"B","N3a",9)=""
^ONCO(165.8,6,7,"B","N3b",10)=""
^ONCO(165.8,6,7,"B","NX",1)=""
^ONCO(165.8,7,0)="11.2^Hypopharynx^^6^6"
^ONCO(165.8,7,1,0)="^165.82IA^8^8"
^ONCO(165.8,7,1,1,0)="TX"
^ONCO(165.8,7,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,7,1,2,0)="Tis"
^ONCO(165.8,7,1,2,1)="Carcinoma in situ"
^ONCO(165.8,7,1,3,0)="T1"
^ONCO(165.8,7,1,3,1)="Tumor limited to one subsite of hypopharynx and/or 2 cm or smaller in greatest dimension"
^ONCO(165.8,7,1,4,0)="T2"
^ONCO(165.8,7,1,4,1)="Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures larger than 2cm but not larger than 4cm in greatest dimension without fixation of hemilarynx"
^ONCO(165.8,7,1,5,0)="T3"
^ONCO(165.8,7,1,5,1)="Tumor larger than 4 cm in greatest dimension or with fixation of hemilarynx or extension to esophageal mucosa"
^ONCO(165.8,7,1,6,0)="T4"
^ONCO(165.8,7,1,6,1)="Moderately advanced and very advanced local disease"
^ONCO(165.8,7,1,7,0)="T4a"
^ONCO(165.8,7,1,7,1)="Moderately advanced local disease; Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, esophageal muscle or central compartment soft tissue"
^ONCO(165.8,7,1,8,0)="T4b"
^ONCO(165.8,7,1,8,1)="Very advanced local disease; Tumor invades prevertebral fascia, encases carotid artery, or involves mediastinal structures"
^ONCO(165.8,7,1,"B","T1",3)=""
^ONCO(165.8,7,1,"B","T2",4)=""
^ONCO(165.8,7,1,"B","T3",5)=""
^ONCO(165.8,7,1,"B","T4",6)=""
^ONCO(165.8,7,1,"B","T4a",7)=""
^ONCO(165.8,7,1,"B","T4b",8)=""
^ONCO(165.8,7,1,"B","TX",1)=""
^ONCO(165.8,7,1,"B","Tis",2)=""
^ONCO(165.8,8,0)="12.1^Maxillary Sinus^^6^6"
^ONCO(165.8,8,1,0)="^165.82IA^8^8"
^ONCO(165.8,8,1,1,0)="TX"
^ONCO(165.8,8,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,8,1,2,0)="Tis"
^ONCO(165.8,8,1,2,1)="Carcinoma in situ"
^ONCO(165.8,8,1,3,0)="T1"
^ONCO(165.8,8,1,3,1)="Tumor limited to maxillary sinus mucosa with no erosion or destruction of bone"
^ONCO(165.8,8,1,4,0)="T2"
^ONCO(165.8,8,1,4,1)="Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates"
^ONCO(165.8,8,1,5,0)="T3"
^ONCO(165.8,8,1,5,1)="Tumor invades any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses"
^ONCO(165.8,8,1,6,0)="T4"
^ONCO(165.8,8,1,6,1)="Moderately advanced or very advanced local disease"
^ONCO(165.8,8,1,7,0)="T4a"
^ONCO(165.8,8,1,7,1)="Moderately advanced local disease; Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses"
^ONCO(165.8,8,1,8,0)="T4b"
^ONCO(165.8,8,1,8,1)="Very advanced local disease; Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve (V2), nasopharynx, or clivus"
^ONCO(165.8,8,1,"B","T1",3)=""
^ONCO(165.8,8,1,"B","T2",4)=""
^ONCO(165.8,8,1,"B","T3",5)=""
^ONCO(165.8,8,1,"B","T4",6)=""
^ONCO(165.8,8,1,"B","T4a",7)=""
^ONCO(165.8,8,1,"B","T4b",8)=""
^ONCO(165.8,8,1,"B","TX",1)=""
^ONCO(165.8,8,1,"B","Tis",2)=""
^ONCO(165.8,9,0)="12.2^Nasal cavity and Ethmoid Sinus^^6^6"
^ONCO(165.8,9,1,0)="^165.82IA^8^8"
^ONCO(165.8,9,1,1,0)="TX"
^ONCO(165.8,9,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,9,1,2,0)="Tis"
^ONCO(165.8,9,1,2,1)="Carcinoma in situ"
^ONCO(165.8,9,1,3,0)="T1"
^ONCO(165.8,9,1,3,1)="Tumor restricted to any one subsite, with or without bony invasion"
^ONCO(165.8,9,1,4,0)="T2"
^ONCO(165.8,9,1,4,1)="Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion"
^ONCO(165.8,9,1,5,0)="T3"
^ONCO(165.8,9,1,5,1)="Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate"
^ONCO(165.8,9,1,6,0)="T4"
^ONCO(165.8,9,1,6,1)="Moderately advanced or very advanced local disease"
^ONCO(165.8,9,1,7,0)="T4a"
^ONCO(165.8,9,1,7,1)="Moderately advanced local disease; Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses"
^ONCO(165.8,9,1,8,0)="T4b"
^ONCO(165.8,9,1,8,1)="Very advanced local disease; Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than (V2), nasopharynx, or clivus"
^ONCO(165.8,9,1,"B","T1",3)=""
^ONCO(165.8,9,1,"B","T2",4)=""
^ONCO(165.8,9,1,"B","T3",5)=""
^ONCO(165.8,9,1,"B","T4",6)=""
^ONCO(165.8,9,1,"B","T4a",7)=""
^ONCO(165.8,9,1,"B","T4b",8)=""
^ONCO(165.8,9,1,"B","TX",1)=""
^ONCO(165.8,9,1,"B","Tis",2)=""
^ONCO(165.8,10,0)="13.1^Larynx: Supraglottis^^6^6"
^ONCO(165.8,10,1,0)="^165.82IA^8^8"
^ONCO(165.8,10,1,1,0)="TX"
^ONCO(165.8,10,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,10,1,2,0)="Tis"
^ONCO(165.8,10,1,2,1)="Carcinoma in situ"
^ONCO(165.8,10,1,3,0)="T1"
^ONCO(165.8,10,1,3,1)="Tumor limited to one subsite of supraglottis with normal vocal cord mobility"
^ONCO(165.8,10,1,4,0)="T2"
^ONCO(165.8,10,1,4,1)="Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx"
^ONCO(165.8,10,1,5,0)="T3"
^ONCO(165.8,10,1,5,1)="Tumor limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, preepiglottic space, paraglottic space, and/or inner cortex of thyroid cartilage"
^ONCO(165.8,10,1,6,0)="T4"
^ONCO(165.8,10,1,6,1)="Moderately advanced or very advanced"
^ONCO(165.8,10,1,7,0)="T4a"
^ONCO(165.8,10,1,7,1)="Moderately advanced local disease; Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus)"
^ONCO(165.8,10,1,8,0)="T4b"
^ONCO(165.8,10,1,8,1)="Very advanced local disease; Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures esophagus)"
^ONCO(165.8,10,1,"B","T1",3)=""
^ONCO(165.8,10,1,"B","T2",4)=""
^ONCO(165.8,10,1,"B","T3",5)=""
^ONCO(165.8,10,1,"B","T4",6)=""
^ONCO(165.8,10,1,"B","T4a",7)=""
^ONCO(165.8,10,1,"B","T4b",8)=""
^ONCO(165.8,10,1,"B","TX",1)=""
^ONCO(165.8,10,1,"B","Tis",2)=""
^ONCO(165.8,11,0)="13.2^Larynx: Glottis^^6^6"
^ONCO(165.8,11,1,0)="^165.82IA^10^10"
^ONCO(165.8,11,1,1,0)="TX"
^ONCO(165.8,11,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,11,1,2,0)="Tis"
^ONCO(165.8,11,1,2,1)="Carcinoma in situ"
^ONCO(165.8,11,1,3,0)="T1"
^ONCO(165.8,11,1,3,1)="Tumor limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility"
^ONCO(165.8,11,1,4,0)="T1a"
^ONCO(165.8,11,1,4,1)="Tumor limited to one vocal cord"
^ONCO(165.8,11,1,5,0)="T1b"
^ONCO(165.8,11,1,5,1)="Tumor involves both vocal cords"
^ONCO(165.8,11,1,6,0)="T2"
^ONCO(165.8,11,1,6,1)="Tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility"
^ONCO(165.8,11,1,7,0)="T3"
^ONCO(165.8,11,1,7,1)="Tumor limited to the larynx with vocal cord fixation and/or invasion of paraglottic space and/or inner cortex of the thyroid cartilage"
^ONCO(165.8,11,1,8,0)="T4"
^ONCO(165.8,11,1,8,1)="Moderately advanced or very advanced"
^ONCO(165.8,11,1,9,0)="T4a"
^ONCO(165.8,11,1,9,1)="Moderately advanced local disease; Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, cricoid cartilage, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus)"
^ONCO(165.8,11,1,10,0)="T4b"
^ONCO(165.8,11,1,10,1)="Very advanced local disease; Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures"
^ONCO(165.8,11,1,"B","T1",3)=""
^ONCO(165.8,11,1,"B","T1a",4)=""
^ONCO(165.8,11,1,"B","T1b",5)=""
^ONCO(165.8,11,1,"B","T2",6)=""
^ONCO(165.8,11,1,"B","T3",7)=""
^ONCO(165.8,11,1,"B","T4",8)=""
^ONCO(165.8,11,1,"B","T4a",9)=""
^ONCO(165.8,11,1,"B","T4b",10)=""
^ONCO(165.8,11,1,"B","TX",1)=""
^ONCO(165.8,11,1,"B","Tis",2)=""
^ONCO(165.8,12,0)="13.3^Larynx: Subglottis^^6^6"
^ONCO(165.8,12,1,0)="^165.82IA^8^8"
^ONCO(165.8,12,1,1,0)="TX"
^ONCO(165.8,12,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,12,1,2,0)="Tis"
^ONCO(165.8,12,1,2,1)="Carcinoma in situ"
^ONCO(165.8,12,1,3,0)="T1"
^ONCO(165.8,12,1,3,1)="Tumor limited to the subglottis"
^ONCO(165.8,12,1,4,0)="T2"
^ONCO(165.8,12,1,4,1)="Tumor extends to vocal cord(s) with normal or impaired mobility"
^ONCO(165.8,12,1,5,0)="T3"
^ONCO(165.8,12,1,5,1)="Tumor limited to larynx with vocal cord fixation and/or invasion of paraglottic space and/or inner cortex of the thyroid cartilage"
^ONCO(165.8,12,1,6,0)="T4"
^ONCO(165.8,12,1,6,1)="Moderately advanced or very advanced"
^ONCO(165.8,12,1,7,0)="T4a"
^ONCO(165.8,12,1,7,1)="Moderately advanced local disease; Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus)"
^ONCO(165.8,12,1,8,0)="T4b"
^ONCO(165.8,12,1,8,1)="Very advanced local disease; Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures"
^ONCO(165.8,12,1,"B","T1",3)=""
^ONCO(165.8,12,1,"B","T2",4)=""
^ONCO(165.8,12,1,"B","T3",5)=""
^ONCO(165.8,12,1,"B","T4",6)=""
^ONCO(165.8,12,1,"B","T4a",7)=""
^ONCO(165.8,12,1,"B","T4b",8)=""
^ONCO(165.8,12,1,"B","TX",1)=""
^ONCO(165.8,12,1,"B","Tis",2)=""
^ONCO(165.8,13,0)="14^Mucosal Melanoma of the Head and Neck^^^6"
^ONCO(165.8,13,1,0)="^165.82IA^4^4"
^ONCO(165.8,13,1,1,0)="T3"
^ONCO(165.8,13,1,1,1)="Tumors limited to the mucosa and immediately underlying soft tissue, regardless of thickness or greatest dimension; for example, polypoid nasal disease, pigmented or nonpigmented lesions of the oral cavity, pharynx, or larynx"
^ONCO(165.8,13,1,2,0)="T4"
^ONCO(165.8,13,1,2,1)="Moderately advanced or very advanced disease"
^ONCO(165.8,13,1,3,0)="T4a"
^ONCO(165.8,13,1,3,1)="Moderately advanced or very advanced disease; Tumor involving deep soft tissue, cartilage, bone, or overlying skin"
^ONCO(165.8,13,1,4,0)="T4b"
^ONCO(165.8,13,1,4,1)="Very advanced disease; Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures"
^ONCO(165.8,13,1,"B","T3",1)=""
^ONCO(165.8,13,1,"B","T4",2)=""
^ONCO(165.8,13,1,"B","T4a",3)=""
^ONCO(165.8,13,1,"B","T4b",4)=""
^ONCO(165.8,13,2,0)="^165.83IA^3^3"
^ONCO(165.8,13,2,1,0)="NX"
^ONCO(165.8,13,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,13,2,2,0)="N0"
^ONCO(165.8,13,2,2,1)="No regional lymph node metastases"
^ONCO(165.8,13,2,3,0)="N1"
^ONCO(165.8,13,2,3,1)="Regional lymph node metastases present"
^ONCO(165.8,13,2,"B","N0",2)=""
^ONCO(165.8,13,2,"B","N1",3)=""
^ONCO(165.8,13,2,"B","NX",1)=""
^ONCO(165.8,14,0)="15^Cutaneous Carcinoma of the Head and Neck^^6^6"
^ONCO(165.8,14,1,0)="^165.82IA^8^8"
^ONCO(165.8,14,1,1,0)="TX"
^ONCO(165.8,14,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,14,1,2,0)="Tis"
^ONCO(165.8,14,1,2,1)="Carcinoma in situ"
^ONCO(165.8,14,1,3,0)="T1"
^ONCO(165.8,14,1,3,1)="Tumor smaller than or equal to 2cm in greatest dimension"
^ONCO(165.8,14,1,4,0)="T2"
^ONCO(165.8,14,1,4,1)="Tumor larger than 2 cm, but smaller than or equal to 4 cm in greatest dimension"
^ONCO(165.8,14,1,5,0)="T3"
^ONCO(165.8,14,1,5,1)="Tumor larger than 4 cm in maximum dimension or minor bone erosion or perineural invasion or deep invasion"
^ONCO(165.8,14,1,6,0)="T4"
^ONCO(165.8,14,1,6,1)="Tumor with gross cortical bone/marrow, skull base invasion and/or skull base foramen invasion"
^ONCO(165.8,14,1,7,0)="T4a"
^ONCO(165.8,14,1,7,1)="Tumor with gross cortical bone/marrow invasion"
^ONCO(165.8,14,1,8,0)="T4b"
^ONCO(165.8,14,1,8,1)="Tumor with skull base invasion and/or skull base foramen involvement"
^ONCO(165.8,14,1,"B","T1",3)=""
^ONCO(165.8,14,1,"B","T2",4)=""
^ONCO(165.8,14,1,"B","T3",5)=""
^ONCO(165.8,14,1,"B","T4",6)=""
^ONCO(165.8,14,1,"B","T4a",7)=""
^ONCO(165.8,14,1,"B","T4b",8)=""
^ONCO(165.8,14,1,"B","TX",1)=""
^ONCO(165.8,14,1,"B","Tis",2)=""
^ONCO(165.8,15,0)="16.1^Esophagus and Esophagogastric Junction: Squamous Cell Carcinoma^^^6"
^ONCO(165.8,15,1,0)="^165.82IA^11^11"
^ONCO(165.8,15,1,1,0)="TX"
^ONCO(165.8,15,1,1,1)="Tumor cannot be assessed"
^ONCO(165.8,15,1,2,0)="T0"
^ONCO(165.8,15,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,15,1,3,0)="Tis"
^ONCO(165.8,15,1,3,1)="High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane"
^ONCO(165.8,15,1,4,0)="T1"
^ONCO(165.8,15,1,4,1)="Tumor invades the lamina propria, muscularis mucosae, or submucosa"
^ONCO(165.8,15,1,5,0)="T1a"
^ONCO(165.8,15,1,5,1)="Tumor invades the lamina propria or muscularis mucosae"
^ONCO(165.8,15,1,6,0)="T1b"
^ONCO(165.8,15,1,6,1)="Tumor invades the submucosa"
^ONCO(165.8,15,1,7,0)="T2"
^ONCO(165.8,15,1,7,1)="Tumor invades the musculans propria"
^ONCO(165.8,15,1,8,0)="T3"
^ONCO(165.8,15,1,8,1)="Tumor invades adventitia"
^ONCO(165.8,15,1,9,0)="T4"
^ONCO(165.8,15,1,9,1)="Tumor invades adjacent structures"
^ONCO(165.8,15,1,10,0)="T4a"
^ONCO(165.8,15,1,10,1)="Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum"
^ONCO(165.8,15,1,11,0)="T4b"
^ONCO(165.8,15,1,11,1)="Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway"
^ONCO(165.8,15,1,"B","T0",2)=""
^ONCO(165.8,15,1,"B","T1",4)=""
^ONCO(165.8,15,1,"B","T1a",5)=""
^ONCO(165.8,15,1,"B","T1b",6)=""
^ONCO(165.8,15,1,"B","T2",7)=""
^ONCO(165.8,15,1,"B","T3",8)=""
^ONCO(165.8,15,1,"B","T4",9)=""
^ONCO(165.8,15,1,"B","T4a",10)=""
^ONCO(165.8,15,1,"B","T4b",11)=""
^ONCO(165.8,15,1,"B","TX",1)=""
^ONCO(165.8,15,1,"B","Tis",3)=""
^ONCO(165.8,15,2,0)="^165.83IA^5^5"
^ONCO(165.8,15,2,1,0)="NX"
^ONCO(165.8,15,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,15,2,2,0)="N0"
^ONCO(165.8,15,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,15,2,3,0)="N1"
^ONCO(165.8,15,2,3,1)="Metastasis in one or two regional lymph nodes"
^ONCO(165.8,15,2,4,0)="N2"
^ONCO(165.8,15,2,4,1)="Metastasis in three to six regional lymph nodes"
^ONCO(165.8,15,2,5,0)="N3"
^ONCO(165.8,15,2,5,1)="Metastasis in seven or more regional lymph nodes"
^ONCO(165.8,15,2,"B","N0",2)=""
^ONCO(165.8,15,2,"B","N1",3)=""
^ONCO(165.8,15,2,"B","N2",4)=""
^ONCO(165.8,15,2,"B","N3",5)=""
^ONCO(165.8,15,2,"B","NX",1)=""
^ONCO(165.8,16,0)="16.2^Esophagus and Esophagogastric Junction: Adenocarcinoma^^16.1^6"
^ONCO(165.8,16,1,0)="^165.82IA^11^11"
^ONCO(165.8,16,1,1,0)="TX"
^ONCO(165.8,16,1,1,1)="Tumor cannot be assessed"
^ONCO(165.8,16,1,2,0)="T0"
^ONCO(165.8,16,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,16,1,3,0)="Tis"
^ONCO(165.8,16,1,3,1)="High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane"
^ONCO(165.8,16,1,4,0)="T1"
^ONCO(165.8,16,1,4,1)="Tumor invades the lamina propria, muscularis mucosae, or submucosa"
^ONCO(165.8,16,1,5,0)="T1a"
^ONCO(165.8,16,1,5,1)="Tumor invades the lamina propria or muscularis mucosae"
^ONCO(165.8,16,1,6,0)="T1b"
^ONCO(165.8,16,1,6,1)="Tumor invades the submucosa"
^ONCO(165.8,16,1,7,0)="T2"
^ONCO(165.8,16,1,7,1)="Tumor invades the muscularis propria"
^ONCO(165.8,16,1,8,0)="T3"
^ONCO(165.8,16,1,8,1)="Tumor invades adventitia"
^ONCO(165.8,16,1,9,0)="T4"
^ONCO(165.8,16,1,9,1)="Tumor invades adjacent structures"
^ONCO(165.8,16,1,10,0)="T4a"
^ONCO(165.8,16,1,10,1)="Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum"
^ONCO(165.8,16,1,11,0)="T4b"
^ONCO(165.8,16,1,11,1)="Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway"
^ONCO(165.8,16,1,"B","T0",2)=""
^ONCO(165.8,16,1,"B","T1",4)=""
^ONCO(165.8,16,1,"B","T1a",5)=""
^ONCO(165.8,16,1,"B","T1b",6)=""
^ONCO(165.8,16,1,"B","T2",7)=""
^ONCO(165.8,16,1,"B","T3",8)=""
^ONCO(165.8,16,1,"B","T4",9)=""
^ONCO(165.8,16,1,"B","T4a",10)=""
^ONCO(165.8,16,1,"B","T4b",11)=""
^ONCO(165.8,16,1,"B","TX",1)=""
^ONCO(165.8,16,1,"B","Tis",3)=""
^ONCO(165.8,17,0)="16.3^Esophagus and Esophagogastric Junction: Other Histologies^^16.1^6"
^ONCO(165.8,17,1,0)="^165.82IA^11^11"
^ONCO(165.8,17,1,1,0)="TX"
^ONCO(165.8,17,1,1,1)="Tumor cannot be assessed"
^ONCO(165.8,17,1,2,0)="T0"
^ONCO(165.8,17,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,17,1,3,0)="Tis"
^ONCO(165.8,17,1,3,1)="High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane"
^ONCO(165.8,17,1,4,0)="T1"
^ONCO(165.8,17,1,4,1)="Tumor invades the lamina propria, muscularis mucosae, or submucosa"
^ONCO(165.8,17,1,5,0)="T1a"
^ONCO(165.8,17,1,5,1)="Tumor invades the lamina propria or muscularis mucosae"
^ONCO(165.8,17,1,6,0)="T1b"
^ONCO(165.8,17,1,6,1)="Tumor invades the submucosa"
^ONCO(165.8,17,1,7,0)="T2"
^ONCO(165.8,17,1,7,1)="Tumor invades the muscularis propria"
^ONCO(165.8,17,1,8,0)="T3"
^ONCO(165.8,17,1,8,1)="Tumor invades adventitia"
^ONCO(165.8,17,1,9,0)="T4"
^ONCO(165.8,17,1,9,1)="Tumor invades adjacent structures"
^ONCO(165.8,17,1,10,0)="T4a"
^ONCO(165.8,17,1,10,1)="Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum"
^ONCO(165.8,17,1,11,0)="T4b"
^ONCO(165.8,17,1,11,1)="Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway"
^ONCO(165.8,17,1,"B","T0",2)=""
^ONCO(165.8,17,1,"B","T1",4)=""
^ONCO(165.8,17,1,"B","T1a",5)=""
^ONCO(165.8,17,1,"B","T1b",6)=""
^ONCO(165.8,17,1,"B","T2",7)=""
^ONCO(165.8,17,1,"B","T3",8)=""
^ONCO(165.8,17,1,"B","T4",9)=""
^ONCO(165.8,17,1,"B","T4a",10)=""
^ONCO(165.8,17,1,"B","T4b",11)=""
^ONCO(165.8,17,1,"B","TX",1)=""
^ONCO(165.8,17,1,"B","Tis",3)=""
^ONCO(165.8,18,0)="17^Stomach^^^6"
^ONCO(165.8,18,1,0)="^165.82IA^11^11"
^ONCO(165.8,18,1,1,0)="TX"
^ONCO(165.8,18,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,18,1,2,0)="T0"
^ONCO(165.8,18,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,18,1,3,0)="Tis"
^ONCO(165.8,18,1,3,1)="Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria, high-grade dysplasia"
^ONCO(165.8,18,1,4,0)="T1"
^ONCO(165.8,18,1,4,1)="Tumor invades the lamina propria, muscularis mucosae, or submucosa"
^ONCO(165.8,18,1,5,0)="T1a"
^ONCO(165.8,18,1,5,1)="Tumor invades the lamina propria or muscularis mucosae"
^ONCO(165.8,18,1,6,0)="T1b"
^ONCO(165.8,18,1,6,1)="Tumor invades the submucosa"
^ONCO(165.8,18,1,7,0)="T2"
^ONCO(165.8,18,1,7,1)="Tumor invades the muscularis propria"
^ONCO(165.8,18,1,8,0)="T3"
^ONCO(165.8,18,1,8,1)="Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures"
^ONCO(165.8,18,1,9,0)="T4"
^ONCO(165.8,18,1,9,1)="Tumor invades the serosa (visceral peritoneum) or adjacent structures"
^ONCO(165.8,18,1,10,0)="T4a"
^ONCO(165.8,18,1,10,1)="Tumor invades the serosa (visceral peritoneum)"
^ONCO(165.8,18,1,11,0)="T4b"
^ONCO(165.8,18,1,11,1)="Tumor invades adjacent structures/organs"
^ONCO(165.8,18,1,"B","T0",2)=""
^ONCO(165.8,18,1,"B","T1",4)=""
^ONCO(165.8,18,1,"B","T1a",5)=""
^ONCO(165.8,18,1,"B","T1b",6)=""
^ONCO(165.8,18,1,"B","T2",7)=""
^ONCO(165.8,18,1,"B","T3",8)=""
^ONCO(165.8,18,1,"B","T4",9)=""
^ONCO(165.8,18,1,"B","T4a",10)=""
^ONCO(165.8,18,1,"B","T4b",11)=""
^ONCO(165.8,18,1,"B","TX",1)=""
^ONCO(165.8,18,1,"B","Tis",3)=""
^ONCO(165.8,18,2,0)="^165.83IA^7^7"
^ONCO(165.8,18,2,1,0)="NX"
^ONCO(165.8,18,2,1,1)="Regional lymph node(s) cannot be assessed"
^ONCO(165.8,18,2,2,0)="N0"
^ONCO(165.8,18,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,18,2,3,0)="N1"
^ONCO(165.8,18,2,3,1)="Metastasis in one or two regional lymph nodes"
^ONCO(165.8,18,2,4,0)="N2"
^ONCO(165.8,18,2,4,1)="Metastasis in three to six regional lymph nodes"
^ONCO(165.8,18,2,5,0)="N3"
^ONCO(165.8,18,2,5,1)="Metastasis in seven or more regional lymph nodes"
^ONCO(165.8,18,2,6,0)="N3a"
^ONCO(165.8,18,2,6,1)="Metastasis in seven to 15 regional lymph nodes"
^ONCO(165.8,18,2,7,0)="N3b"
^ONCO(165.8,18,2,7,1)="Metastasis in 16 or more regional lymph nodes"
^ONCO(165.8,18,2,"B","N0",2)=""
^ONCO(165.8,18,2,"B","N1",3)=""
^ONCO(165.8,18,2,"B","N2",4)=""
^ONCO(165.8,18,2,"B","N3",5)=""
^ONCO(165.8,18,2,"B","N3a",6)=""
^ONCO(165.8,18,2,"B","N3b",7)=""
^ONCO(165.8,18,2,"B","NX",1)=""
^ONCO(165.8,19,0)="18.1^Small Intestine: Adenocarcinoma^^^6"
^ONCO(165.8,19,1,0)="^165.82IA^9^9"
^ONCO(165.8,19,1,1,0)="TX"
^ONCO(165.8,19,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,19,1,2,0)="T0"
^ONCO(165.8,19,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,19,1,3,0)="Tis"
^ONCO(165.8,19,1,3,1)="High-grade dysplasia/carcinoma in situ"
^ONCO(165.8,19,1,4,0)="T1"
^ONCO(165.8,19,1,4,1)="Tumor invades the lamina propria or submucosa"
^ONCO(165.8,19,1,5,0)="T1a"
^ONCO(165.8,19,1,5,1)="Tumor invades the lamina propria"
^ONCO(165.8,19,1,6,0)="T1b"
^ONCO(165.8,19,1,6,1)="Tumor invades the submucosa"
^ONCO(165.8,19,1,7,0)="T2"
^ONCO(165.8,19,1,7,1)="Tumor invades the muscularis propria"
^ONCO(165.8,19,1,8,0)="T3"
^ONCO(165.8,19,1,8,1)="Tumor invades through the muscularis propria into the subserosa, or extends into nonperitonealized perimuscular tissue (mesentery or retroperitoneum) without serosal penetration"
^ONCO(165.8,19,1,9,0)="T4"
^ONCO(165.8,19,1,9,1)="Tumor perforates the visceral peritoneum or directly invades other organs or structures (e.g., other loops of small intestine, mesentery of adjacent loops of bowel, and abdominal wall by way of serosa; for duodenum only, invasion of pancreas or bile duct)"
^ONCO(165.8,19,1,"B","T0",2)=""
^ONCO(165.8,19,1,"B","T1",4)=""
^ONCO(165.8,19,1,"B","T1a",5)=""
^ONCO(165.8,19,1,"B","T1b",6)=""
^ONCO(165.8,19,1,"B","T2",7)=""
^ONCO(165.8,19,1,"B","T3",8)=""
^ONCO(165.8,19,1,"B","T4",9)=""
^ONCO(165.8,19,1,"B","TX",1)=""
^ONCO(165.8,19,1,"B","Tis",3)=""
^ONCO(165.8,19,2,0)="^165.83IA^4^4"
^ONCO(165.8,19,2,1,0)="NX"
^ONCO(165.8,19,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,19,2,2,0)="N0"
^ONCO(165.8,19,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,19,2,3,0)="N1"
^ONCO(165.8,19,2,3,1)="Metastasis in one or two regional lymph nodes"
^ONCO(165.8,19,2,4,0)="N2"
^ONCO(165.8,19,2,4,1)="Metastasis in three or more regional lymph nodes"
^ONCO(165.8,19,2,"B","N0",2)=""
^ONCO(165.8,19,2,"B","N1",3)=""
^ONCO(165.8,19,2,"B","N2",4)=""
^ONCO(165.8,19,2,"B","NX",1)=""
^ONCO(165.8,20,0)="18.2^Small Intestine: Other Histologies^^18.1^6"
^ONCO(165.8,20,1,0)="^165.82IA^9^9"
^ONCO(165.8,20,1,1,0)="TX"
^ONCO(165.8,20,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,20,1,2,0)="T0"
^ONCO(165.8,20,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,20,1,3,0)="Tis"
^ONCO(165.8,20,1,3,1)="High-grade dysplasia/carcinoma in situ"
^ONCO(165.8,20,1,4,0)="T1"
^ONCO(165.8,20,1,4,1)="Tumor invades the lamina propria or submucosa"
^ONCO(165.8,20,1,5,0)="T1a"
^ONCO(165.8,20,1,5,1)="Tumor invades the lamina propria"
^ONCO(165.8,20,1,6,0)="T1b"
^ONCO(165.8,20,1,6,1)="Tumor invades the submucosa"
^ONCO(165.8,20,1,7,0)="T2"
^ONCO(165.8,20,1,7,1)="Tumor invades the muscularis propria"
^ONCO(165.8,20,1,8,0)="T3"
^ONCO(165.8,20,1,8,1)="Tumor invades through the muscularis propria into the subserosa, or extends into nonperitonealized perimuscular tissue (mesentery or retroperitoneum) without serosal penetration"
^ONCO(165.8,20,1,9,0)="T4"
^ONCO(165.8,20,1,9,1)="Tumor perforates the visceral peritoneum or directly invades other organs or structures (e.g., other loops of small intestine, mesentery of adjacent loops of bowel, and abdominal wall by way of serosa; for duodenum only, invasion of pancreas or bile duct)"
^ONCO(165.8,20,1,"B","T0",2)=""
^ONCO(165.8,20,1,"B","T1",4)=""
^ONCO(165.8,20,1,"B","T1a",5)=""
^ONCO(165.8,20,1,"B","T1b",6)=""
^ONCO(165.8,20,1,"B","T2",7)=""
^ONCO(165.8,20,1,"B","T3",8)=""
^ONCO(165.8,20,1,"B","T4",9)=""
^ONCO(165.8,20,1,"B","TX",1)=""
^ONCO(165.8,20,1,"B","Tis",3)=""
^ONCO(165.8,21,0)="19^Appendix - Carcinoma"
^ONCO(165.8,21,1,0)="^165.82IA^10^10"
^ONCO(165.8,21,1,1,0)="TX"
^ONCO(165.8,21,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,21,1,2,0)="T0"
^ONCO(165.8,21,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,21,1,3,0)="Tis"
^ONCO(165.8,21,1,3,1)="Carcinoma in situ (intramucosal carcinoma; invasion of the lamina propria or extension into but not through the muscularis mucosae)"
^ONCO(165.8,21,1,4,0)="Tis(LAMN)"
^ONCO(165.8,21,1,4,1)="Low-grade appendiceal mucinous neoplasm confined by the muscularis propria. Acellular mucin or mucinous epithelium may invade into the muscularis propria.  T1 and T2 are not applicable to LAMN. Acellular mucin or mucinous epithelium that extends into the subserosa or serosa should be classified as T3 or T4a, respectively."
^ONCO(165.8,21,1,5,0)="T1"
^ONCO(165.8,21,1,5,1)="Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria)"
^ONCO(165.8,21,1,6,0)="T2"
^ONCO(165.8,21,1,6,1)="Tumor invades the muscularis propria"
^ONCO(165.8,21,1,7,0)="T3"
^ONCO(165.8,21,1,7,1)="Tumor invades through the muscularis propria into the subserosa or the mesoappendix"
^ONCO(165.8,21,1,8,0)="T4"
^ONCO(165.8,21,1,8,1)="Tumor invades the visceral peritoneum, including the acellular mucin or mucinous epithelium involving the serosa of the appendix or mesoappendix, and/or directly invades adjacent organs or structures"
^ONCO(165.8,21,1,9,0)="T4a"
^ONCO(165.8,21,1,9,1)="Tumor invades through the visceral peritoneum, including the acellular mucin or mucinous epithelium involving the serosa of the appendix or serosa of the mesoappendix"
^ONCO(165.8,21,1,10,0)="T4b"
^ONCO(165.8,21,1,10,1)="Tumor directly invades or adheres to adjacent organs or structures"
^ONCO(165.8,21,1,"B","T0",2)=""
^ONCO(165.8,21,1,"B","T1",5)=""
^ONCO(165.8,21,1,"B","T2",6)=""
^ONCO(165.8,21,1,"B","T3",7)=""
^ONCO(165.8,21,1,"B","T4",8)=""
^ONCO(165.8,21,1,"B","T4a",9)=""
^ONCO(165.8,21,1,"B","T4b",10)=""
^ONCO(165.8,21,1,"B","TX",1)=""
^ONCO(165.8,21,1,"B","Tis",3)=""
^ONCO(165.8,21,1,"B","Tis(LAMN)",4)=""
^ONCO(165.8,21,2,0)="^165.83IA^7^7"
^ONCO(165.8,21,2,1,0)="NX"
^ONCO(165.8,21,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,21,2,2,0)="N0"
^ONCO(165.8,21,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,21,2,3,0)="N1"
^ONCO(165.8,21,2,3,1)="One to three regional lymph nodes are positive (tumor in lymph node measuring =0.2 mm) or any number of tumor deposits is present, and all identifiable lymph nodes are negative"
^ONCO(165.8,21,2,4,0)="N1a"
^ONCO(165.8,21,2,4,1)="One regional lymph node is positive"
^ONCO(165.8,21,2,5,0)="N1b"
^ONCO(165.8,21,2,5,1)="Two or three regional lymph nodes are positive"
^ONCO(165.8,21,2,6,0)="N1c"
^ONCO(165.8,21,2,6,1)="No regional lymph nodes are positive, but there are tumor deposits in the subserosa or mesentery"
^ONCO(165.8,21,2,7,0)="N2"
^ONCO(165.8,21,2,7,1)="Four or more regional lymph nodes are positive"
^ONCO(165.8,21,2,"B","N0",2)=""
^ONCO(165.8,21,2,"B","N1",3)=""
^ONCO(165.8,21,2,"B","N1a",4)=""
^ONCO(165.8,21,2,"B","N1b",5)=""
^ONCO(165.8,21,2,"B","N1c",6)=""
^ONCO(165.8,21,2,"B","N2",7)=""
^ONCO(165.8,21,2,"B","NX",1)=""
^ONCO(165.8,21,3,0)="^165.84IA^9^9"
^ONCO(165.8,21,3,1,0)="cM0"
^ONCO(165.8,21,3,1,1)="No distant metastasis"
^ONCO(165.8,21,3,2,0)="cM1"
^ONCO(165.8,21,3,2,1)="Distant metastasis"
^ONCO(165.8,21,3,3,0)="cM1a"
^ONCO(165.8,21,3,3,1)="Intraperitoneal acellular mucin, without identifiable tumor cells in the disseminated peritoneal mucinous deposits"
^ONCO(165.8,21,3,4,0)="cM1b"
^ONCO(165.8,21,3,4,1)="Intraperitoneal metastasis only, including peritoneal mucinous deposits containing tumor cells"
^ONCO(165.8,21,3,5,0)="cM1c"
^ONCO(165.8,21,3,5,1)="Metastasis to sites other than peritoneum"
^ONCO(165.8,21,3,6,0)="pM1"
^ONCO(165.8,21,3,6,1)="Distant metastasis, microscopically confirmed"
^ONCO(165.8,21,3,7,0)="pM1a"
^ONCO(165.8,21,3,7,1)="Microscopically confirmed intraperitoneal acellular mucin, without identifiable tumor cells in the disseminated peritoneal mucinous deposits"
^ONCO(165.8,21,3,8,0)="pM1b"
^ONCO(165.8,21,3,8,1)="Microscopically confirmed intraperitoneal metastasis only, including peritoneal mucinous deposits containing tumor cells"
^ONCO(165.8,21,3,9,0)="pM1c"
^ONCO(165.8,21,3,9,1)="Microscopically confirmed metastasis to sites other than peritoneum"
^ONCO(165.8,21,3,"B","cM0",1)=""
^ONCO(165.8,21,3,"B","cM1",2)=""
^ONCO(165.8,21,3,"B","cM1a",3)=""
^ONCO(165.8,21,3,"B","cM1b",4)=""
^ONCO(165.8,21,3,"B","cM1c",5)=""
^ONCO(165.8,21,3,"B","pM1",6)=""
^ONCO(165.8,21,3,"B","pM1a",7)=""
^ONCO(165.8,21,3,"B","pM1b",8)=""
^ONCO(165.8,21,3,"B","pM1c",9)=""
^ONCO(165.8,22,0)="20^Colon and Rectum"
^ONCO(165.8,22,1,0)="^165.82IA^9^9"
^ONCO(165.8,22,1,1,0)="TX"
^ONCO(165.8,22,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,22,1,2,0)="T0"
^ONCO(165.8,22,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,22,1,3,0)="Tis"
^ONCO(165.8,22,1,3,1)="Carcinoma in situ, intramucosal carcinoma (involvement of lamina propria with no extension through muscularis mucosae)"
^ONCO(165.8,22,1,4,0)="T1"
^ONCO(165.8,22,1,4,1)="Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria)"
^ONCO(165.8,22,1,5,0)="T2"
^ONCO(165.8,22,1,5,1)="Tumor invades the muscularis propria"
^ONCO(165.8,22,1,6,0)="T3"
^ONCO(165.8,22,1,6,1)="Tumor invades through the muscularis propria into pericolorectal tissues"
^ONCO(165.8,22,1,7,0)="T4"
^ONCO(165.8,22,1,7,1)="Tumor invades the visceral peritoneum or invades or adheres to adjacent organ or structure"
^ONCO(165.8,22,1,8,0)="T4a"
^ONCO(165.8,22,1,8,1)="Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum)"
^ONCO(165.8,22,1,9,0)="T4b"
^ONCO(165.8,22,1,9,1)="Tumor directly invades or adheres to adjacent organs or structures"
^ONCO(165.8,22,1,"B","T0",2)=""
^ONCO(165.8,22,1,"B","T1",4)=""
^ONCO(165.8,22,1,"B","T2",5)=""
^ONCO(165.8,22,1,"B","T3",6)=""
^ONCO(165.8,22,1,"B","T4",7)=""
^ONCO(165.8,22,1,"B","T4a",8)=""
^ONCO(165.8,22,1,"B","T4b",9)=""
^ONCO(165.8,22,1,"B","TX",1)=""
^ONCO(165.8,22,1,"B","Tis",3)=""
^ONCO(165.8,22,2,0)="^165.83IA^9^9"
^ONCO(165.8,22,2,1,0)="NX"
^ONCO(165.8,22,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,22,2,2,0)="N0"
^ONCO(165.8,22,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,22,2,3,0)="N1"
^ONCO(165.8,22,2,3,1)="One to three regional lymph nodes are positive (tumor in lymph nodes measuring = 0.2 mm), or any number of tumor deposits are present and all identifiable lymph nodes are negative"
^ONCO(165.8,22,2,4,0)="N1a"
^ONCO(165.8,22,2,4,1)="One regional lymph node is positive"
^ONCO(165.8,22,2,5,0)="N1b"
^ONCO(165.8,22,2,5,1)="Two or three regional lymph nodes are positive"
^ONCO(165.8,22,2,6,0)="N1c"
^ONCO(165.8,22,2,6,1)="No regional lymph nodes are positive, but there are tumor deposits in the: subserosa, mesentary or nonperitonealized pericolic, or perirectal/mesorectal tissues."
^ONCO(165.8,22,2,7,0)="N2"
^ONCO(165.8,22,2,7,1)="Four or more regional lymph nodes are positive"
^ONCO(165.8,22,2,8,0)="N2a"
^ONCO(165.8,22,2,8,1)="Four to six regional lymph nodes are positive"
^ONCO(165.8,22,2,9,0)="N2b"
^ONCO(165.8,22,2,9,1)="Seven or more regional lymph nodes are positive"
^ONCO(165.8,22,2,"B","N0",2)=""
^ONCO(165.8,22,2,"B","N1",3)=""
^ONCO(165.8,22,2,"B","N1a",4)=""
^ONCO(165.8,22,2,"B","N1b",5)=""
^ONCO(165.8,22,2,"B","N1c",6)=""
^ONCO(165.8,22,2,"B","N2",7)=""
^ONCO(165.8,22,2,"B","N2a",8)=""
^ONCO(165.8,22,2,"B","N2b",9)=""
^ONCO(165.8,22,2,"B","NX",1)=""
^ONCO(165.8,22,3,0)="^165.84IA^9^9"
^ONCO(165.8,22,3,1,0)="cM0"
^ONCO(165.8,22,3,1,1)="No distant metastasis by imaging, etc.; no evidence of tumor in distant sites or organs (This category is not assigned by pathologists.)"
^ONCO(165.8,22,3,2,0)="cM1"
^ONCO(165.8,22,3,2,1)="Metastasis to one or more distant sites or organs or peritoneal metastasis is identified"
^ONCO(165.8,22,3,3,0)="cM1a"
^ONCO(165.8,22,3,3,1)="Metastasis to one site or organ is identified without peritoneal metastasis"
^ONCO(165.8,22,3,4,0)="cM1b"
^ONCO(165.8,22,3,4,1)="Metastasis to two or more sites or organs is identified without peritoneal metastasis"
^ONCO(165.8,22,3,5,0)="cM1c"
^ONCO(165.8,22,3,5,1)="Metastasis to the peritoneal surface is identified alone or with other site or organ metastases"
^ONCO(165.8,22,3,6,0)="pM1"
^ONCO(165.8,22,3,6,1)="Metastasis to one or more distant sites or organs or peritoneal metastasis is identified and microscopically confirmed"
^ONCO(165.8,22,3,7,0)="pM1a"
^ONCO(165.8,22,3,7,1)="Metastasis to one site or organ is identified without peritoneal metastasis and microscopically confirmed"
^ONCO(165.8,22,3,8,0)="pM1b"
^ONCO(165.8,22,3,8,1)="Metastasis to two or more sites or organs is identified without peritoneal metastasis and microscopically confirmed"
^ONCO(165.8,22,3,9,0)="pM1c"
^ONCO(165.8,22,3,9,1)="Metastasis to the peritoneal surface is identified alone or with other site or organ metastases and microscopically confirmed"
^ONCO(165.8,22,3,"B","cM0",1)=""
^ONCO(165.8,22,3,"B","cM1",2)=""
^ONCO(165.8,22,3,"B","cM1a",3)=""
^ONCO(165.8,22,3,"B","cM1b",4)=""
^ONCO(165.8,22,3,"B","cM1c",5)=""
^ONCO(165.8,22,3,"B","pM1",6)=""
^ONCO(165.8,22,3,"B","pM1a",7)=""
^ONCO(165.8,22,3,"B","pM1b",8)=""
^ONCO(165.8,22,3,"B","pM1c",9)=""
^ONCO(165.8,23,0)="21^Anus^^^6"
^ONCO(165.8,23,1,0)="^165.82IA^7^7"
^ONCO(165.8,23,1,1,0)="TX"
^ONCO(165.8,23,1,1,1)="Primary tumor not assessed"
^ONCO(165.8,23,1,2,0)="T0"
^ONCO(165.8,23,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,23,1,3,0)="Tis"
^ONCO(165.8,23,1,3,1)="High-grade squamous intraepithelial lesion (previously termed carcinoma in situ, Bowen disease, anal intraepithelial neoplasia II-III, high-grade anal intraepithelial neoplasia)"
^ONCO(165.8,23,1,4,0)="T1"
^ONCO(165.8,23,1,4,1)="Tumor <= 2cm"
^ONCO(165.8,23,1,5,0)="T2"
^ONCO(165.8,23,1,5,1)="Tumor > 2cm but <= 5cm"
^ONCO(165.8,23,1,6,0)="T3"
^ONCO(165.8,23,1,6,1)="Tumor > 5cm"
^ONCO(165.8,23,1,7,0)="T4"
^ONCO(165.8,23,1,7,1)="Tumor of any size invading adjacent organ(s), such as the vagina, urethra, or bladder"
^ONCO(165.8,23,1,"B","T0",2)=""
^ONCO(165.8,23,1,"B","T1",4)=""
^ONCO(165.8,23,1,"B","T2",5)=""
^ONCO(165.8,23,1,"B","T3",6)=""
^ONCO(165.8,23,1,"B","T4",7)=""
^ONCO(165.8,23,1,"B","TX",1)=""
^ONCO(165.8,23,1,"B","Tis",3)=""
^ONCO(165.8,23,2,0)="^165.83IA^6^6"
^ONCO(165.8,23,2,1,0)="NX"
^ONCO(165.8,23,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,23,2,2,0)="N0"
^ONCO(165.8,23,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,23,2,3,0)="N1"
^ONCO(165.8,23,2,3,1)="Metastasis in inguinal, mesorectal, internal iliac, or external iliac nodes"
^ONCO(165.8,23,2,4,0)="N1a"
^ONCO(165.8,23,2,4,1)="Metastasis in inguinal, mesorectal or internal iliac nodes"
^ONCO(165.8,23,2,5,0)="N1b"
^ONCO(165.8,23,2,5,1)="Metastasis in external iliac nodes"
^ONCO(165.8,23,2,6,0)="N1c"
^ONCO(165.8,23,2,6,1)="Metastasis in external iliac with any N1a nodes"
^ONCO(165.8,23,2,"B","N0",2)=""
^ONCO(165.8,23,2,"B","N1",3)=""
^ONCO(165.8,23,2,"B","N1a",4)=""
^ONCO(165.8,23,2,"B","N1b",5)=""
^ONCO(165.8,23,2,"B","N1c",6)=""
^ONCO(165.8,23,2,"B","NX",1)=""
^ONCO(165.8,24,0)="22^Liver^^14^6"
^ONCO(165.8,24,1,0)="^165.82IA^8^8"
^ONCO(165.8,24,1,1,0)="TX"
^ONCO(165.8,24,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,24,1,2,0)="T0"
^ONCO(165.8,24,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,24,1,3,0)="T1"
^ONCO(165.8,24,1,3,1)="Solitary tumor = 2cm, or > 2cm without vascular invasion"
^ONCO(165.8,24,1,4,0)="T1a"
^ONCO(165.8,24,1,4,1)="Solitary tumor <= 2cm"
^ONCO(165.8,24,1,5,0)="T1b"
^ONCO(165.8,24,1,5,1)="Solitary tumor > 2cm without vascular invasion"
^ONCO(165.8,24,1,6,0)="T2"
^ONCO(165.8,24,1,6,1)="Solitary tumor > 2cm with vascular invasion, or multiple tumors, none > 5cm"
^ONCO(165.8,24,1,7,0)="T3"
^ONCO(165.8,24,1,7,1)="Multiple tumors, at least one of which is >5 cm"
^ONCO(165.8,24,1,8,0)="T4"
^ONCO(165.8,24,1,8,1)="Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein, or tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum"
^ONCO(165.8,24,1,"B","T0",2)=""
^ONCO(165.8,24,1,"B","T1",3)=""
^ONCO(165.8,24,1,"B","T1a",4)=""
^ONCO(165.8,24,1,"B","T1b",5)=""
^ONCO(165.8,24,1,"B","T2",6)=""
^ONCO(165.8,24,1,"B","T3",7)=""
^ONCO(165.8,24,1,"B","T4",8)=""
^ONCO(165.8,24,1,"B","TX",1)=""
^ONCO(165.8,25,0)="23^Intrahepatic Bile Duct^^14^6"
^ONCO(165.8,25,1,0)="^165.82IA^9^9"
^ONCO(165.8,25,1,1,0)="TX"
^ONCO(165.8,25,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,25,1,2,0)="T0"
^ONCO(165.8,25,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,25,1,3,0)="Tis"
^ONCO(165.8,25,1,3,1)="Carcinoma in situ (intraductal tumor)"
^ONCO(165.8,25,1,4,0)="T1"
^ONCO(165.8,25,1,4,1)="Solitary tumor without vascular invasion, = 5cm or > 5cm"
^ONCO(165.8,25,1,5,0)="T1a"
^ONCO(165.8,25,1,5,1)="Solitary tumor <= 5cm without vascular invasion"
^ONCO(165.8,25,1,6,0)="T1b"
^ONCO(165.8,25,1,6,1)="Solitary tumor > 5cm without vascular invasion"
^ONCO(165.8,25,1,7,0)="T2"
^ONCO(165.8,25,1,7,1)="Solitary tumor with intrahepatic vascular invasion or multiple tumors, with or without vascular invasion"
^ONCO(165.8,25,1,8,0)="T3"
^ONCO(165.8,25,1,8,1)="Tumor perforating the visceral peritoneum"
^ONCO(165.8,25,1,9,0)="T4"
^ONCO(165.8,25,1,9,1)="Tumor involving local extrahepatic structures by direct invasion"
^ONCO(165.8,25,1,"B","T0",2)=""
^ONCO(165.8,25,1,"B","T1",4)=""
^ONCO(165.8,25,1,"B","T1a",5)=""
^ONCO(165.8,25,1,"B","T1b",6)=""
^ONCO(165.8,25,1,"B","T2",7)=""
^ONCO(165.8,25,1,"B","T3",8)=""
^ONCO(165.8,25,1,"B","T4",9)=""
^ONCO(165.8,25,1,"B","TX",1)=""
^ONCO(165.8,25,1,"B","Tis",3)=""
^ONCO(165.8,26,0)="24^Gallbladder^^^6"
^ONCO(165.8,26,1,0)="^165.82IA^11^11"
^ONCO(165.8,26,1,1,0)="TX"
^ONCO(165.8,26,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,26,1,2,0)="T0"
^ONCO(165.8,26,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,26,1,3,0)="Tis"
^ONCO(165.8,26,1,3,1)="Carcinoma in situ"
^ONCO(165.8,26,1,4,0)="T1"
^ONCO(165.8,26,1,4,1)="Tumor invades the lamina propria or muscular layer"
^ONCO(165.8,26,1,5,0)="T1a"
^ONCO(165.8,26,1,5,1)="Tumor invades the lamina propria"
^ONCO(165.8,26,1,6,0)="T1b"
^ONCO(165.8,26,1,6,1)="Tumor invades the muscular layer"
^ONCO(165.8,26,1,7,0)="T2"
^ONCO(165.8,26,1,7,1)="Tumor invades the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum) Or tumor invades the perimuscular connective tissue on the hepatic side, with no extension into the liver"
^ONCO(165.8,26,1,8,0)="T2a"
^ONCO(165.8,26,1,8,1)="Tumor invades the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum)"
^ONCO(165.8,26,1,9,0)="T2b"
^ONCO(165.8,26,1,9,1)="Tumor invades the perimuscular connective tissue on the hepatic side, with no extension into the liver"
^ONCO(165.8,26,1,10,0)="T3"
^ONCO(165.8,26,1,10,1)="Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts"
^ONCO(165.8,26,1,11,0)="T4"
^ONCO(165.8,26,1,11,1)="Tumor invades the main portal vein or hepatic artery or invades two or more extrahepatic organs or structures"
^ONCO(165.8,26,1,"B","T0",2)=""
^ONCO(165.8,26,1,"B","T1",4)=""
^ONCO(165.8,26,1,"B","T1a",5)=""
^ONCO(165.8,26,1,"B","T1b",6)=""
^ONCO(165.8,26,1,"B","T2",7)=""
^ONCO(165.8,26,1,"B","T2a",8)=""
^ONCO(165.8,26,1,"B","T2b",9)=""
^ONCO(165.8,26,1,"B","T3",10)=""
^ONCO(165.8,26,1,"B","T4",11)=""
^ONCO(165.8,26,1,"B","TX",1)=""
^ONCO(165.8,26,1,"B","Tis",3)=""
^ONCO(165.8,26,2,0)="^165.83IA^4^4"
^ONCO(165.8,26,2,1,0)="NX"
^ONCO(165.8,26,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,26,2,2,0)="N0"
^ONCO(165.8,26,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,26,2,3,0)="N1"
^ONCO(165.8,26,2,3,1)="Metastases to one to three regional lymph nodes"
^ONCO(165.8,26,2,4,0)="N2"
^ONCO(165.8,26,2,4,1)="Metastases to four or more regional lymph nodes"
^ONCO(165.8,26,2,"B","N0",2)=""
^ONCO(165.8,26,2,"B","N1",3)=""
^ONCO(165.8,26,2,"B","N2",4)=""
^ONCO(165.8,26,2,"B","NX",1)=""
^ONCO(165.8,27,0)="25^Perihilar Bile Ducts^^^6"
^ONCO(165.8,27,1,0)="^165.82IA^9^9"
^ONCO(165.8,27,1,1,0)="TX"
^ONCO(165.8,27,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,27,1,2,0)="T0"
^ONCO(165.8,27,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,27,1,3,0)="Tis"
^ONCO(165.8,27,1,3,1)="Carcinoma in situ/high-grade dysplasia"
^ONCO(165.8,27,1,4,0)="T1"
^ONCO(165.8,27,1,4,1)="Tumor confined to the bile duct, with extension up to the muscle layer or fibrous tissue"
^ONCO(165.8,27,1,5,0)="T2"
^ONCO(165.8,27,1,5,1)="Tumor invades beyond the wall of the bile duct to surrounding adipose tissue, or tumor invades adjacent hepatic parenchyma"
^ONCO(165.8,27,1,6,0)="T2a"
^ONCO(165.8,27,1,6,1)="Tumor invades beyond the wall of the bile duct to surrounding adipose tissue"
^ONCO(165.8,27,1,7,0)="T2b"
^ONCO(165.8,27,1,7,1)="Tumor invades adjacent hepatic parenchyma"
^ONCO(165.8,27,1,8,0)="T3"
^ONCO(165.8,27,1,8,1)="Tumor invades unilateral branches of the portal vein or hepatic artery"
^ONCO(165.8,27,1,9,0)="T4"
^ONCO(165.8,27,1,9,1)="Tumor invades the main portal vein or its branches bilaterally, or the common hepatic artery; or unilateral second-order biliary radicals with contralateral portal vein or hepatic artery involvement"
^ONCO(165.8,27,1,"B","T0",2)=""
^ONCO(165.8,27,1,"B","T1",4)=""
^ONCO(165.8,27,1,"B","T2",5)=""
^ONCO(165.8,27,1,"B","T2a",6)=""
^ONCO(165.8,27,1,"B","T2b",7)=""
^ONCO(165.8,27,1,"B","T3",8)=""
^ONCO(165.8,27,1,"B","T4",9)=""
^ONCO(165.8,27,1,"B","TX",1)=""
^ONCO(165.8,27,1,"B","Tis",3)=""
^ONCO(165.8,27,2,0)="^165.83IA^4^4"
^ONCO(165.8,27,2,1,0)="NX"
^ONCO(165.8,27,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,27,2,2,0)="N0"
^ONCO(165.8,27,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,27,2,3,0)="N1"
^ONCO(165.8,27,2,3,1)="One to three positive lymph nodes typically involving the hilar, cystic duct, common bile duct, hepatic artery, posterior pancreatoduodenal, and portal vein lymph nodes"
^ONCO(165.8,27,2,4,0)="N2"
^ONCO(165.8,27,2,4,1)="Four or more positive lymph nodes from the sites described for N1"
^ONCO(165.8,27,2,"B","N0",2)=""
^ONCO(165.8,27,2,"B","N1",3)=""
^ONCO(165.8,27,2,"B","N2",4)=""
^ONCO(165.8,27,2,"B","NX",1)=""
^ONCO(165.8,28,0)="26^Distal Bile Duct^^24^6"
^ONCO(165.8,28,1,0)="^165.82IA^6^6"
^ONCO(165.8,28,1,1,0)="TX"
^ONCO(165.8,28,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,28,1,2,0)="Tis"
^ONCO(165.8,28,1,2,1)="Carcinoma in situ/high-grade dysplasia"
^ONCO(165.8,28,1,3,0)="T1"
^ONCO(165.8,28,1,3,1)="Tumor invades the bile duct wall with a depth less than 5mm"
^ONCO(165.8,28,1,4,0)="T2"
^ONCO(165.8,28,1,4,1)="Tumor invades the bile duct wall with a depth of 5-12mm"
^ONCO(165.8,28,1,5,0)="T3"
^ONCO(165.8,28,1,5,1)="Tumor invades the bile duct wall with a depth greater than 12mm"
^ONCO(165.8,28,1,6,0)="T4"
^ONCO(165.8,28,1,6,1)="Tumor involves the celiac axis, superior mesenteric artery, and/or common hepatic artery"
^ONCO(165.8,28,1,"B","T1",3)=""
^ONCO(165.8,28,1,"B","T2",4)=""
^ONCO(165.8,28,1,"B","T3",5)=""
^ONCO(165.8,28,1,"B","T4",6)=""
^ONCO(165.8,28,1,"B","TX",1)=""
^ONCO(165.8,28,1,"B","Tis",2)=""
^ONCO(165.8,29,0)="27^Ampulla of Vater^^24^6"
^ONCO(165.8,29,1,0)="^165.82IA^11^11"
^ONCO(165.8,29,1,1,0)="TX"
^ONCO(165.8,29,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,29,1,2,0)="T0"
^ONCO(165.8,29,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,29,1,3,0)="Tis"
^ONCO(165.8,29,1,3,1)="Carcinoma in situ"
^ONCO(165.8,29,1,4,0)="T1"
^ONCO(165.8,29,1,4,1)="Tumor limited to ampulla of Vater or sphincter of Oddi or tumor invades beyond the sphincter of Oddi (perisphincteric invasion) and/or into the duodenal submucosa"
^ONCO(165.8,29,1,5,0)="T1a"
^ONCO(165.8,29,1,5,1)="Tumor limited to ampulla of Vater or sphincter of Oddi"
^ONCO(165.8,29,1,6,0)="T1b"
^ONCO(165.8,29,1,6,1)="Tumor invades beyond the sphincter of Oddi (perisphincteric invasion) and/or into the duodenal submucosa"
^ONCO(165.8,29,1,7,0)="T2"
^ONCO(165.8,29,1,7,1)="Tumor invades into the muscularis propria of the duodenum"
^ONCO(165.8,29,1,8,0)="T3"
^ONCO(165.8,29,1,8,1)="Tumor directly invades the pancreas (up to 0.5 cm) or tumor extends more than 0.5 cm into the pancreas, or extends into peripancreatic or periduodenal tissue or duodenal serosa without involvement of the celiac axis or superior mesenteric artery"
^ONCO(165.8,29,1,9,0)="T3a"
^ONCO(165.8,29,1,9,1)="Tumor directly invades the pancreas (up to 0.5 cm)"
^ONCO(165.8,29,1,10,0)="T3b"
^ONCO(165.8,29,1,10,1)="Tumor extends more than 0.5 cm into the pancreas, or extends into peripancreatic or periduodenal tissue or duodenal serosa without involvement of the celiac axis or superior mesenteric artery"
^ONCO(165.8,29,1,11,0)="T4"
^ONCO(165.8,29,1,11,1)="Tumor involves the celiac axis, superior mesenteric artery, and/or common hepatic artery, irrespective of size"
^ONCO(165.8,29,1,"B","T0",2)=""
^ONCO(165.8,29,1,"B","T1",4)=""
^ONCO(165.8,29,1,"B","T1a",5)=""
^ONCO(165.8,29,1,"B","T1b",6)=""
^ONCO(165.8,29,1,"B","T2",7)=""
^ONCO(165.8,29,1,"B","T3",8)=""
^ONCO(165.8,29,1,"B","T3a",9)=""
^ONCO(165.8,29,1,"B","T3b",10)=""
^ONCO(165.8,29,1,"B","T4",11)=""
^ONCO(165.8,29,1,"B","TX",1)=""
^ONCO(165.8,29,1,"B","Tis",3)=""
^ONCO(165.8,30,0)="28^Exocrine Pancreas^^24^6"
^ONCO(165.8,30,1,0)="^165.82IA^10^10"
^ONCO(165.8,30,1,1,0)="TX"
^ONCO(165.8,30,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,30,1,2,0)="T0"
^ONCO(165.8,30,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,30,1,3,0)="Tis"
^ONCO(165.8,30,1,3,1)="Carcinoma in situ. This includes high-grade pancreatic intraepithelial neoplasia (PanIn-3), intraductal papillary mucinous neoplasm with high-grade dysplasia, intraductal tubulopapillary neoplasm with high-grade dysplasia, and mucinous cystic neoplasm with high-grade dysplasia."
^ONCO(165.8,30,1,4,0)="T1"
^ONCO(165.8,30,1,4,1)="Tumor <= 2cm in greatest dimension"
^ONCO(165.8,30,1,5,0)="T1a"
^ONCO(165.8,30,1,5,1)="Tumor <= 0.5cm in greatest dimension"
^ONCO(165.8,30,1,6,0)="T1b"
^ONCO(165.8,30,1,6,1)="Tumor > 0.5cm and < 1cm in greatest dimension"
^ONCO(165.8,30,1,7,0)="T1c"
^ONCO(165.8,30,1,7,1)="Tumor 1-2cm in greatest dimension"
^ONCO(165.8,30,1,8,0)="T2"
^ONCO(165.8,30,1,8,1)="Tumor > 2cm and <= 4cm in greatest dimension"
^ONCO(165.8,30,1,9,0)="T3"
^ONCO(165.8,30,1,9,1)="Tumor > 4cm in greatest dimension"
^ONCO(165.8,30,1,10,0)="T4"
^ONCO(165.8,30,1,10,1)="Tumor involves celiac axis, superior mesenteric artery, and/or common hepatic artery, regardless of size"
^ONCO(165.8,30,1,"B","T0",2)=""
^ONCO(165.8,30,1,"B","T1",4)=""
^ONCO(165.8,30,1,"B","T1a",5)=""
^ONCO(165.8,30,1,"B","T1b",6)=""
^ONCO(165.8,30,1,"B","T1c",7)=""
^ONCO(165.8,30,1,"B","T2",8)=""
^ONCO(165.8,30,1,"B","T3",9)=""
^ONCO(165.8,30,1,"B","T4",10)=""
^ONCO(165.8,30,1,"B","TX",1)=""
^ONCO(165.8,30,1,"B","Tis",3)=""
^ONCO(165.8,31,0)="29^Neuroendocrine Tumors of the Stomach^^14"
^ONCO(165.8,31,1,0)="^165.82IA^6^6"
^ONCO(165.8,31,1,1,0)="TX"
^ONCO(165.8,31,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,31,1,2,0)="T0"
^ONCO(165.8,31,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,31,1,3,0)="T1"
^ONCO(165.8,31,1,3,1)="Invades the lamina propria or submucosa and less than or equal to 1 cm in size"
^ONCO(165.8,31,1,4,0)="T2"
^ONCO(165.8,31,1,4,1)="Invades the muscularis propria or greater than 1 cm in size"
^ONCO(165.8,31,1,5,0)="T3"
^ONCO(165.8,31,1,5,1)="Invades through the muscularis propria into subserosal tissue without penetration of overlying serosa"
^ONCO(165.8,31,1,6,0)="T4"
^ONCO(165.8,31,1,6,1)="Invades visceral peritoneum (serosa) or other organs or adjacent structures"
^ONCO(165.8,31,1,"B","T0",2)=""
^ONCO(165.8,31,1,"B","T1",3)=""
^ONCO(165.8,31,1,"B","T2",4)=""
^ONCO(165.8,31,1,"B","T3",5)=""
^ONCO(165.8,31,1,"B","T4",6)=""
^ONCO(165.8,31,1,"B","TX",1)=""
^ONCO(165.8,31,3,0)="^165.84IA^9^9"
^ONCO(165.8,31,3,1,0)="cM0"
^ONCO(165.8,31,3,1,1)="No distant metastasis"
^ONCO(165.8,31,3,2,0)="cM1"
^ONCO(165.8,31,3,2,1)="Distant metastasis"
^ONCO(165.8,31,3,3,0)="cM1a"
^ONCO(165.8,31,3,3,1)="Metastasis confined to liver"
^ONCO(165.8,31,3,4,0)="cM1b"
^ONCO(165.8,31,3,4,1)="Metastases in at least one extrahepatic site (e.g., lung, ovary, nonregional lymph node, peritoneum, bone)"
^ONCO(165.8,31,3,5,0)="cM1c"
^ONCO(165.8,31,3,5,1)="Both hepatic and extrahepatic metastases"
^ONCO(165.8,31,3,6,0)="pM1"
^ONCO(165.8,31,3,6,1)="Distant metastasis, microscopically confirmed"
^ONCO(165.8,31,3,7,0)="pM1a"
^ONCO(165.8,31,3,7,1)="Metastasis confined to liver, microscopically confirmed"
^ONCO(165.8,31,3,8,0)="pM1b"
^ONCO(165.8,31,3,8,1)="Metastases in at least one extrahepatic site (e.g., lung, ovary, nonregional lymph node, peritoneum, bone), microscopically confirmed"
^ONCO(165.8,31,3,9,0)="pM1c"
^ONCO(165.8,31,3,9,1)="Both hepatic and extrahepatic metastases, microscopically confirmed"
^ONCO(165.8,31,3,"B","cM0",1)=""
^ONCO(165.8,31,3,"B","cM1",2)=""
^ONCO(165.8,31,3,"B","cM1a",3)=""
^ONCO(165.8,31,3,"B","cM1b",4)=""
^ONCO(165.8,31,3,"B","cM1c",5)=""
^ONCO(165.8,31,3,"B","pM1",6)=""
^ONCO(165.8,31,3,"B","pM1a",7)=""
^ONCO(165.8,31,3,"B","pM1b",8)=""
^ONCO(165.8,31,3,"B","pM1c",9)=""
^ONCO(165.8,32,0)="30^Neuroendocrine Tumors of the Duodenum and Ampulla of Vater^^^29"
^ONCO(165.8,32,1,0)="^165.82IA^5^5"
^ONCO(165.8,32,1,1,0)="TX"
^ONCO(165.8,32,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,32,1,2,0)="T1"
^ONCO(165.8,32,1,2,1)="Tumor invades the mucosa or submucosa only and is =1 cm (duodenal tumors); Tumor =1 cm and confined within the sphincter of Oddi (ampullary tumors)"
^ONCO(165.8,32,1,3,0)="T2"
^ONCO(165.8,32,1,3,1)="Tumor invades the muscularis propria or is >1 cm (duodenal); Tumor invades through sphincter into duodenal submucosa or muscularis propria, or is >1 cm (ampullary)"
^ONCO(165.8,32,1,4,0)="T3"
^ONCO(165.8,32,1,4,1)="Tumor invades the pancreas or peripancreatic adipose tissue"
^ONCO(165.8,32,1,5,0)="T4"
^ONCO(165.8,32,1,5,1)="Tumor invades the visceral peritoneum (serosa) or other organs"
^ONCO(165.8,32,1,"B","T1",2)=""
^ONCO(165.8,32,1,"B","T2",3)=""
^ONCO(165.8,32,1,"B","T3",4)=""
^ONCO(165.8,32,1,"B","T4",5)=""
^ONCO(165.8,32,1,"B","TX",1)=""
^ONCO(165.8,32,2,0)="^165.83IA^3^3"
^ONCO(165.8,32,2,1,0)="NX"
^ONCO(165.8,32,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,32,2,2,0)="N0"
^ONCO(165.8,32,2,2,1)="No regional lymph node involvement"
^ONCO(165.8,32,2,3,0)="N1"
^ONCO(165.8,32,2,3,1)="Regional lymph node involvement"
^ONCO(165.8,32,2,"B","N0",2)=""
^ONCO(165.8,32,2,"B","N1",3)=""
^ONCO(165.8,32,2,"B","NX",1)=""
^ONCO(165.8,33,0)="31^Neuroendocrine Tumors of the Jejunum and Ileum^^^29"
^ONCO(165.8,33,1,0)="^165.82IA^6^6"
^ONCO(165.8,33,1,1,0)="TX"
^ONCO(165.8,33,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,33,1,2,0)="T0"
^ONCO(165.8,33,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,33,1,3,0)="T1"
^ONCO(165.8,33,1,3,1)="Invades lamina propria or submucosa and less than or equal to 1 cm in size"
^ONCO(165.8,33,1,4,0)="T2"
^ONCO(165.8,33,1,4,1)="Invades muscularis propria or greater than 1 cm in size"
^ONCO(165.8,33,1,5,0)="T3"
^ONCO(165.8,33,1,5,1)="Invades through the muscularis propria into subserosal tissue without penetration of overlying serosa"
^ONCO(165.8,33,1,6,0)="T4"
^ONCO(165.8,33,1,6,1)="Invades visceral peritoneum (serosal) or other organs or adjacent structures"
^ONCO(165.8,33,1,"B","T0",2)=""
^ONCO(165.8,33,1,"B","T1",3)=""
^ONCO(165.8,33,1,"B","T2",4)=""
^ONCO(165.8,33,1,"B","T3",5)=""
^ONCO(165.8,33,1,"B","T4",6)=""
^ONCO(165.8,33,1,"B","TX",1)=""
^ONCO(165.8,33,2,0)="^165.83IA^4^4"
^ONCO(165.8,33,2,1,0)="NX"
^ONCO(165.8,33,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,33,2,2,0)="N0"
^ONCO(165.8,33,2,2,1)="No regional lymph node metastasis has occurred"
^ONCO(165.8,33,2,3,0)="N1"
^ONCO(165.8,33,2,3,1)="Regional lymph node metastasis less than 12 nodes"
^ONCO(165.8,33,2,4,0)="N2"
^ONCO(165.8,33,2,4,1)="Large mesenteric masses (>2 cm) and/or extensive nodal deposits (12 or greater), especially those that encase the superior mesenteric vessels"
^ONCO(165.8,33,2,"B","N0",2)=""
^ONCO(165.8,33,2,"B","N1",3)=""
^ONCO(165.8,33,2,"B","N2",4)=""
^ONCO(165.8,33,2,"B","NX",1)=""
^ONCO(165.8,34,0)="32^Neuroendocrine Tumors of the Appendix^^14^29"
^ONCO(165.8,34,1,0)="^165.82IA^6^6"
^ONCO(165.8,34,1,1,0)="TX"
^ONCO(165.8,34,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,34,1,2,0)="T0"
^ONCO(165.8,34,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,34,1,3,0)="T1"
^ONCO(165.8,34,1,3,1)="Tumor 2cm or less in greatest dimension"
^ONCO(165.8,34,1,4,0)="T2"
^ONCO(165.8,34,1,4,1)="Tumor more than 2cm but less then or equal to 4cm"
^ONCO(165.8,34,1,5,0)="T3"
^ONCO(165.8,34,1,5,1)="Tumor more than 4 cm or with subserosal invasion or involvement of the mesoappendix"
^ONCO(165.8,34,1,6,0)="T4"
^ONCO(165.8,34,1,6,1)="Tumor perforates the peritoneum or directly invades other adjacent organs or structures (excluding direct mural extension to adjacent subserosa of adjacent bowel), e.g., abdominal wall and skeletal muscle"
^ONCO(165.8,34,1,"B","T0",2)=""
^ONCO(165.8,34,1,"B","T1",3)=""
^ONCO(165.8,34,1,"B","T2",4)=""
^ONCO(165.8,34,1,"B","T3",5)=""
^ONCO(165.8,34,1,"B","T4",6)=""
^ONCO(165.8,34,1,"B","TX",1)=""
^ONCO(165.8,35,0)="33^Neuroendocrine Tumors of the Colon and Rectum^^14^29"
^ONCO(165.8,35,1,0)="^165.82IA^8^8"
^ONCO(165.8,35,1,1,0)="TX"
^ONCO(165.8,35,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,35,1,2,0)="T0"
^ONCO(165.8,35,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,35,1,3,0)="T1"
^ONCO(165.8,35,1,3,1)="Tumor invades the lamina propria or submucosa and is <= 2cm"
^ONCO(165.8,35,1,4,0)="T1a"
^ONCO(165.8,35,1,4,1)="Tumor < 1cm in greatest dimension"
^ONCO(165.8,35,1,5,0)="T1b"
^ONCO(165.8,35,1,5,1)="Tumor 1-2cm in greatest dimension"
^ONCO(165.8,35,1,6,0)="T2"
^ONCO(165.8,35,1,6,1)="Tumor invades the muscularis propria or is >2 cm with invasion of the lamina propria or submucosa"
^ONCO(165.8,35,1,7,0)="T3"
^ONCO(165.8,35,1,7,1)="Tumor invades through the muscularis propria into subserosal tissue without penetration of overlying serosa"
^ONCO(165.8,35,1,8,0)="T4"
^ONCO(165.8,35,1,8,1)="Tumor invades the visceral peritoneum (serosa) or other organs or adjacent structures"
^ONCO(165.8,35,1,"B","T0",2)=""
^ONCO(165.8,35,1,"B","T1",3)=""
^ONCO(165.8,35,1,"B","T1a",4)=""
^ONCO(165.8,35,1,"B","T1b",5)=""
^ONCO(165.8,35,1,"B","T2",6)=""
^ONCO(165.8,35,1,"B","T3",7)=""
^ONCO(165.8,35,1,"B","T4",8)=""
^ONCO(165.8,35,1,"B","TX",1)=""
^ONCO(165.8,36,0)="34^Neuroendocrine Tumors of the Pancreas^^30^29"
^ONCO(165.8,36,1,0)="^165.82IA^5^5"
^ONCO(165.8,36,1,1,0)="TX"
^ONCO(165.8,36,1,1,1)="Tumor cannot be assessed"
^ONCO(165.8,36,1,2,0)="T1"
^ONCO(165.8,36,1,2,1)="Tumor limited to the pancreas, < 2cm"
^ONCO(165.8,36,1,3,0)="T2"
^ONCO(165.8,36,1,3,1)="Tumor limited to the pancreas, 2-4cm"
^ONCO(165.8,36,1,4,0)="T3"
^ONCO(165.8,36,1,4,1)="Tumor limited to the pancreas, > 4cm; or tumor invading the duodenum or common bile duct"
^ONCO(165.8,36,1,5,0)="T4"
^ONCO(165.8,36,1,5,1)="Tumor invading adjacent organs (stomach, spleen, colon, adrenal gland) or the wall of large vessels (celiac axis or the superior mesenteric artery)"
^ONCO(165.8,36,1,"B","T1",2)=""
^ONCO(165.8,36,1,"B","T2",3)=""
^ONCO(165.8,36,1,"B","T3",4)=""
^ONCO(165.8,36,1,"B","T4",5)=""
^ONCO(165.8,36,1,"B","TX",1)=""
^ONCO(165.8,37,0)="35^Thymus"
^ONCO(165.8,37,1,0)="^165.82IA^8^8"
^ONCO(165.8,37,1,1,0)="TX"
^ONCO(165.8,37,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,37,1,2,0)="T0"
^ONCO(165.8,37,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,37,1,3,0)="T1"
^ONCO(165.8,37,1,3,1)="Tumor encapsulated or extending into the mediastinal fat; may involve the mediastinal pleura"
^ONCO(165.8,37,1,4,0)="T1a"
^ONCO(165.8,37,1,4,1)="Tumor with no mediastinal pleura involvement"
^ONCO(165.8,37,1,5,0)="T1b"
^ONCO(165.8,37,1,5,1)="Tumor with direct invasion of mediastinal pleura"
^ONCO(165.8,37,1,6,0)="T2"
^ONCO(165.8,37,1,6,1)="Tumor with direct invasion of the pericardium (either partial or full thickness)"
^ONCO(165.8,37,1,7,0)="T3"
^ONCO(165.8,37,1,7,1)="Tumor with direct invasion into any of the following: lung, brachiocephalic vein, superior vena cava, phrenic nerve, chest wall, or extrapericardial pulmonary artery or veins"
^ONCO(165.8,37,1,8,0)="T4"
^ONCO(165.8,37,1,8,1)="Tumor with invasion into any of the following: aorta (ascending, arch, or descending), arch vessels, intrapericardial pulmonary artery, myocardium, trachea, esophagus"
^ONCO(165.8,37,1,"B","T0",2)=""
^ONCO(165.8,37,1,"B","T1",3)=""
^ONCO(165.8,37,1,"B","T1a",4)=""
^ONCO(165.8,37,1,"B","T1b",5)=""
^ONCO(165.8,37,1,"B","T2",6)=""
^ONCO(165.8,37,1,"B","T3",7)=""
^ONCO(165.8,37,1,"B","T4",8)=""
^ONCO(165.8,37,1,"B","TX",1)=""
^ONCO(165.8,37,2,0)="^165.83IA^4^4"
^ONCO(165.8,37,2,1,0)="NX"
^ONCO(165.8,37,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,37,2,2,0)="N0"
^ONCO(165.8,37,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,37,2,3,0)="N1"
^ONCO(165.8,37,2,3,1)="Metastasis in anterior (perithymic) lymph nodes"
^ONCO(165.8,37,2,4,0)="N2"
^ONCO(165.8,37,2,4,1)="Metastasis in deep intrathoracic or cervical lymph nodes"
^ONCO(165.8,37,2,"B","N0",2)=""
^ONCO(165.8,37,2,"B","N1",3)=""
^ONCO(165.8,37,2,"B","N2",4)=""
^ONCO(165.8,37,2,"B","NX",1)=""
^ONCO(165.8,37,3,0)="^165.84IA^7^7"
^ONCO(165.8,37,3,1,0)="cM0"
^ONCO(165.8,37,3,1,1)="No pleural, pericardial, or distant metastasis"
^ONCO(165.8,37,3,2,0)="cM1"
^ONCO(165.8,37,3,2,1)="Pleural, pericardial, or distant metastasis"
^ONCO(165.8,37,3,3,0)="cM1a"
^ONCO(165.8,37,3,3,1)="Separate pleural or pericardial nodule(s)"
^ONCO(165.8,37,3,4,0)="cM1b"
^ONCO(165.8,37,3,4,1)="Pulmonary intraparenchymal nodule or distant organ metastasis"
^ONCO(165.8,37,3,5,0)="pM1"
^ONCO(165.8,37,3,5,1)="Pleural, pericardial, or distant metastasis, microscopically confirmed"
^ONCO(165.8,37,3,6,0)="pM1a"
^ONCO(165.8,37,3,6,1)="Separate pleural or pericardial nodule(s), microscopically confirmed"
^ONCO(165.8,37,3,7,0)="pM1b"
^ONCO(165.8,37,3,7,1)="Pulmonary intraparenchymal nodule or distant organ metastasis, microscopically confirmed"
^ONCO(165.8,37,3,"B","cM0",1)=""
^ONCO(165.8,37,3,"B","cM1",2)=""
^ONCO(165.8,37,3,"B","cM1a",3)=""
^ONCO(165.8,37,3,"B","cM1b",4)=""
^ONCO(165.8,37,3,"B","pM1",5)=""
^ONCO(165.8,37,3,"B","pM1a",6)=""
^ONCO(165.8,37,3,"B","pM1b",7)=""
^ONCO(165.8,38,0)="36^Lung"
^ONCO(165.8,38,1,0)="^165.82IA^13^13"
^ONCO(165.8,38,1,1,0)="TX"
^ONCO(165.8,38,1,1,1)="Primary tumor cannot be assessed, or tumor proven by the presence of malignant cells in sputum or bronchial washings but not visualized by imaging or bronchoscopy"
^ONCO(165.8,38,1,2,0)="T0"
^ONCO(165.8,38,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,38,1,3,0)="Tis"
^ONCO(165.8,38,1,3,1)="Carcinoma is situ; Squamous cell carcinoma in situ (SCIS); Adenocarcinoma in situ (AIS): adenocarcinoma with pure lepidic pattern, <= 3cm in greatest dimension"
^ONCO(165.8,38,1,4,0)="T1"
^ONCO(165.8,38,1,4,1)="Tumor <= 3cm in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus)"
^ONCO(165.8,38,1,5,0)="T1mi"
^ONCO(165.8,38,1,5,1)="Minimally invasive adenocarcinoma: adenocarcinoma (<= 3cm in greatest dimension) with a predominantly lepidic pattern and <= 5mm invasion in greatest dimension"
^ONCO(165.8,38,1,6,0)="T1a"
^ONCO(165.8,38,1,6,1)="Tumor <= 1cm in greatest dimension. A superficial, spreading tumor of any size whose invasive component is limited to the bronchial wall and may extend proximal to the main bronchus also is classified as T1a, but these tumors are uncommon"
^ONCO(165.8,38,1,7,0)="T1b"
^ONCO(165.8,38,1,7,1)="Tumor > 1cm but <= 2cm in greatest dimension"
^ONCO(165.8,38,1,8,0)="T1c"
^ONCO(165.8,38,1,8,1)="Tumor > 2cm but <= 3cm in greatest dimension"
^ONCO(165.8,38,1,9,0)="T2"
^ONCO(165.8,38,1,9,1)="Tumor >3 cm but <= 5cm or having any of the following features: Involves the main bronchus regardless of distance to the carina, but without involvement of the carina/Invades visceral pleura (PL1 or PL2)/Associated with atelectasis or obstructive pneumonitis that extends to the hilar region, involving part or all of the lung"
^ONCO(165.8,38,1,10,0)="T2a"
^ONCO(165.8,38,1,10,1)="Tumor > 3cm but <= 4cm in greatest dimension"
^ONCO(165.8,38,1,11,0)="T2b"
^ONCO(165.8,38,1,11,1)="Tumor > 4cm but <= 5cm in greatest dimension"
^ONCO(165.8,38,1,12,0)="T3"
^ONCO(165.8,38,1,12,1)="Tumor > 5cm but <= 7cm in greatest dimension or directly invading any of the following: parietal pleura (PL3), chest wall (including superior sulcus tumors), phrenic nerve, parietal pericardium; or separate tumor nodule(s) in the same lobe as the primary"
^ONCO(165.8,38,1,13,0)="T4"
^ONCO(165.8,38,1,13,1)="Tumor > 7cm or tumor of any size invading one or more of the following: diaphragm, mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, or carina; separate tumor nodule(s) in an ipsilateral node different from that of the primary"
^ONCO(165.8,38,1,"B","T0",2)=""
^ONCO(165.8,38,1,"B","T1",4)=""
^ONCO(165.8,38,1,"B","T1a",6)=""
^ONCO(165.8,38,1,"B","T1b",7)=""
^ONCO(165.8,38,1,"B","T1c",8)=""
^ONCO(165.8,38,1,"B","T1mi",5)=""
^ONCO(165.8,38,1,"B","T2",9)=""
^ONCO(165.8,38,1,"B","T2a",10)=""
^ONCO(165.8,38,1,"B","T2b",11)=""
^ONCO(165.8,38,1,"B","T3",12)=""
^ONCO(165.8,38,1,"B","T4",13)=""
^ONCO(165.8,38,1,"B","TX",1)=""
^ONCO(165.8,38,1,"B","Tis",3)=""
^ONCO(165.8,38,2,0)="^165.83IA^5^5"
^ONCO(165.8,38,2,1,0)="NX"
^ONCO(165.8,38,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,38,2,2,0)="N0"
^ONCO(165.8,38,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,38,2,3,0)="N1"
^ONCO(165.8,38,2,3,1)="Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension"
^ONCO(165.8,38,2,4,0)="N2"
^ONCO(165.8,38,2,4,1)="Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s)"
^ONCO(165.8,38,2,5,0)="N3"
^ONCO(165.8,38,2,5,1)="Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s)"
^ONCO(165.8,38,2,"B","N0",2)=""
^ONCO(165.8,38,2,"B","N1",3)=""
^ONCO(165.8,38,2,"B","N2",4)=""
^ONCO(165.8,38,2,"B","N3",5)=""
^ONCO(165.8,38,2,"B","NX",1)=""
^ONCO(165.8,38,3,0)="^165.84IA^9^9"
^ONCO(165.8,38,3,1,0)="cM0"
^ONCO(165.8,38,3,1,1)="No distant metastasis"
^ONCO(165.8,38,3,2,0)="cM1"
^ONCO(165.8,38,3,2,1)="Distant metastasis"
^ONCO(165.8,38,3,3,0)="cM1a"
^ONCO(165.8,38,3,3,1)="Separate tumor nodule(s) in a contralateral lobe; tumor with pleural or pericardial nodules or malignant pleural or pericardial effusion. Most pleural (pericardial) effusions with lung cancer are a result of the tumor."
^ONCO(165.8,38,3,4,0)="cM1b"
^ONCO(165.8,38,3,4,1)="Single extrathoracic metastasis in a single organ (including involvement of a single nonregional node)"
^ONCO(165.8,38,3,5,0)="cM1c"
^ONCO(165.8,38,3,5,1)="Multiple extrathoracic metastases in a single organ or in multiple organs"
^ONCO(165.8,38,3,6,0)="pM1"
^ONCO(165.8,38,3,6,1)="Distant metastasis, microscopically confirmed"
^ONCO(165.8,38,3,7,0)="pM1a"
^ONCO(165.8,38,3,7,1)="Separate tumor nodule(s) in a contralateral lobe; tumor with pleural or pericardial nodules or malignant pleural or pericardial effusion, microscopically confirmed. Most pleural (pericardial) effusions with lung cancer are a result of the tumor."
^ONCO(165.8,38,3,8,0)="pM1b"
^ONCO(165.8,38,3,8,1)="Single extrathoracic metastasis in a single organ (including involvement of a single nonregional node), microscopically confirmed"
^ONCO(165.8,38,3,9,0)="pM1c"
^ONCO(165.8,38,3,9,1)="Multiple extrathoracic metastases in a single organ or in multiple organs, microscopically confirmed"
^ONCO(165.8,38,3,"B","cM0",1)=""
^ONCO(165.8,38,3,"B","cM1",2)=""
^ONCO(165.8,38,3,"B","cM1a",3)=""
^ONCO(165.8,38,3,"B","cM1b",4)=""
^ONCO(165.8,38,3,"B","cM1c",5)=""
^ONCO(165.8,38,3,"B","pM1",6)=""
^ONCO(165.8,38,3,"B","pM1a",7)=""
^ONCO(165.8,38,3,"B","pM1b",8)=""
^ONCO(165.8,38,3,"B","pM1c",9)=""
^ONCO(165.8,39,0)="37^Malignant Pleural Mesothelioma^^^6"
^ONCO(165.8,39,1,0)="^165.82IA^6^6"
^ONCO(165.8,39,1,1,0)="TX"
^ONCO(165.8,39,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,39,1,2,0)="T0"
^ONCO(165.8,39,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,39,1,3,0)="T1"
^ONCO(165.8,39,1,3,1)="Tumor limited to the ipsilateral parietal pleura with or without involvement of visceral pleura/mediastinal pleura/diaphragmatic pleura"
^ONCO(165.8,39,1,4,0)="T2"
^ONCO(165.8,39,1,4,1)="Tumor involving each of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features: involvement of diaphragmatic muscle/extension of tumor from visceral pleura into the underlying pulmonary parenchyma"
^ONCO(165.8,39,1,5,0)="T3"
^ONCO(165.8,39,1,5,1)="Describes locally advanced but potentially resectable tumor"
^ONCO(165.8,39,1,6,0)="T4"
^ONCO(165.8,39,1,6,1)="Describes locally advanced technically unresectable tumor"
^ONCO(165.8,39,1,"B","T0",2)=""
^ONCO(165.8,39,1,"B","T1",3)=""
^ONCO(165.8,39,1,"B","T2",4)=""
^ONCO(165.8,39,1,"B","T3",5)=""
^ONCO(165.8,39,1,"B","T4",6)=""
^ONCO(165.8,39,1,"B","TX",1)=""
^ONCO(165.8,39,2,0)="^165.83IA^4^4"
^ONCO(165.8,39,2,1,0)="NX"
^ONCO(165.8,39,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,39,2,2,0)="N0"
^ONCO(165.8,39,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,39,2,3,0)="N1"
^ONCO(165.8,39,2,3,1)="Metastases in the ipsilateral bronchopulmonary, hilar, or mediastinal (including the internal mammary, peridiaphragmatic, pericardial fat pad, or intercostal) lymph nodes"
^ONCO(165.8,39,2,4,0)="N2"
^ONCO(165.8,39,2,4,1)="Metastases in the contralateral mediastinal, ipsilateral, or contralateral supraclavicular lymph nodes"
^ONCO(165.8,39,2,"B","N0",2)=""
^ONCO(165.8,39,2,"B","N1",3)=""
^ONCO(165.8,39,2,"B","N2",4)=""
^ONCO(165.8,39,2,"B","NX",1)=""
^ONCO(165.8,40,0)="38.1^Bone: Appendicular Skeleton, Trunk, Skull and Facial Bones"
^ONCO(165.8,40,1,0)="^165.82IA^5^5"
^ONCO(165.8,40,1,1,0)="TX"
^ONCO(165.8,40,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,40,1,2,0)="T0"
^ONCO(165.8,40,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,40,1,3,0)="T1"
^ONCO(165.8,40,1,3,1)="Tumor <= 8cm in greatest dimension"
^ONCO(165.8,40,1,4,0)="T2"
^ONCO(165.8,40,1,4,1)="Tumor > 8cm in greatest dimension"
^ONCO(165.8,40,1,5,0)="T3"
^ONCO(165.8,40,1,5,1)="Discontinous tumors in the primary bone site"
^ONCO(165.8,40,1,"B","T0",2)=""
^ONCO(165.8,40,1,"B","T1",3)=""
^ONCO(165.8,40,1,"B","T2",4)=""
^ONCO(165.8,40,1,"B","T3",5)=""
^ONCO(165.8,40,1,"B","TX",1)=""
^ONCO(165.8,40,2,0)="^165.83IA^3^3"
^ONCO(165.8,40,2,1,0)="NX"
^ONCO(165.8,40,2,1,1)="Regional lymph nodes cannot be assessed; Because of the rarity of lymph node involvement in bone sarcomas, the designation NX may not be appropriate, and cases should be considered NO unless clinical node involvement clearly is evident"
^ONCO(165.8,40,2,2,0)="N0"
^ONCO(165.8,40,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,40,2,3,0)="N1"
^ONCO(165.8,40,2,3,1)="Regional lymph node metastasis"
^ONCO(165.8,40,2,"B","N0",2)=""
^ONCO(165.8,40,2,"B","N1",3)=""
^ONCO(165.8,40,2,"B","NX",1)=""
^ONCO(165.8,40,3,0)="^165.84IA^7^7"
^ONCO(165.8,40,3,1,0)="cM0"
^ONCO(165.8,40,3,1,1)="No distant metastasis"
^ONCO(165.8,40,3,2,0)="cM1"
^ONCO(165.8,40,3,2,1)="Distant metastasis"
^ONCO(165.8,40,3,3,0)="cM1a"
^ONCO(165.8,40,3,3,1)="Lung"
^ONCO(165.8,40,3,4,0)="cM1b"
^ONCO(165.8,40,3,4,1)="Bone or other distant sites"
^ONCO(165.8,40,3,5,0)="pM1"
^ONCO(165.8,40,3,5,1)="Distant metastasis, microscopically confirmed"
^ONCO(165.8,40,3,6,0)="pM1a"
^ONCO(165.8,40,3,6,1)="Lung, microscopically confirmed"
^ONCO(165.8,40,3,7,0)="pM1b"
^ONCO(165.8,40,3,7,1)="Bone or other distant sites. Microscopically confirmed"
^ONCO(165.8,40,3,"B","cM0",1)=""
^ONCO(165.8,40,3,"B","cM1",2)=""
^ONCO(165.8,40,3,"B","cM1a",3)=""
^ONCO(165.8,40,3,"B","cM1b",4)=""
^ONCO(165.8,40,3,"B","pM1",5)=""
^ONCO(165.8,40,3,"B","pM1a",6)=""
^ONCO(165.8,40,3,"B","pM1b",7)=""
^ONCO(165.8,41,0)="38.2^Bone: Spine^^38.1^38.1"
^ONCO(165.8,41,1,0)="^165.82IA^8^8"
^ONCO(165.8,41,1,1,0)="TX"
^ONCO(165.8,41,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,41,1,2,0)="T0"
^ONCO(165.8,41,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,41,1,3,0)="T1"
^ONCO(165.8,41,1,3,1)="Tumor confined to one vertebral segment or two adjacent vertebral segments"
^ONCO(165.8,41,1,4,0)="T2"
^ONCO(165.8,41,1,4,1)="Tumor confined to three adjacent vertebral segments"
^ONCO(165.8,41,1,5,0)="T3"
^ONCO(165.8,41,1,5,1)="Tumor confined to four or more adjacent vertebral segments, or any nonadjacent vertebral segments"
^ONCO(165.8,41,1,6,0)="T4"
^ONCO(165.8,41,1,6,1)="Extension into the spinal canal or great vessels"
^ONCO(165.8,41,1,7,0)="T4a"
^ONCO(165.8,41,1,7,1)="Extension into the spinal canal"
^ONCO(165.8,41,1,8,0)="T4b"
^ONCO(165.8,41,1,8,1)="Evidence of gross vascular invasion or tumor thrombus in the great vessels"
^ONCO(165.8,41,1,"B","T0",2)=""
^ONCO(165.8,41,1,"B","T1",3)=""
^ONCO(165.8,41,1,"B","T2",4)=""
^ONCO(165.8,41,1,"B","T3",5)=""
^ONCO(165.8,41,1,"B","T4",6)=""
^ONCO(165.8,41,1,"B","T4a",7)=""
^ONCO(165.8,41,1,"B","T4b",8)=""
^ONCO(165.8,41,1,"B","TX",1)=""
^ONCO(165.8,42,0)="38.3^Bone: Pelvis^^38.1^38.1"
^ONCO(165.8,42,1,0)="^165.82IA^14^14"
^ONCO(165.8,42,1,1,0)="TX"
^ONCO(165.8,42,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,42,1,2,0)="T0"
^ONCO(165.8,42,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,42,1,3,0)="T1"
^ONCO(165.8,42,1,3,1)="Tumor confined to one pelvic segment with no extraosseous extension"
^ONCO(165.8,42,1,4,0)="T1a"
^ONCO(165.8,42,1,4,1)="Tumor <= 8cm in greatest dimension"
^ONCO(165.8,42,1,5,0)="T1b"
^ONCO(165.8,42,1,5,1)="Tumor > 8cm in greatest dimension"
^ONCO(165.8,42,1,6,0)="T2"
^ONCO(165.8,42,1,6,1)="Tumor confined to one pelvic segment with extraosseous extension or two segments without extraosseous extension"
^ONCO(165.8,42,1,7,0)="T2a"
^ONCO(165.8,42,1,7,1)="Tumor <= 8cm in greatest dimension"
^ONCO(165.8,42,1,8,0)="T2b"
^ONCO(165.8,42,1,8,1)="Tumor > 8cm in greatest dimension"
^ONCO(165.8,42,1,9,0)="T3"
^ONCO(165.8,42,1,9,1)="Tumor spanning two pelvic segments with extraosseous extension"
^ONCO(165.8,42,1,10,0)="T3a"
^ONCO(165.8,42,1,10,1)="Tumor <= 8cm in greatest dimension"
^ONCO(165.8,42,1,11,0)="T3b"
^ONCO(165.8,42,1,11,1)="Tumor > 8cm in greatest dimension"
^ONCO(165.8,42,1,12,0)="T4"
^ONCO(165.8,42,1,12,1)="Tumor spanning three pelvic segments or crossing the sacroiliac joint"
^ONCO(165.8,42,1,13,0)="T4a"
^ONCO(165.8,42,1,13,1)="Tumor involves sacroiliac joint and extends medial to the sacral neuroforamen"
^ONCO(165.8,42,1,14,0)="T4b"
^ONCO(165.8,42,1,14,1)="Tumor encasement of external iliac vessels or presence of gross tumor thrombus in major pelvic vessels"
^ONCO(165.8,42,1,"B","T0",2)=""
^ONCO(165.8,42,1,"B","T1",3)=""
^ONCO(165.8,42,1,"B","T1a",4)=""
^ONCO(165.8,42,1,"B","T1b",5)=""
^ONCO(165.8,42,1,"B","T2",6)=""
^ONCO(165.8,42,1,"B","T2a",7)=""
^ONCO(165.8,42,1,"B","T2b",8)=""
^ONCO(165.8,42,1,"B","T3",9)=""
^ONCO(165.8,42,1,"B","T3a",10)=""
^ONCO(165.8,42,1,"B","T3b",11)=""
^ONCO(165.8,42,1,"B","T4",12)=""
^ONCO(165.8,42,1,"B","T4a",13)=""
^ONCO(165.8,42,1,"B","T4b",14)=""
^ONCO(165.8,42,1,"B","TX",1)=""
^ONCO(165.8,43,0)="40^Soft Tissue Sarcoma of the Head and Neck^^^6"
^ONCO(165.8,43,1,0)="^165.82IA^7^7"
^ONCO(165.8,43,1,1,0)="TX"
^ONCO(165.8,43,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,43,1,2,0)="T1"
^ONCO(165.8,43,1,2,1)="Tumor <= 2cm"
^ONCO(165.8,43,1,3,0)="T2"
^ONCO(165.8,43,1,3,1)="Tumor > 2cm and <= 4cm"
^ONCO(165.8,43,1,4,0)="T3"
^ONCO(165.8,43,1,4,1)="Tumor > 4cm"
^ONCO(165.8,43,1,5,0)="T4"
^ONCO(165.8,43,1,5,1)="Tumor with invasion of adjoining structures"
^ONCO(165.8,43,1,6,0)="T4a"
^ONCO(165.8,43,1,6,1)="Tumor with orbital invasion, skull base/dural invasion, invasion of central compartment viscera, involvement of facial skeleton, or invasion of pterygoid muscles"
^ONCO(165.8,43,1,7,0)="T4b"
^ONCO(165.8,43,1,7,1)="Tumor with brain parenchymal invasion, carotid artery encasement, prevertebral muscle invasion, or central nervous system involvement via perineural spread"
^ONCO(165.8,43,1,"B","T1",2)=""
^ONCO(165.8,43,1,"B","T2",3)=""
^ONCO(165.8,43,1,"B","T3",4)=""
^ONCO(165.8,43,1,"B","T4",5)=""
^ONCO(165.8,43,1,"B","T4a",6)=""
^ONCO(165.8,43,1,"B","T4b",7)=""
^ONCO(165.8,43,1,"B","TX",1)=""
^ONCO(165.8,43,2,0)="^165.83IA^2^2"
^ONCO(165.8,43,2,1,0)="N0"
^ONCO(165.8,43,2,1,1)="No regional lymph node metastases or unknown lymph node status"
^ONCO(165.8,43,2,2,0)="N1"
^ONCO(165.8,43,2,2,1)="Regional lymph node metastasis"
^ONCO(165.8,43,2,"B","N0",1)=""
^ONCO(165.8,43,2,"B","N1",2)=""
^ONCO(165.8,44,0)="41^Soft Tissue Sarcoma of the Trunk and Extremities^^40^6"
^ONCO(165.8,44,1,0)="^165.82IA^6^6"
^ONCO(165.8,44,1,1,0)="TX"
^ONCO(165.8,44,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,44,1,2,0)="T0"
^ONCO(165.8,44,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,44,1,3,0)="T1"
^ONCO(165.8,44,1,3,1)="Tumor 5cm or less in greatest dimension"
^ONCO(165.8,44,1,4,0)="T2"
^ONCO(165.8,44,1,4,1)="Tumor more than 5cm and less than or equal to 10cm in greatest dimension"
^ONCO(165.8,44,1,5,0)="T3"
^ONCO(165.8,44,1,5,1)="Tumor more than 10cm and less than or equal to 15cm in greatest dimension"
^ONCO(165.8,44,1,6,0)="T4"
^ONCO(165.8,44,1,6,1)="Tumor more than 15cm in greatest dimension"
^ONCO(165.8,44,1,"B","T0",2)=""
^ONCO(165.8,44,1,"B","T1",3)=""
^ONCO(165.8,44,1,"B","T2",4)=""
^ONCO(165.8,44,1,"B","T3",5)=""
^ONCO(165.8,44,1,"B","T4",6)=""
^ONCO(165.8,44,1,"B","TX",1)=""
^ONCO(165.8,45,0)="42^Soft Tissue Sarcoma of the Abdomen and Thoracic Visceral Organs^^40^6"
^ONCO(165.8,45,1,0)="^165.82IA^10^10"
^ONCO(165.8,45,1,1,0)="TX"
^ONCO(165.8,45,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,45,1,2,0)="T1"
^ONCO(165.8,45,1,2,1)="Organ confined"
^ONCO(165.8,45,1,3,0)="T2"
^ONCO(165.8,45,1,3,1)="Tumor extension into tissue beyond organ"
^ONCO(165.8,45,1,4,0)="T2a"
^ONCO(165.8,45,1,4,1)="Invades serosa or visceral peritoneum"
^ONCO(165.8,45,1,5,0)="T2b"
^ONCO(165.8,45,1,5,1)="Extension beyond serosa (mesentery)"
^ONCO(165.8,45,1,6,0)="T3"
^ONCO(165.8,45,1,6,1)="Invades another organ"
^ONCO(165.8,45,1,7,0)="T4"
^ONCO(165.8,45,1,7,1)="Multifocal involvement"
^ONCO(165.8,45,1,8,0)="T4a"
^ONCO(165.8,45,1,8,1)="Multifocal (2 sites)"
^ONCO(165.8,45,1,9,0)="T4b"
^ONCO(165.8,45,1,9,1)="Multifocal (3-5 sites)"
^ONCO(165.8,45,1,10,0)="T4c"
^ONCO(165.8,45,1,10,1)="Multifocal (> 5 sites)"
^ONCO(165.8,45,1,"B","T1",2)=""
^ONCO(165.8,45,1,"B","T2",3)=""
^ONCO(165.8,45,1,"B","T2a",4)=""
^ONCO(165.8,45,1,"B","T2b",5)=""
^ONCO(165.8,45,1,"B","T3",6)=""
^ONCO(165.8,45,1,"B","T4",7)=""
^ONCO(165.8,45,1,"B","T4a",8)=""
^ONCO(165.8,45,1,"B","T4b",9)=""
^ONCO(165.8,45,1,"B","T4c",10)=""
^ONCO(165.8,45,1,"B","TX",1)=""
^ONCO(165.8,46,0)="43.1^Gastrointestinal Stromal Tumor: Gastric and Omental GIST^^40^6"
^ONCO(165.8,46,1,0)="^165.82IA^6^6"
^ONCO(165.8,46,1,1,0)="TX"
^ONCO(165.8,46,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,46,1,2,0)="T0"
^ONCO(165.8,46,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,46,1,3,0)="T1"
^ONCO(165.8,46,1,3,1)="Tumor 2cm or less"
^ONCO(165.8,46,1,4,0)="T2"
^ONCO(165.8,46,1,4,1)="Tumor more than 2cm but not more than 5cm"
^ONCO(165.8,46,1,5,0)="T3"
^ONCO(165.8,46,1,5,1)="Tumor more than 5cm but not more than 10cm"
^ONCO(165.8,46,1,6,0)="T4"
^ONCO(165.8,46,1,6,1)="Tumor more than 10am in greatest dimension"
^ONCO(165.8,46,1,"B","T0",2)=""
^ONCO(165.8,46,1,"B","T1",3)=""
^ONCO(165.8,46,1,"B","T2",4)=""
^ONCO(165.8,46,1,"B","T3",5)=""
^ONCO(165.8,46,1,"B","T4",6)=""
^ONCO(165.8,46,1,"B","TX",1)=""
^ONCO(165.8,47,0)="43.2^Gastrointestinal Stromal Tumor: Small Intestinal, Esophageal, Colorectal, ^^40^6"
^ONCO(165.8,47,1,0)="^165.82IA^6^6"
^ONCO(165.8,47,1,1,0)="TX"
^ONCO(165.8,47,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,47,1,2,0)="T0"
^ONCO(165.8,47,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,47,1,3,0)="T1"
^ONCO(165.8,47,1,3,1)="Tumor 2cm or less"
^ONCO(165.8,47,1,4,0)="T2"
^ONCO(165.8,47,1,4,1)="Tumor more than 2cm but not more than 5cm"
^ONCO(165.8,47,1,5,0)="T3"
^ONCO(165.8,47,1,5,1)="Tumor more than 5cm but not more than 10cm"
^ONCO(165.8,47,1,6,0)="T4"
^ONCO(165.8,47,1,6,1)="Tumor more than 10cm in greatest dimension "
^ONCO(165.8,47,1,"B","T0",2)=""
^ONCO(165.8,47,1,"B","T1",3)=""
^ONCO(165.8,47,1,"B","T2",4)=""
^ONCO(165.8,47,1,"B","T3",5)=""
^ONCO(165.8,47,1,"B","T4",6)=""
^ONCO(165.8,47,1,"B","TX",1)=""
^ONCO(165.8,48,0)="44^Soft Tissue Sarcoma of the Retroperitoneum^^40^6"
^ONCO(165.8,48,1,0)="^165.82IA^6^6"
^ONCO(165.8,48,1,1,0)="TX"
^ONCO(165.8,48,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,48,1,2,0)="T0"
^ONCO(165.8,48,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,48,1,3,0)="T1"
^ONCO(165.8,48,1,3,1)="Tumor 5cm or less in greatest dimension"
^ONCO(165.8,48,1,4,0)="T2"
^ONCO(165.8,48,1,4,1)="Tumor more than 5cm and less than or equal to 10cm in greatest dimension"
^ONCO(165.8,48,1,5,0)="T3"
^ONCO(165.8,48,1,5,1)="Tumor more than 10cm and less than or equal to 15cm in greatest dimension"
^ONCO(165.8,48,1,6,0)="T4"
^ONCO(165.8,48,1,6,1)="Tumor more than 15cm in greatest dimension "
^ONCO(165.8,48,1,"B","T0",2)=""
^ONCO(165.8,48,1,"B","T1",3)=""
^ONCO(165.8,48,1,"B","T2",4)=""
^ONCO(165.8,48,1,"B","T3",5)=""
^ONCO(165.8,48,1,"B","T4",6)=""
^ONCO(165.8,48,1,"B","TX",1)=""
^ONCO(165.8,49,0)="45^Soft Tissue Sarcoma - Unusual Histologies and Sites"
^ONCO(165.8,50,0)="46^Merkel Cell Carcinoma"
^ONCO(165.8,50,1,0)="^165.82IA^7^7"
^ONCO(165.8,50,1,1,0)="TX"
^ONCO(165.8,50,1,1,1)="Primary tumor cannot be assessed (e.g. curetted)"
^ONCO(165.8,50,1,2,0)="T0"
^ONCO(165.8,50,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,50,1,3,0)="Tis"
^ONCO(165.8,50,1,3,1)="In situ primary tumor"
^ONCO(165.8,50,1,4,0)="T1"
^ONCO(165.8,50,1,4,1)="Maximum clinical tumor diameter <= 2cm"
^ONCO(165.8,50,1,5,0)="T2"
^ONCO(165.8,50,1,5,1)="Maximum clinical tumor diameter > 2cm but <= 5cm"
^ONCO(165.8,50,1,6,0)="T3"
^ONCO(165.8,50,1,6,1)="Maximum clinical tumor diameter > 5cm"
^ONCO(165.8,50,1,7,0)="T4"
^ONCO(165.8,50,1,7,1)="Primary tumor invades fascia, muscle, cartilage or bone"
^ONCO(165.8,50,1,"B","T0",2)=""
^ONCO(165.8,50,1,"B","T1",4)=""
^ONCO(165.8,50,1,"B","T2",5)=""
^ONCO(165.8,50,1,"B","T3",6)=""
^ONCO(165.8,50,1,"B","T4",7)=""
^ONCO(165.8,50,1,"B","TX",1)=""
^ONCO(165.8,50,1,"B","Tis",3)=""
^ONCO(165.8,50,2,0)="^165.83IA^5^5"
^ONCO(165.8,50,2,1,0)="NX"
^ONCO(165.8,50,2,1,1)="Regional lymph nodes cannot be clinically assessed (e.g., previously removed for another reason, or because of body habitus)"
^ONCO(165.8,50,2,2,0)="N0"
^ONCO(165.8,50,2,2,1)="No regional lymph node metastasis detected on clinical and/or radiologic examination"
^ONCO(165.8,50,2,3,0)="N1"
^ONCO(165.8,50,2,3,1)="Metastasis in regional lymph node(s)"
^ONCO(165.8,50,2,4,0)="N2"
^ONCO(165.8,50,2,4,1)="In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) without lymph node metastasis"
^ONCO(165.8,50,2,5,0)="N3"
^ONCO(165.8,50,2,5,1)="In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) with lymph node metastasis"
^ONCO(165.8,50,2,"B","N0",2)=""
^ONCO(165.8,50,2,"B","N1",3)=""
^ONCO(165.8,50,2,"B","N2",4)=""
^ONCO(165.8,50,2,"B","N3",5)=""
^ONCO(165.8,50,2,"B","NX",1)=""
^ONCO(165.8,50,3,0)="^165.84IA^9^9"
^ONCO(165.8,50,3,1,0)="cM0"
^ONCO(165.8,50,3,1,1)="No distant metastasis detected on clinical and/or radiologic examination"
^ONCO(165.8,50,3,2,0)="cM1"
^ONCO(165.8,50,3,2,1)="Distant metastasis detected on clinical and/or radiologic examination"
^ONCO(165.8,50,3,3,0)="cM1a"
^ONCO(165.8,50,3,3,1)="Metastasis to distant skin, distant subcutaneous tissue, or distant lymph node(s)"
^ONCO(165.8,50,3,4,0)="cM1b"
^ONCO(165.8,50,3,4,1)="Metastasis to lung"
^ONCO(165.8,50,3,5,0)="cM1c"
^ONCO(165.8,50,3,5,1)="Metastasis to all other visceral sites"
^ONCO(165.8,50,3,6,0)="pM1"
^ONCO(165.8,50,3,6,1)="Distant metastasis microscopically confirmed"
^ONCO(165.8,50,3,7,0)="pM1a"
^ONCO(165.8,50,3,7,1)="Metastasis to distant skin, distant subcutaneous tissue, or distant lymph node(s), microscopically confirmed"
^ONCO(165.8,50,3,8,0)="pM1b"
^ONCO(165.8,50,3,8,1)="Metastasis to lung, microscopically confirmed"
^ONCO(165.8,50,3,9,0)="pM1c"
^ONCO(165.8,50,3,9,1)="Metastasis to all other distant sites, microscopically confirmed"
^ONCO(165.8,50,3,"B","cM0",1)=""
^ONCO(165.8,50,3,"B","cM1",2)=""
^ONCO(165.8,50,3,"B","cM1a",3)=""
^ONCO(165.8,50,3,"B","cM1b",4)=""
^ONCO(165.8,50,3,"B","cM1c",5)=""
^ONCO(165.8,50,3,"B","pM1",6)=""
^ONCO(165.8,50,3,"B","pM1a",7)=""
^ONCO(165.8,50,3,"B","pM1b",8)=""
^ONCO(165.8,50,3,"B","pM1c",9)=""
^ONCO(165.8,50,7,0)="^165.88AI^7^7"
^ONCO(165.8,50,7,1,0)="NX"
^ONCO(165.8,50,7,1,1)="Regional lymph nodes cannot be assessed (e.g., previously removed for another reason or not removed for pathological evaluation)"
^ONCO(165.8,50,7,2,0)="N0"
^ONCO(165.8,50,7,2,1)="No regional lymph node metastasis detected on pathological evaluation"
^ONCO(165.8,50,7,3,0)="N1"
^ONCO(165.8,50,7,3,1)="Metastasis in regional lymph node(s)"
^ONCO(165.8,50,7,4,0)="N1a"
^ONCO(165.8,50,7,4,1)="Clinically occult regional lymph node metastasis identified only by sentinel lymph node biopsy"
^ONCO(165.8,50,7,5,0)="N1b"
^ONCO(165.8,50,7,5,1)="Clinically and/or radiologically detected regional lymph node metastasis"
^ONCO(165.8,50,7,6,0)="N2"
^ONCO(165.8,50,7,6,1)="In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) without lymph node metastasis"
^ONCO(165.8,50,7,7,0)="N3"
^ONCO(165.8,50,7,7,1)="In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) with lymph node metastasis"
^ONCO(165.8,50,7,"B","N0",2)=""
^ONCO(165.8,50,7,"B","N1",3)=""
^ONCO(165.8,50,7,"B","N1a",4)=""
^ONCO(165.8,50,7,"B","N1b",5)=""
^ONCO(165.8,50,7,"B","N2",6)=""
^ONCO(165.8,50,7,"B","N3",7)=""
^ONCO(165.8,50,7,"B","NX",1)=""
^ONCO(165.8,51,0)="47^Melanoma of the Skin"
^ONCO(165.8,51,1,0)="^165.82IA^16^15"
^ONCO(165.8,51,1,1,0)="TX"
^ONCO(165.8,51,1,1,1)="Primary tumor thickness cannot be assessed (e.g., diagnosis by curettage)"
^ONCO(165.8,51,1,2,0)="T0"
^ONCO(165.8,51,1,2,1)="No evidence of primary tumor (e.g., unknown primary or completely regressed melanoma)"
^ONCO(165.8,51,1,3,0)="Tis"
^ONCO(165.8,51,1,3,1)="Melanoma in situ"
^ONCO(165.8,51,1,4,0)="T1"
^ONCO(165.8,51,1,4,1)="<= 1.0mm"
^ONCO(165.8,51,1,5,0)="T1a"
^ONCO(165.8,51,1,5,1)="< 0.8mm (without ulceration)"
^ONCO(165.8,51,1,6,0)="T1b"
^ONCO(165.8,51,1,6,1)="< 0.8mm (with ulceration) OR 0.8-1.0mm (with or without ulceration)"
^ONCO(165.8,51,1,8,0)="T2"
^ONCO(165.8,51,1,8,1)="> 1.0-2.0mm"
^ONCO(165.8,51,1,9,0)="T2a"
^ONCO(165.8,51,1,9,1)="> 1.0-2.0mm (without ulceration)"
^ONCO(165.8,51,1,10,0)="T2b"
^ONCO(165.8,51,1,10,1)="> 1.0-2.0mm (with ulceration)"
^ONCO(165.8,51,1,11,0)="T3"
^ONCO(165.8,51,1,11,1)="> 2.0-4.0mm"
^ONCO(165.8,51,1,12,0)="T3a"
^ONCO(165.8,51,1,12,1)="> 2.0-4.0mm (without ulceration)"
^ONCO(165.8,51,1,13,0)="T3b"
^ONCO(165.8,51,1,13,1)="> 2.0-4.0mm (with ulceration)"
^ONCO(165.8,51,1,14,0)="T4"
^ONCO(165.8,51,1,14,1)="> 4.0mm"
^ONCO(165.8,51,1,15,0)="T4a"
^ONCO(165.8,51,1,15,1)="> 4.0mm (without ulceration)"
^ONCO(165.8,51,1,16,0)="T4b"
^ONCO(165.8,51,1,16,1)="> 4.0mm (with ulceration)"
^ONCO(165.8,51,1,"B","T0",2)=""
^ONCO(165.8,51,1,"B","T1",4)=""
^ONCO(165.8,51,1,"B","T1a",5)=""
^ONCO(165.8,51,1,"B","T1b",6)=""
^ONCO(165.8,51,1,"B","T2",8)=""
^ONCO(165.8,51,1,"B","T2a",9)=""
^ONCO(165.8,51,1,"B","T2b",10)=""
^ONCO(165.8,51,1,"B","T3",11)=""
^ONCO(165.8,51,1,"B","T3a",12)=""
^ONCO(165.8,51,1,"B","T3b",13)=""
^ONCO(165.8,51,1,"B","T4",14)=""
^ONCO(165.8,51,1,"B","T4a",15)=""
^ONCO(165.8,51,1,"B","T4b",16)=""
^ONCO(165.8,51,1,"B","TX",1)=""
^ONCO(165.8,51,1,"B","Tis",3)=""
^ONCO(165.8,51,2,0)="^165.83IA^14^14"
^ONCO(165.8,51,2,1,0)="NX"
^ONCO(165.8,51,2,1,1)="Regional nodes not assessed (e.g., SLN biopsy not performed, regional nodes previously removed for another reason) Exception: pathological N category is not required for T1 melanomas, use cN."
^ONCO(165.8,51,2,2,0)="N0"
^ONCO(165.8,51,2,2,1)="No regional metastases detected"
^ONCO(165.8,51,2,3,0)="N1"
^ONCO(165.8,51,2,3,1)="One tumor-involved node or in-transit, satellite, and/or microsatellite metastases with no tumor-involved nodes"
^ONCO(165.8,51,2,4,0)="N1a"
^ONCO(165.8,51,2,4,1)="One clinically occult (i.e., detected by SLN biopsy)"
^ONCO(165.8,51,2,5,0)="N1b"
^ONCO(165.8,51,2,5,1)="One clinically detected"
^ONCO(165.8,51,2,6,0)="N1c"
^ONCO(165.8,51,2,6,1)="No regional lymph node disease"
^ONCO(165.8,51,2,7,0)="N2"
^ONCO(165.8,51,2,7,1)="Two or three tumor-involved nodes or in-transit, satellite, and/or microsatellite metastases with one tumor-involved node"
^ONCO(165.8,51,2,8,0)="N2a"
^ONCO(165.8,51,2,8,1)="Two or three clinically occult (i.e., detected by SLN biopsy)"
^ONCO(165.8,51,2,9,0)="N2b"
^ONCO(165.8,51,2,9,1)="Two or three, at least one of which was clinically detected"
^ONCO(165.8,51,2,10,0)="N2c"
^ONCO(165.8,51,2,10,1)="One clinically occult or clinically detected"
^ONCO(165.8,51,2,11,0)="N3"
^ONCO(165.8,51,2,11,1)="Four or more tumor-involved nodes or in-transit, satellite, and/or microsatellite metastases with two or more tumor-involved nodes, or any number of matted nodes with or without in-transit, satellite, and/or microsatellite metastases"
^ONCO(165.8,51,2,12,0)="N3a"
^ONCO(165.8,51,2,12,1)="Four or more clinically occult (i.e., detected by SLN biopsy)"
^ONCO(165.8,51,2,13,0)="N3b"
^ONCO(165.8,51,2,13,1)="Four or more, at least one of which was clinically detected, or presence of any number of matted nodes"
^ONCO(165.8,51,2,14,0)="N3c"
^ONCO(165.8,51,2,14,1)="Two or more clinically occult or clinically detected and/or presence of any number of matted nodes"
^ONCO(165.8,51,2,"B","N0",2)=""
^ONCO(165.8,51,2,"B","N1",3)=""
^ONCO(165.8,51,2,"B","N1a",4)=""
^ONCO(165.8,51,2,"B","N1b",5)=""
^ONCO(165.8,51,2,"B","N1c",6)=""
^ONCO(165.8,51,2,"B","N2",7)=""
^ONCO(165.8,51,2,"B","N2a",8)=""
^ONCO(165.8,51,2,"B","N2b",9)=""
^ONCO(165.8,51,2,"B","N2c",10)=""
^ONCO(165.8,51,2,"B","N3",11)=""
^ONCO(165.8,51,2,"B","N3a",12)=""
^ONCO(165.8,51,2,"B","N3b",13)=""
^ONCO(165.8,51,2,"B","N3c",14)=""
^ONCO(165.8,51,2,"B","NX",1)=""
^ONCO(165.8,51,3,0)="^165.84IA^27^27"
^ONCO(165.8,51,3,1,0)="cM0"
^ONCO(165.8,51,3,1,1)="No evidence of distant metastasis"
^ONCO(165.8,51,3,2,0)="cM1"
^ONCO(165.8,51,3,2,1)="Evidence of distant metastasis"
^ONCO(165.8,51,3,3,0)="cM1a"
^ONCO(165.8,51,3,3,1)="Distant metastasis to skin, soft tissue including muscle, and/or nonregional lymph nodes + LDH Level Not recorded or unspecified"
^ONCO(165.8,51,3,4,0)="cM1a(0)"
^ONCO(165.8,51,3,4,1)="Distant metastasis to skin, soft tissue including muscle, and/or nonregional lymph nodes + LDH Level Not elevated"
^ONCO(165.8,51,3,5,0)="cM1a(1)"
^ONCO(165.8,51,3,5,1)="Distant metastasis to skin, soft tissue including muscle, and/or nonregional lymph nodes + LDH Level Elevated"
^ONCO(165.8,51,3,6,0)="cM1b"
^ONCO(165.8,51,3,6,1)="Distant metastasis to lung with or without M1a sites of disease + LDH Level Not recorded or specified"
^ONCO(165.8,51,3,7,0)="cM1b(0)"
^ONCO(165.8,51,3,7,1)="Distant metastasis to lung with or without M1a sites of disease + LDH Level Not elevated"
^ONCO(165.8,51,3,8,0)="cM1b(1)"
^ONCO(165.8,51,3,8,1)="Distant metastasis to lung with or without M1a sites of disease + LDH Level Elevated"
^ONCO(165.8,51,3,9,0)="cM1c"
^ONCO(165.8,51,3,9,1)="Distant metastasis to non-CNS visceral sites with or without M1a or M1b sites of disease + LDH Level Not recorded or unspecified"
^ONCO(165.8,51,3,10,0)="cM1c(0)"
^ONCO(165.8,51,3,10,1)="Distant metastasis to non-CNS visceral sites with or without M1a or M1b sites of disease + LDH Level Not elevated"
^ONCO(165.8,51,3,11,0)="cM1c(1)"
^ONCO(165.8,51,3,11,1)="Distant metastasis to non-CNS visceral sites with or without M1a or M1b sites of disease + LDH Level Elevated"
^ONCO(165.8,51,3,12,0)="cM1d"
^ONCO(165.8,51,3,12,1)="Distant metastasis to CNS with or without M1a, M1b, or M1c sites of disease + LDH Level Not recorded or unspecified"
^ONCO(165.8,51,3,13,0)="cM1d(0)"
^ONCO(165.8,51,3,13,1)="Distant metastasis to CNS with or without M1a, M1b, or M1c sites of disease + LDH Level Not elevated"
^ONCO(165.8,51,3,14,0)="cM1d(1)"
^ONCO(165.8,51,3,14,1)="Distant metastasis to CNS with or without M1a, M1b, or M1c sites of disease + LDH Level Elevated"
^ONCO(165.8,51,3,15,0)="pM1"
^ONCO(165.8,51,3,15,1)="Evidence of distant metastasis, microscopically proven"
^ONCO(165.8,51,3,16,0)="pM1a"
^ONCO(165.8,51,3,16,1)="Distant metastasis to skin, soft tissue including muscle, and/or nonregional lymph node, microscopically proven + LDH Level Not reported or unspecified"
^ONCO(165.8,51,3,17,0)="pM1a(0)"
^ONCO(165.8,51,3,17,1)="Distant metastasis to skin, soft tissue including muscle, and/or nonregional lymph node, microscopically proven + LDH Level Not elevated"
^ONCO(165.8,51,3,18,0)="pM1a(1)"
^ONCO(165.8,51,3,18,1)="Distant metastasis to skin, soft tissue including muscle, and/or nonregional lymph node, microscopically proven + LDH Level Elevated"
^ONCO(165.8,51,3,19,0)="pM1b"
^ONCO(165.8,51,3,19,1)="Distant metastasis to lung with or without M1a sites of disease, microscopically proven + LDH Level Not reported or unspecified"
^ONCO(165.8,51,3,20,0)="pM1b(0)"
^ONCO(165.8,51,3,20,1)="Distant metastasis to lung with or without M1a sites of disease, microscopically proven + LDH Level Not elevated"
^ONCO(165.8,51,3,21,0)="pM1b(1)"
^ONCO(165.8,51,3,21,1)="Distant metastasis to lung with or without M1a sites of disease, microscopically proven + LDH Level Elevated"
^ONCO(165.8,51,3,22,0)="pM1c"
^ONCO(165.8,51,3,22,1)="Distant metastasis to non-CNS visceral sites with or without M1a or M1b sites of disease, microscopically proven + LDH Level Not reported or unspecified"
^ONCO(165.8,51,3,23,0)="pM1c(0)"
^ONCO(165.8,51,3,23,1)="Distant metastasis to non-CNS visceral sites with or without M1a or M1b sites of disease, microscopically proven + LDH Level Not elevated"
^ONCO(165.8,51,3,24,0)="pM1c(1)"
^ONCO(165.8,51,3,24,1)="Distant metastasis to non-CNS visceral sites with or without M1a or M1b sites of disease, microscopically proven + LDH Level Elevated"
^ONCO(165.8,51,3,25,0)="pM1d"
^ONCO(165.8,51,3,25,1)="Distant metastasis to CNS with or without M1a, M1b, or M1c sites of disease, microscopically proven + LDH Level Not reported or unspecified"
^ONCO(165.8,51,3,26,0)="pM1d(0)"
^ONCO(165.8,51,3,26,1)="Distant metastasis to CNS with or without M1a, M1b, or M1c sites of disease, microscopically proven + LDH Level Not elevated"
^ONCO(165.8,51,3,27,0)="pM1d(1)"
^ONCO(165.8,51,3,27,1)="Distant metastasis to CNS with or without M1a, M1b, or M1c sites of disease, microscopically proven + LDH Level Elevated"
^ONCO(165.8,51,3,"B","cM0",1)=""
^ONCO(165.8,51,3,"B","cM1",2)=""
^ONCO(165.8,51,3,"B","cM1a",3)=""
^ONCO(165.8,51,3,"B","cM1a(0)",4)=""
^ONCO(165.8,51,3,"B","cM1a(1)",5)=""
^ONCO(165.8,51,3,"B","cM1b",6)=""
^ONCO(165.8,51,3,"B","cM1b(0)",7)=""
^ONCO(165.8,51,3,"B","cM1b(1)",8)=""
^ONCO(165.8,51,3,"B","cM1c",9)=""
^ONCO(165.8,51,3,"B","cM1c(0)",10)=""
^ONCO(165.8,51,3,"B","cM1c(1)",11)=""
^ONCO(165.8,51,3,"B","cM1d",12)=""
^ONCO(165.8,51,3,"B","cM1d(0)",13)=""
^ONCO(165.8,51,3,"B","cM1d(1)",14)=""
^ONCO(165.8,51,3,"B","pM1",15)=""
^ONCO(165.8,51,3,"B","pM1a",16)=""
^ONCO(165.8,51,3,"B","pM1a(0)",17)=""
^ONCO(165.8,51,3,"B","pM1a(1)",18)=""
^ONCO(165.8,51,3,"B","pM1b",19)=""
^ONCO(165.8,51,3,"B","pM1b(0)",20)=""
^ONCO(165.8,51,3,"B","pM1b(1)",21)=""
^ONCO(165.8,51,3,"B","pM1c",22)=""
^ONCO(165.8,51,3,"B","pM1c(0)",23)=""
^ONCO(165.8,51,3,"B","pM1c(1)",24)=""
^ONCO(165.8,51,3,"B","pM1d",25)=""
^ONCO(165.8,51,3,"B","pM1d(0)",26)=""
^ONCO(165.8,51,3,"B","pM1d(1)",27)=""
^ONCO(165.8,52,0)="48^Breast"
^ONCO(165.8,52,1,0)="^165.82IA^16^16"
^ONCO(165.8,52,1,1,0)="TX"
^ONCO(165.8,52,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,52,1,2,0)="T0"
^ONCO(165.8,52,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,52,1,3,0)="Tis(DCIS)"
^ONCO(165.8,52,1,3,1)="Ductal carcinoma in situ"
^ONCO(165.8,52,1,4,0)="Tis(Paget)"
^ONCO(165.8,52,1,4,1)="Paget disease of the nipple NOT associated w/invasive carcinoma and/or carcinoma in situ (DCIS) in the underlying breast parenchyma. Carcinomas in the breast parenchyma associated w/Paget disease are categorized based on size and characteristics of the parenchymal disease, although presence of Paget disease should still be noted"
^ONCO(165.8,52,1,5,0)="T1"
^ONCO(165.8,52,1,5,1)="Tumor <= 20mm in greatest dimension"
^ONCO(165.8,52,1,6,0)="T1mi"
^ONCO(165.8,52,1,6,1)="Tumor <= 1mm in greatest dimension"
^ONCO(165.8,52,1,7,0)="T1a"
^ONCO(165.8,52,1,7,1)="Tumor > 1mm but <= 5mm in greatest dimension (round any measurement >1.0-1.9mm to 2mm)"
^ONCO(165.8,52,1,8,0)="T1b"
^ONCO(165.8,52,1,8,1)="Tumor > 5mm but <= 10mm in greatest dimension"
^ONCO(165.8,52,1,9,0)="T1c"
^ONCO(165.8,52,1,9,1)="Tumor > 10mm but <= 20mm in greatest dimension"
^ONCO(165.8,52,1,10,0)="T2"
^ONCO(165.8,52,1,10,1)="Tumor > 20mm but <= 50mm in greatest dimension"
^ONCO(165.8,52,1,11,0)="T3"
^ONCO(165.8,52,1,11,1)="Tumor > 50mm in greatest dimension"
^ONCO(165.8,52,1,12,0)="T4"
^ONCO(165.8,52,1,12,1)="Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or macroscopic nodules); invasion of the dermis alone does not qualify as T4"
^ONCO(165.8,52,1,13,0)="T4a"
^ONCO(165.8,52,1,13,1)="Extension to the chest wall; invasion or adherence to pectoralis muscle in the absence of invasion of chest wall structures does not qualify as T4"
^ONCO(165.8,52,1,14,0)="T4b"
^ONCO(165.8,52,1,14,1)="Ulceration and/or ipsilateral macroscopic satellite nodules and/or edema (including peau d'orange) of the skin that does not meet the criteria for inflammatory carcinoma"
^ONCO(165.8,52,1,15,0)="T4c"
^ONCO(165.8,52,1,15,1)="Both T4a and T4b are present"
^ONCO(165.8,52,1,16,0)="T4d"
^ONCO(165.8,52,1,16,1)="Inflammatory carcinoma "
^ONCO(165.8,52,1,"B","T0",2)=""
^ONCO(165.8,52,1,"B","T1",5)=""
^ONCO(165.8,52,1,"B","T1a",7)=""
^ONCO(165.8,52,1,"B","T1b",8)=""
^ONCO(165.8,52,1,"B","T1c",9)=""
^ONCO(165.8,52,1,"B","T1mi",6)=""
^ONCO(165.8,52,1,"B","T2",10)=""
^ONCO(165.8,52,1,"B","T3",11)=""
^ONCO(165.8,52,1,"B","T4",12)=""
^ONCO(165.8,52,1,"B","T4a",13)=""
^ONCO(165.8,52,1,"B","T4b",14)=""
^ONCO(165.8,52,1,"B","T4c",15)=""
^ONCO(165.8,52,1,"B","T4d",16)=""
^ONCO(165.8,52,1,"B","TX",1)=""
^ONCO(165.8,52,1,"B","Tis(DCIS)",3)=""
^ONCO(165.8,52,1,"B","Tis(Paget)",4)=""
^ONCO(165.8,52,2,0)="^165.83IA^11^11"
^ONCO(165.8,52,2,1,0)="NX"
^ONCO(165.8,52,2,1,1)="Regional lymph nodes cannot be assessed (e.g., previously removed)"
^ONCO(165.8,52,2,2,0)="N0"
^ONCO(165.8,52,2,2,1)="No regional lymph node metastases (by imaging or clinical examination)"
^ONCO(165.8,52,2,3,0)="N1"
^ONCO(165.8,52,2,3,1)="Metastases to movable ipsilateral Level I, II axillary lymph node(s)"
^ONCO(165.8,52,2,4,0)="N1mi"
^ONCO(165.8,52,2,4,1)="Micrometastases (approximately 200 cells, larger than 0.2 mm, but none larger than 2.0 mm)"
^ONCO(165.8,52,2,5,0)="N2"
^ONCO(165.8,52,2,5,1)="Metastases in ipsilateral Level I, II axillary lymph nodes that are clinically fixed or matted; or in ipsilateral internal mammary nodes in the absence of axillary lymph node metastases"
^ONCO(165.8,52,2,6,0)="N2a"
^ONCO(165.8,52,2,6,1)="Metastases in ipsilateral Level I, II axillary lymph nodes fixed to one another (matted) or to other structures"
^ONCO(165.8,52,2,7,0)="N2b"
^ONCO(165.8,52,2,7,1)="Metastases only in ipsilateral internal mammary nodes in the absence of axillary lymph node metastases"
^ONCO(165.8,52,2,8,0)="N3"
^ONCO(165.8,52,2,8,1)="Metastases in ipsilateral infraclavicular (Level III axillary) LN w or w/o Level I, II axillary lymph node involvement; or in ipsilateral internal mammary LN with Level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular LN w or w/o axillary or internal mammary LN inv "
^ONCO(165.8,52,2,9,0)="N3a"
^ONCO(165.8,52,2,9,1)="Metastases in ipsilateral infraclavicular lymph node(s)"
^ONCO(165.8,52,2,10,0)="N3b"
^ONCO(165.8,52,2,10,1)="Metastases in ipsilateral internal mammary lymph node(s) and axillary lymph node(s)"
^ONCO(165.8,52,2,11,0)="N3c"
^ONCO(165.8,52,2,11,1)="Metastases in ipsilateral supraclavicular lymph node(s)"
^ONCO(165.8,52,2,"B","N0",2)=""
^ONCO(165.8,52,2,"B","N1",3)=""
^ONCO(165.8,52,2,"B","N1mi",4)=""
^ONCO(165.8,52,2,"B","N2",5)=""
^ONCO(165.8,52,2,"B","N2a",6)=""
^ONCO(165.8,52,2,"B","N2b",7)=""
^ONCO(165.8,52,2,"B","N3",8)=""
^ONCO(165.8,52,2,"B","N3a",9)=""
^ONCO(165.8,52,2,"B","N3b",10)=""
^ONCO(165.8,52,2,"B","N3c",11)=""
^ONCO(165.8,52,2,"B","NX",1)=""
^ONCO(165.8,52,3,0)="^165.84IA^4^4"
^ONCO(165.8,52,3,1,0)="cM0"
^ONCO(165.8,52,3,1,1)="No clinical or radiographic evidence of distant metastases"
^ONCO(165.8,52,3,2,0)="cM0(i+)"
^ONCO(165.8,52,3,2,1)="No clinical or radiographic evidence of distant metastases in the presence of tumor cells or deposits no larger than 0.2mm detected microscopically or by molecular techniques in circulating blood, bone marrow, or other nonregional nodal tissue in a patient without symptoms or signs of metastases"
^ONCO(165.8,52,3,3,0)="cM1"
^ONCO(165.8,52,3,3,1)="Distant metastases detected by clinical and radiographic means"
^ONCO(165.8,52,3,4,0)="pM1"
^ONCO(165.8,52,3,4,1)="Any histologically proven metastases in distant organs; or if in non-regional nodes, metastases greater than 0.2mm"
^ONCO(165.8,52,3,"B","cM0",1)=""
^ONCO(165.8,52,3,"B","cM0(i+)",2)=""
^ONCO(165.8,52,3,"B","cM1",3)=""
^ONCO(165.8,52,3,"B","pM1",4)=""
^ONCO(165.8,52,7,0)="^165.88AI^16^16"
^ONCO(165.8,52,7,1,0)="NX"
^ONCO(165.8,52,7,1,1)="Regional lymph nodes cannot be assessed (e.g., not removed for pathological study or previously removed)"
^ONCO(165.8,52,7,2,0)="N0"
^ONCO(165.8,52,7,2,1)="No regional lymph node metastases identified or ITCs only"
^ONCO(165.8,52,7,3,0)="N0(i+)"
^ONCO(165.8,52,7,3,1)="ITCs only (malignant cell clusters no larger than 0.2 mm) in regional lymph node(s)"
^ONCO(165.8,52,7,4,0)="N0(mol+)"
^ONCO(165.8,52,7,4,1)="Positive molecular findings by reverse transcriptase polymerase chain reaction (RT-PCR); no ITCs detected"
^ONCO(165.8,52,7,5,0)="N1"
^ONCO(165.8,52,7,5,1)="Micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy"
^ONCO(165.8,52,7,6,0)="N1mi"
^ONCO(165.8,52,7,6,1)="Micrometastases (approximately 200 cells, larger than 0.2mm, but none larger than 2.0mm)"
^ONCO(165.8,52,7,7,0)="N1a"
^ONCO(165.8,52,7,7,1)="Metastases in 1-3 axillary lymph nodes, at least one metastasis larger than 2.0mm"
^ONCO(165.8,52,7,8,0)="N1b"
^ONCO(165.8,52,7,8,1)="Metastases in ipsilateral internal mammary sentinel nodes, excluding ITCs"
^ONCO(165.8,52,7,9,0)="N1c"
^ONCO(165.8,52,7,9,1)="pN1a and pN1b combined"
^ONCO(165.8,52,7,10,0)="N2"
^ONCO(165.8,52,7,10,1)="Metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases"
^ONCO(165.8,52,7,11,0)="N2a"
^ONCO(165.8,52,7,11,1)="Metastases in 4-9 axillary lymph nodes (at least one tumor deposit larger than 2.0mm)"
^ONCO(165.8,52,7,12,0)="N2b"
^ONCO(165.8,52,7,12,1)="Metastases in clinically detected internal mammary lymph nodes with or without microscopic confirmation; with pathologically negative axillary nodes"
^ONCO(165.8,52,7,13,0)="N3"
^ONCO(165.8,52,7,13,1)="Metastases in 10 or more axillary lymph nodes; or in infraclavicular (Level III axillary) lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the presence of one or more positive Level I, II axillary lymph nodes"
^ONCO(165.8,52,7,14,0)="N3a"
^ONCO(165.8,52,7,14,1)="Metastases in 10 or more axillary lymph nodes (at least one tumor deposit larger than 2.0mm); or metastases to the infraclavicular (Level III axillary lymph) nodes"
^ONCO(165.8,52,7,15,0)="N3b"
^ONCO(165.8,52,7,15,1)="pN1a or pN2a in the presence of cN2b (positive internal mammary nodes by imaging); or pN2a in the presence of pN1b"
^ONCO(165.8,52,7,16,0)="N3c"
^ONCO(165.8,52,7,16,1)="Metastases in ipsilateral supraclavicular lymph nodes"
^ONCO(165.8,52,7,"B","N0",2)=""
^ONCO(165.8,52,7,"B","N0(i+)",3)=""
^ONCO(165.8,52,7,"B","N0(mol+)",4)=""
^ONCO(165.8,52,7,"B","N1",5)=""
^ONCO(165.8,52,7,"B","N1a",7)=""
^ONCO(165.8,52,7,"B","N1b",8)=""
^ONCO(165.8,52,7,"B","N1c",9)=""
^ONCO(165.8,52,7,"B","N1mi",6)=""
^ONCO(165.8,52,7,"B","N2",10)=""
^ONCO(165.8,52,7,"B","N2a",11)=""
^ONCO(165.8,52,7,"B","N2b",12)=""
^ONCO(165.8,52,7,"B","N3",13)=""
^ONCO(165.8,52,7,"B","N3a",14)=""
^ONCO(165.8,52,7,"B","N3b",15)=""
^ONCO(165.8,52,7,"B","N3c",16)=""
^ONCO(165.8,52,7,"B","NX",1)=""
^ONCO(165.8,53,0)="50^Vulva"
^ONCO(165.8,53,1,0)="^165.82IA^7^7"
^ONCO(165.8,53,1,1,0)="TX"
^ONCO(165.8,53,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,53,1,2,0)="T0"
^ONCO(165.8,53,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,53,1,3,0)="T1"
^ONCO(165.8,53,1,3,1)="Tumor confined to the vulva and/or perineum; Multifocal lesions should be designated as such. The largest lesion or the lesion with the greatest depth of invasion will be the target lesion identified to address the highest pT stage."
^ONCO(165.8,53,1,4,0)="T1a"
^ONCO(165.8,53,1,4,1)="Lesions 2cm or less, confined to the vulva and/or perineum, and with stromal invasion of 1.0mm or less"
^ONCO(165.8,53,1,5,0)="T1b"
^ONCO(165.8,53,1,5,1)="Lesions more than 2cm, or any size with stromal invasion of more than 1.0mm, confined to the vulva and/or perineum"
^ONCO(165.8,53,1,6,0)="T2"
^ONCO(165.8,53,1,6,1)="Tumor of any size with extension to adjacent perineal structures (lower/distal third of the urethra, lower/distal third of the vagina, anal involvement)"
^ONCO(165.8,53,1,7,0)="T3"
^ONCO(165.8,53,1,7,1)="Tumor of any size with extension to any of the following-upper/proximal two thirds of the urethra, upper/proximal two thirds of the vagina, bladder mucosa, or rectal mucosa-or fixed to pelvic bone"
^ONCO(165.8,53,1,"B","T0",2)=""
^ONCO(165.8,53,1,"B","T1",3)=""
^ONCO(165.8,53,1,"B","T1a",4)=""
^ONCO(165.8,53,1,"B","T1b",5)=""
^ONCO(165.8,53,1,"B","T2",6)=""
^ONCO(165.8,53,1,"B","T3",7)=""
^ONCO(165.8,53,1,"B","TX",1)=""
^ONCO(165.8,53,2,0)="^165.83IA^11^11"
^ONCO(165.8,53,2,1,0)="NX"
^ONCO(165.8,53,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,53,2,2,0)="N0"
^ONCO(165.8,53,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,53,2,3,0)="N0(i+)"
^ONCO(165.8,53,2,3,1)="Isolated tumor cells in regional lymph node(s) no greater than 0.2 mm"
^ONCO(165.8,53,2,4,0)="N1"
^ONCO(165.8,53,2,4,1)="Regional lymph node metastasis with one or two lymph node metastases each less than 5mm, or one lymph node metastasis >= 5mm"
^ONCO(165.8,53,2,5,0)="N1a"
^ONCO(165.8,53,2,5,1)="One or two lymph node metastases each less than 5mm"
^ONCO(165.8,53,2,6,0)="N1b"
^ONCO(165.8,53,2,6,1)="One lymph node metastasis >= 5mm"
^ONCO(165.8,53,2,7,0)="N2"
^ONCO(165.8,53,2,7,1)="Regional lymph node metastasis with three or more lymph node metastases each less than 5mm, or two or more lymph node metastases >= 5mm, or lymph node(s) with extranodal extension"
^ONCO(165.8,53,2,8,0)="N2a"
^ONCO(165.8,53,2,8,1)="Three or more lymph node metastases each less than 5mm"
^ONCO(165.8,53,2,9,0)="N2b"
^ONCO(165.8,53,2,9,1)="Two or more lymph node metastases >= 5mm"
^ONCO(165.8,53,2,10,0)="N2c"
^ONCO(165.8,53,2,10,1)="Lymph node(s) with extranodal extension"
^ONCO(165.8,53,2,11,0)="N3"
^ONCO(165.8,53,2,11,1)="Fixed or ulcerated regional lymph node metastasis"
^ONCO(165.8,53,2,"B","N0",2)=""
^ONCO(165.8,53,2,"B","N0(i+)",3)=""
^ONCO(165.8,53,2,"B","N1",4)=""
^ONCO(165.8,53,2,"B","N1a",5)=""
^ONCO(165.8,53,2,"B","N1b",6)=""
^ONCO(165.8,53,2,"B","N2",7)=""
^ONCO(165.8,53,2,"B","N2a",8)=""
^ONCO(165.8,53,2,"B","N2b",9)=""
^ONCO(165.8,53,2,"B","N2c",10)=""
^ONCO(165.8,53,2,"B","N3",11)=""
^ONCO(165.8,53,2,"B","NX",1)=""
^ONCO(165.8,53,3,0)="^165.84IA^3^3"
^ONCO(165.8,53,3,1,0)="cM0"
^ONCO(165.8,53,3,1,1)="No distant metastasis (no pathological M0; use clinical M to complete stage group)"
^ONCO(165.8,53,3,2,0)="cM1"
^ONCO(165.8,53,3,2,1)="Distant metastasis (including pelvic lymph node metastasis)"
^ONCO(165.8,53,3,3,0)="pM1"
^ONCO(165.8,53,3,3,1)="Distant metastasis (including pelvic lymph node metastasis), microscopically confirmed"
^ONCO(165.8,53,3,"B","cM0",1)=""
^ONCO(165.8,53,3,"B","cM1",2)=""
^ONCO(165.8,53,3,"B","pM1",3)=""
^ONCO(165.8,54,0)="51^Vagina^^^6"
^ONCO(165.8,54,1,0)="^165.82IA^10^10"
^ONCO(165.8,54,1,1,0)="TX"
^ONCO(165.8,54,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,54,1,2,0)="T0"
^ONCO(165.8,54,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,54,1,3,0)="T1"
^ONCO(165.8,54,1,3,1)="Tumor confined to the vagina"
^ONCO(165.8,54,1,4,0)="T1a"
^ONCO(165.8,54,1,4,1)="Tumor confined to the vagina, measuring <= 2.0cm"
^ONCO(165.8,54,1,5,0)="T1b"
^ONCO(165.8,54,1,5,1)="Tumor confined to the vagina, measuring > 2.0cm"
^ONCO(165.8,54,1,6,0)="T2"
^ONCO(165.8,54,1,6,1)="Tumor invading paravaginal tissues but not to pelvic sidewall"
^ONCO(165.8,54,1,7,0)="T2a"
^ONCO(165.8,54,1,7,1)="Tumor invading paravaginal tissues but not to pelvic wall, measuring <= 2.0cm"
^ONCO(165.8,54,1,8,0)="T2b"
^ONCO(165.8,54,1,8,1)="Tumor invading paravaginal tissues but not to pelvic wall, measuring > 2.0cm"
^ONCO(165.8,54,1,9,0)="T3"
^ONCO(165.8,54,1,9,1)="Tumor extending to the pelvic sidewall* and/or causing hydronephrosis or nonfunctioning kidney"
^ONCO(165.8,54,1,10,0)="T4"
^ONCO(165.8,54,1,10,1)="Tumor invading the mucosa of the bladder or rectum and/or extending beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4)"
^ONCO(165.8,54,1,"B","T0",2)=""
^ONCO(165.8,54,1,"B","T1",3)=""
^ONCO(165.8,54,1,"B","T1a",4)=""
^ONCO(165.8,54,1,"B","T1b",5)=""
^ONCO(165.8,54,1,"B","T2",6)=""
^ONCO(165.8,54,1,"B","T2a",7)=""
^ONCO(165.8,54,1,"B","T2b",8)=""
^ONCO(165.8,54,1,"B","T3",9)=""
^ONCO(165.8,54,1,"B","T4",10)=""
^ONCO(165.8,54,1,"B","TX",1)=""
^ONCO(165.8,54,2,0)="^165.83IA^4^4"
^ONCO(165.8,54,2,1,0)="NX"
^ONCO(165.8,54,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,54,2,2,0)="N0"
^ONCO(165.8,54,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,54,2,3,0)="N0(i+)"
^ONCO(165.8,54,2,3,1)="Isolated tumor cells in regional lymph node(s) no greater than 0.2mm"
^ONCO(165.8,54,2,4,0)="N1"
^ONCO(165.8,54,2,4,1)="Pelvic or inguinal lymph node metastasis"
^ONCO(165.8,54,2,"B","N0",2)=""
^ONCO(165.8,54,2,"B","N0(i+)",3)=""
^ONCO(165.8,54,2,"B","N1",4)=""
^ONCO(165.8,54,2,"B","NX",1)=""
^ONCO(165.8,55,0)="52^Cervix Uteri"
^ONCO(165.8,55,1,0)="^165.82IA^18^18"
^ONCO(165.8,55,1,1,0)="TX"
^ONCO(165.8,55,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,55,1,2,0)="T0"
^ONCO(165.8,55,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,55,1,3,0)="T1"
^ONCO(165.8,55,1,3,1)="Cervical carcinoma confined to the uterus (extension to corpus should be disregarded)"
^ONCO(165.8,55,1,4,0)="T1a"
^ONCO(165.8,55,1,4,1)="Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification."
^ONCO(165.8,55,1,5,0)="T1a1"
^ONCO(165.8,55,1,5,1)="Measured stromal invasion of 3.0mm or less in depth and 7.0mm or less in horizontal spread"
^ONCO(165.8,55,1,6,0)="T1a2"
^ONCO(165.8,55,1,6,1)="Measured stromal invasion of more than 3.0mm and not more than 5.0mm, with a horizontal spread of 7.0mm or less"
^ONCO(165.8,55,1,7,0)="T1b"
^ONCO(165.8,55,1,7,1)="Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. Includes all macroscopically visible lesions, even those with superficial invasion."
^ONCO(165.8,55,1,8,0)="T1b1"
^ONCO(165.8,55,1,8,1)="Clinically visible lesion 4.0cm or less in greatest dimension"
^ONCO(165.8,55,1,9,0)="T1b2"
^ONCO(165.8,55,1,9,1)="Clinically visible lesion more than 4.0cm in greatest dimension"
^ONCO(165.8,55,1,10,0)="T2"
^ONCO(165.8,55,1,10,1)="Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of the vagina"
^ONCO(165.8,55,1,11,0)="T2a"
^ONCO(165.8,55,1,11,1)="Tumor without parametrial invasion"
^ONCO(165.8,55,1,12,0)="T2a1"
^ONCO(165.8,55,1,12,1)="Clinically visible lesion 4.0cm or less in greatest dimension"
^ONCO(165.8,55,1,13,0)="T2a2"
^ONCO(165.8,55,1,13,1)="Clinically visible lesion more than 4.0cm in greatest dimension"
^ONCO(165.8,55,1,14,0)="T2b"
^ONCO(165.8,55,1,14,1)="Tumor with parametrial invasion"
^ONCO(165.8,55,1,15,0)="T3"
^ONCO(165.8,55,1,15,1)="Tumor extending to the pelvic sidewall and/or involving the lower third of the vagina and/or causing hydronephrosis or nonfunctioning kidney"
^ONCO(165.8,55,1,16,0)="T3a"
^ONCO(165.8,55,1,16,1)="Tumor involving the lower third of the vagina but not extending to the pelvic wall"
^ONCO(165.8,55,1,17,0)="T3b"
^ONCO(165.8,55,1,17,1)="Tumor extending to the pelvic wall and/or causing hydronephrosis or nonfunctioning kidney"
^ONCO(165.8,55,1,18,0)="T4"
^ONCO(165.8,55,1,18,1)="Tumor invading the mucosa of the bladder or rectum and/or extending beyond the true pelvis (bullous edema is not sufficient to classify a tumor as T4)"
^ONCO(165.8,55,1,"B","T0",2)=""
^ONCO(165.8,55,1,"B","T1",3)=""
^ONCO(165.8,55,1,"B","T1a",4)=""
^ONCO(165.8,55,1,"B","T1a1",5)=""
^ONCO(165.8,55,1,"B","T1a2",6)=""
^ONCO(165.8,55,1,"B","T1b",7)=""
^ONCO(165.8,55,1,"B","T1b1",8)=""
^ONCO(165.8,55,1,"B","T1b2",9)=""
^ONCO(165.8,55,1,"B","T2",10)=""
^ONCO(165.8,55,1,"B","T2a",11)=""
^ONCO(165.8,55,1,"B","T2a1",12)=""
^ONCO(165.8,55,1,"B","T2a2",13)=""
^ONCO(165.8,55,1,"B","T2b",14)=""
^ONCO(165.8,55,1,"B","T3",15)=""
^ONCO(165.8,55,1,"B","T3a",16)=""
^ONCO(165.8,55,1,"B","T3b",17)=""
^ONCO(165.8,55,1,"B","T4",18)=""
^ONCO(165.8,55,1,"B","TX",1)=""
^ONCO(165.8,55,2,0)="^165.83IA^4^4"
^ONCO(165.8,55,2,1,0)="NX"
^ONCO(165.8,55,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,55,2,2,0)="N0"
^ONCO(165.8,55,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,55,2,3,0)="N0(i+)"
^ONCO(165.8,55,2,3,1)="Isolated tumor cells in regional lymph node(s) no greater than 0.2mm"
^ONCO(165.8,55,2,4,0)="N1"
^ONCO(165.8,55,2,4,1)="Regional lymph node metastasis"
^ONCO(165.8,55,2,"B","N0",2)=""
^ONCO(165.8,55,2,"B","N0(i+)",3)=""
^ONCO(165.8,55,2,"B","N1",4)=""
^ONCO(165.8,55,2,"B","NX",1)=""
^ONCO(165.8,55,3,0)="^165.84IA^3^3"
^ONCO(165.8,55,3,1,0)="cM0"
^ONCO(165.8,55,3,1,1)="No distant metastasis"
^ONCO(165.8,55,3,2,0)="cM1"
^ONCO(165.8,55,3,2,1)="Distant metastasis (including peritoneal spread or involvement of the supraclavicular, mediastinal, or distant lymph nodes; lung; liver; or bone)"
^ONCO(165.8,55,3,3,0)="pM1"
^ONCO(165.8,55,3,3,1)="Distant metastasis (including peritoneal spread or involvement of the supraclavicular, mediastinal, or distant lymph nodes; lung; liver; or bone) microscopically confirmed"
^ONCO(165.8,55,3,"B","cM0",1)=""
^ONCO(165.8,55,3,"B","cM1",2)=""
^ONCO(165.8,55,3,"B","pM1",3)=""
^ONCO(165.8,55,"V9M",0)="^165.803AI^3^3"
^ONCO(165.8,55,"V9M",1,0)="cM0"
^ONCO(165.8,55,"V9M",1,1)="No distant metastasis"
^ONCO(165.8,55,"V9M",2,0)="cM1"
^ONCO(165.8,55,"V9M",2,1)="Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone) (excludes metastasis to pelvic or para-aortic lymph nodes, or vagina)"
^ONCO(165.8,55,"V9M",3,0)="pM1"
^ONCO(165.8,55,"V9M",3,1)="Microscopic confirmation of distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone) (excludes metastasis to pelvic or para-aortic lymph nodes, or vagina)"
^ONCO(165.8,55,"V9M","B","cM0",1)=""
^ONCO(165.8,55,"V9M","B","cM1",2)=""
^ONCO(165.8,55,"V9M","B","pM1",3)=""
^ONCO(165.8,55,"V9N",0)="^165.802AI^9^9"
^ONCO(165.8,55,"V9N",1,0)="NX"
^ONCO(165.8,55,"V9N",1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,55,"V9N",2,0)="N0"
^ONCO(165.8,55,"V9N",2,1)="No regional lymph node metastasis"
^ONCO(165.8,55,"V9N",3,0)="N0(i+)"
^ONCO(165.8,55,"V9N",3,1)="Isolated tumor cells in regional lymph node(s) <0.2 mm, or single cells or clusters of cells <200 cells in a single lymph node cross section"
^ONCO(165.8,55,"V9N",4,0)="N1"
^ONCO(165.8,55,"V9N",4,1)="Regional lymph node metastasis to pelvic lymph nodes only"
^ONCO(165.8,55,"V9N",5,0)="N1mi"
^ONCO(165.8,55,"V9N",5,1)="Regional lymph node metastasis (>0.2 mm but <2.0 mm in diameter) to pelvic lymph nodes"
^ONCO(165.8,55,"V9N",6,0)="N1a"
^ONCO(165.8,55,"V9N",6,1)="Regional lymph node metastasis (>2.0 mm in diameter) to pelvic lymph node"
^ONCO(165.8,55,"V9N",7,0)="N2"
^ONCO(165.8,55,"V9N",7,1)="Regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes"
^ONCO(165.8,55,"V9N",8,0)="N2mi"
^ONCO(165.8,55,"V9N",8,1)="Regional lymph node metastasis (>0.2 mm but <2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes"
^ONCO(165.8,55,"V9N",9,0)="N2a"
^ONCO(165.8,55,"V9N",9,1)="Regional lymph node metastasis (>2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes"
^ONCO(165.8,55,"V9N","B","N0",2)=""
^ONCO(165.8,55,"V9N","B","N0(i+)",3)=""
^ONCO(165.8,55,"V9N","B","N1",4)=""
^ONCO(165.8,55,"V9N","B","N1a",6)=""
^ONCO(165.8,55,"V9N","B","N1mi",5)=""
^ONCO(165.8,55,"V9N","B","N2",7)=""
^ONCO(165.8,55,"V9N","B","N2a",9)=""
^ONCO(165.8,55,"V9N","B","N2mi",8)=""
^ONCO(165.8,55,"V9N","B","NX",1)=""
^ONCO(165.8,55,"V9T",0)="^165.801AI^19^19"
^ONCO(165.8,55,"V9T",1,0)="TX"
^ONCO(165.8,55,"V9T",1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,55,"V9T",2,0)="T0"
^ONCO(165.8,55,"V9T",2,1)="No evidence of primary tumor"
^ONCO(165.8,55,"V9T",3,0)="T1"
^ONCO(165.8,55,"V9T",3,1)="Carcinoma is strictly confined to the cervix (extension to the corpus should be disregarded)."
^ONCO(165.8,55,"V9T",4,0)="T1a"
^ONCO(165.8,55,"V9T",4,1)="Invasive carcinoma that can be diagnosed only by microscopy with maximum depth of invasion <5 mm"
^ONCO(165.8,55,"V9T",5,0)="T1a1"
^ONCO(165.8,55,"V9T",5,1)="Measured stromal invasion <3 mm in depth"
^ONCO(165.8,55,"V9T",6,0)="T1a2"
^ONCO(165.8,55,"V9T",6,1)="Measured stromal invasion >3 mm and <5 mm in depth"
^ONCO(165.8,55,"V9T",7,0)="T1b"
^ONCO(165.8,55,"V9T",7,1)="Invasive carcinoma with measured deepest invasion >5 mm (greater than stage IA); lesion limited to the cervix uteri with size measured by maximum tumor diameter Note: The involvement of vascular/lymphatic spaces should not change the staging. The lateral extent of the lesion is no longer considered."
^ONCO(165.8,55,"V9T",8,0)="T1b1"
^ONCO(165.8,55,"V9T",8,1)="Invasive carcinoma >5 mm depth of stromal invasion and <2 cm in greatest dimension"
^ONCO(165.8,55,"V9T",9,0)="T1b2"
^ONCO(165.8,55,"V9T",9,1)="Invasive carcinoma >2 cm and <4 cm in greatest dimension"
^ONCO(165.8,55,"V9T",10,0)="T1b3"
^ONCO(165.8,55,"V9T",10,1)="Invasive carcinoma >4 cm in greatest dimension"
^ONCO(165.8,55,"V9T",11,0)="T2"
^ONCO(165.8,55,"V9T",11,1)="Carcinoma invades beyond the uterus, but has not extended onto the lower third of the vagina or to the pelvic wall"
^ONCO(165.8,55,"V9T",12,0)="T2a"
^ONCO(165.8,55,"V9T",12,1)="Involvement limited to the upper two-thirds of the vagina without parametrial invasion"
^ONCO(165.8,55,"V9T",13,0)="T2a1"
^ONCO(165.8,55,"V9T",13,1)="Invasive carcinoma <4 cm in greatest dimension"
^ONCO(165.8,55,"V9T",14,0)="T2a2"
^ONCO(165.8,55,"V9T",14,1)="Invasive carcinoma >4 cm in greatest dimension"
^ONCO(165.8,55,"V9T",15,0)="T2b"
^ONCO(165.8,55,"V9T",15,1)="With parametrial invasion but not up to the pelvic wall"
^ONCO(165.8,55,"V9T",16,0)="T3"
^ONCO(165.8,55,"V9T",16,1)="Carcinoma involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney"
^ONCO(165.8,55,"V9T",17,0)="T3a"
^ONCO(165.8,55,"V9T",17,1)="Carcinoma involves lower third of the vagina, with no extension to the pelvic wall"
^ONCO(165.8,55,"V9T",18,0)="T3b"
^ONCO(165.8,55,"V9T",18,1)="Extension to the pelvic wall and/or hydronephrosis or nonfunctioning kidney (unless known to be due to another cause)"
^ONCO(165.8,55,"V9T",19,0)="T4"
^ONCO(165.8,55,"V9T",19,1)="Carcinoma has involved (biopsy-proven) the mucosa of the bladder or rectum, or has spread to adjacent organs. (Bullous edema, as such, does not permit a case to be assigned to stage IVA.)"
^ONCO(165.8,55,"V9T","B","T0",2)=""
^ONCO(165.8,55,"V9T","B","T1",3)=""
^ONCO(165.8,55,"V9T","B","T1a",4)=""
^ONCO(165.8,55,"V9T","B","T1a1",5)=""
^ONCO(165.8,55,"V9T","B","T1a2",6)=""
^ONCO(165.8,55,"V9T","B","T1b",7)=""
^ONCO(165.8,55,"V9T","B","T1b1",8)=""
^ONCO(165.8,55,"V9T","B","T1b2",9)=""
^ONCO(165.8,55,"V9T","B","T1b3",10)=""
^ONCO(165.8,55,"V9T","B","T2",11)=""
^ONCO(165.8,55,"V9T","B","T2a",12)=""
^ONCO(165.8,55,"V9T","B","T2a1",13)=""
^ONCO(165.8,55,"V9T","B","T2a2",14)=""
^ONCO(165.8,55,"V9T","B","T2b",15)=""
^ONCO(165.8,55,"V9T","B","T3",16)=""
^ONCO(165.8,55,"V9T","B","T3a",17)=""
^ONCO(165.8,55,"V9T","B","T3b",18)=""
^ONCO(165.8,55,"V9T","B","T4",19)=""
^ONCO(165.8,55,"V9T","B","TX",1)=""
^ONCO(165.8,56,0)="53^Corpus Uteri - Carcinoma and Carcinosarcoma"
^ONCO(165.8,56,1,0)="^165.82IA^10^10"
^ONCO(165.8,56,1,1,0)="TX"
^ONCO(165.8,56,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,56,1,2,0)="T0"
^ONCO(165.8,56,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,56,1,3,0)="T1"
^ONCO(165.8,56,1,3,1)="Tumor confined to the corpus uteri, including endocervical glandular involvement"
^ONCO(165.8,56,1,4,0)="T1a"
^ONCO(165.8,56,1,4,1)="Tumor limited to the endometrium or invading less than half the myometrium"
^ONCO(165.8,56,1,5,0)="T1b"
^ONCO(165.8,56,1,5,1)="Tumor invading one half or more of the myometrium"
^ONCO(165.8,56,1,6,0)="T2"
^ONCO(165.8,56,1,6,1)="Tumor invading the stromal connective tissue of the cervix but not extending beyond the uterus. Does NOT include endocervical glandular involvement."
^ONCO(165.8,56,1,7,0)="T3"
^ONCO(165.8,56,1,7,1)="Tumor involving serosa, adnexa, vagina, or parametrium"
^ONCO(165.8,56,1,8,0)="T3a"
^ONCO(165.8,56,1,8,1)="Tumor involving the serosa and/or adnexa (direct extension or metastasis)"
^ONCO(165.8,56,1,9,0)="T3b"
^ONCO(165.8,56,1,9,1)="Vaginal involvement (direct extension or metastasis) or parametrial involvement"
^ONCO(165.8,56,1,10,0)="T4"
^ONCO(165.8,56,1,10,1)="Tumor invading the bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4)"
^ONCO(165.8,56,1,"B","T0",2)=""
^ONCO(165.8,56,1,"B","T1",3)=""
^ONCO(165.8,56,1,"B","T1a",4)=""
^ONCO(165.8,56,1,"B","T1b",5)=""
^ONCO(165.8,56,1,"B","T2",6)=""
^ONCO(165.8,56,1,"B","T3",7)=""
^ONCO(165.8,56,1,"B","T3a",8)=""
^ONCO(165.8,56,1,"B","T3b",9)=""
^ONCO(165.8,56,1,"B","T4",10)=""
^ONCO(165.8,56,1,"B","TX",1)=""
^ONCO(165.8,56,2,0)="^165.83IA^9^9"
^ONCO(165.8,56,2,1,0)="NX"
^ONCO(165.8,56,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,56,2,2,0)="N0"
^ONCO(165.8,56,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,56,2,3,0)="N0(i+)"
^ONCO(165.8,56,2,3,1)="Isolated tumor cells in regional lymph node(s) no greater than 0.2 mm"
^ONCO(165.8,56,2,4,0)="N1"
^ONCO(165.8,56,2,4,1)="Regional lymph node metastasis to pelvic lymph nodes"
^ONCO(165.8,56,2,5,0)="N1mi"
^ONCO(165.8,56,2,5,1)="Regional lymph node metastasis (greater than 0.2mm but not greater than 2.0mm in diameter) to pelvic lymph nodes"
^ONCO(165.8,56,2,6,0)="N1a"
^ONCO(165.8,56,2,6,1)="Regional lymph node metastasis (greater than 2.0 mm in diameter) to pelvic lymph nodes"
^ONCO(165.8,56,2,7,0)="N2"
^ONCO(165.8,56,2,7,1)="Regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes"
^ONCO(165.8,56,2,8,0)="N2mi"
^ONCO(165.8,56,2,8,1)="Regional lymph node metastasis (greater than 0.2mm but not greater than 2.0mm in diameter) para-aortic lymph nodes, with or without positive pelvic lymph nodes to"
^ONCO(165.8,56,2,9,0)="N2a"
^ONCO(165.8,56,2,9,1)="Regional lymph node metastasis (greater than 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes"
^ONCO(165.8,56,2,"B","N0",2)=""
^ONCO(165.8,56,2,"B","N0(i+)",3)=""
^ONCO(165.8,56,2,"B","N1",4)=""
^ONCO(165.8,56,2,"B","N1a",6)=""
^ONCO(165.8,56,2,"B","N1mi",5)=""
^ONCO(165.8,56,2,"B","N2",7)=""
^ONCO(165.8,56,2,"B","N2a",9)=""
^ONCO(165.8,56,2,"B","N2mi",8)=""
^ONCO(165.8,56,2,"B","NX",1)=""
^ONCO(165.8,56,3,0)="^165.84IA^3^3"
^ONCO(165.8,56,3,1,0)="cM0"
^ONCO(165.8,56,3,1,1)="No distant metastasis"
^ONCO(165.8,56,3,2,0)="cM1"
^ONCO(165.8,56,3,2,1)="Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone) with FIGO Stage IVB (It excludes metastasis to pelvic or para-aortic lymph nodes, vagina, uterine serosa, or adnexa.)"
^ONCO(165.8,56,3,3,0)="pM1"
^ONCO(165.8,56,3,3,1)="Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone) with FIGO Stage IVB (It excludes metastasis to pelvic or para-aortic lymph nodes, vagina, uterine serosa, or adnexa.)"
^ONCO(165.8,56,3,"B","cM0",1)=""
^ONCO(165.8,56,3,"B","cM1",2)=""
^ONCO(165.8,56,3,"B","pM1",3)=""
^ONCO(165.8,57,0)="54.1^Corpus Uteri - Leiomyosarcoma and Endometrial Stromal Sarcoma"
^ONCO(165.8,57,1,0)="^165.82IA^12^12"
^ONCO(165.8,57,1,1,0)="TX"
^ONCO(165.8,57,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,57,1,2,0)="T0"
^ONCO(165.8,57,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,57,1,3,0)="T1"
^ONCO(165.8,57,1,3,1)="Tumor limited to the uterus"
^ONCO(165.8,57,1,4,0)="T1a"
^ONCO(165.8,57,1,4,1)="Tumor 5 cm or less in greatest dimension"
^ONCO(165.8,57,1,5,0)="T1b"
^ONCO(165.8,57,1,5,1)="Tumor more than 5 cm"
^ONCO(165.8,57,1,6,0)="T2"
^ONCO(165.8,57,1,6,1)="Tumor extends beyond the uterus, within the pelvis"
^ONCO(165.8,57,1,7,0)="T2a"
^ONCO(165.8,57,1,7,1)="Tumor involves adnexa"
^ONCO(165.8,57,1,8,0)="T2b"
^ONCO(165.8,57,1,8,1)="Tumor involves other pelvic tissues"
^ONCO(165.8,57,1,9,0)="T3"
^ONCO(165.8,57,1,9,1)="Tumor infiltrates abdominal tissues"
^ONCO(165.8,57,1,10,0)="T3a"
^ONCO(165.8,57,1,10,1)="Tumor infiltrates abdominal tissues in one site"
^ONCO(165.8,57,1,11,0)="T3b"
^ONCO(165.8,57,1,11,1)="Tumor infiltrates abdominal tissues in more than one site"
^ONCO(165.8,57,1,12,0)="T4"
^ONCO(165.8,57,1,12,1)="Tumor ivades bladder or rectum"
^ONCO(165.8,57,1,"B","T0",2)=""
^ONCO(165.8,57,1,"B","T1",3)=""
^ONCO(165.8,57,1,"B","T1a",4)=""
^ONCO(165.8,57,1,"B","T1b",5)=""
^ONCO(165.8,57,1,"B","T2",6)=""
^ONCO(165.8,57,1,"B","T2a",7)=""
^ONCO(165.8,57,1,"B","T2b",8)=""
^ONCO(165.8,57,1,"B","T3",9)=""
^ONCO(165.8,57,1,"B","T3a",10)=""
^ONCO(165.8,57,1,"B","T3b",11)=""
^ONCO(165.8,57,1,"B","T4",12)=""
^ONCO(165.8,57,1,"B","TX",1)=""
^ONCO(165.8,57,2,0)="^165.83IA^4^4"
^ONCO(165.8,57,2,1,0)="NX"
^ONCO(165.8,57,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,57,2,2,0)="N0"
^ONCO(165.8,57,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,57,2,3,0)="N0(i+)"
^ONCO(165.8,57,2,3,1)="Isolated tumor cells in regional lymph node(s) no greater than 0.2mm"
^ONCO(165.8,57,2,4,0)="N1"
^ONCO(165.8,57,2,4,1)="Regional lymph node metastasis"
^ONCO(165.8,57,2,"B","N0",2)=""
^ONCO(165.8,57,2,"B","N0(i+)",3)=""
^ONCO(165.8,57,2,"B","N1",4)=""
^ONCO(165.8,57,2,"B","NX",1)=""
^ONCO(165.8,57,3,0)="^165.84IA^3^3"
^ONCO(165.8,57,3,1,0)="cM0"
^ONCO(165.8,57,3,1,1)="No distant metastasis"
^ONCO(165.8,57,3,2,0)="cM1"
^ONCO(165.8,57,3,2,1)="Distant metastasis (excluding adnexa, pelvic, and abdominal tissues)"
^ONCO(165.8,57,3,3,0)="pM1"
^ONCO(165.8,57,3,3,1)="Distant metastasis (excluding adnexa, pelvic, and abdominal tissues) microscopically confirmed"
^ONCO(165.8,57,3,"B","cM0",1)=""
^ONCO(165.8,57,3,"B","cM1",2)=""
^ONCO(165.8,57,3,"B","pM1",3)=""
^ONCO(165.8,58,0)="54.2^Corpus Uteri - Adenosarcoma^^54.1"
^ONCO(165.8,58,1,0)="^165.82IA^13^13"
^ONCO(165.8,58,1,1,0)="TX"
^ONCO(165.8,58,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,58,1,2,0)="T0"
^ONCO(165.8,58,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,58,1,3,0)="T1"
^ONCO(165.8,58,1,3,1)="Tumor limited to the uterus"
^ONCO(165.8,58,1,4,0)="T1a"
^ONCO(165.8,58,1,4,1)="Tumor limited to the endometrium/endocervix"
^ONCO(165.8,58,1,5,0)="T1b"
^ONCO(165.8,58,1,5,1)="Tumor invades to less than half of the myometrium"
^ONCO(165.8,58,1,6,0)="T1c"
^ONCO(165.8,58,1,6,1)="Tumor invades one half or more of the myometrium"
^ONCO(165.8,58,1,7,0)="T2"
^ONCO(165.8,58,1,7,1)="Tumor extends beyond the uterus, within the pelvis"
^ONCO(165.8,58,1,8,0)="T2a"
^ONCO(165.8,58,1,8,1)="Tumor involves adnexa"
^ONCO(165.8,58,1,9,0)="T2b"
^ONCO(165.8,58,1,9,1)="Tumor involves other pelvic tissues"
^ONCO(165.8,58,1,10,0)="T3"
^ONCO(165.8,58,1,10,1)="Tumor infiltrates abdominal tissues"
^ONCO(165.8,58,1,11,0)="T3a"
^ONCO(165.8,58,1,11,1)="Tumor infiltrates abdominal tissues in one site"
^ONCO(165.8,58,1,12,0)="T3b"
^ONCO(165.8,58,1,12,1)="Tumor infiltrates abdominal tissues in more than one site"
^ONCO(165.8,58,1,13,0)="T4"
^ONCO(165.8,58,1,13,1)="Tumor invades bladder or rectum"
^ONCO(165.8,58,1,"B","T0",2)=""
^ONCO(165.8,58,1,"B","T1",3)=""
^ONCO(165.8,58,1,"B","T1a",4)=""
^ONCO(165.8,58,1,"B","T1b",5)=""
^ONCO(165.8,58,1,"B","T1c",6)=""
^ONCO(165.8,58,1,"B","T2",7)=""
^ONCO(165.8,58,1,"B","T2a",8)=""
^ONCO(165.8,58,1,"B","T2b",9)=""
^ONCO(165.8,58,1,"B","T3",10)=""
^ONCO(165.8,58,1,"B","T3a",11)=""
^ONCO(165.8,58,1,"B","T3b",12)=""
^ONCO(165.8,58,1,"B","T4",13)=""
^ONCO(165.8,58,1,"B","TX",1)=""
^ONCO(165.8,59,0)="55^Ovary, Fallopian Tube and Primary Peritoneal Carcinoma"
^ONCO(165.8,59,1,0)="^165.82IA^16^16"
^ONCO(165.8,59,1,1,0)="TX"
^ONCO(165.8,59,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,59,1,2,0)="T0"
^ONCO(165.8,59,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,59,1,3,0)="T1"
^ONCO(165.8,59,1,3,1)="Tumor limited to ovaries (one or both) or fallopian tube(s)"
^ONCO(165.8,59,1,4,0)="T1a"
^ONCO(165.8,59,1,4,1)="Tumor limited to one ovary (capsule intact) or fallopian tube, no tumor on ovarian or fallopian tube surface; no malignant cells in ascites or peritoneal washings"
^ONCO(165.8,59,1,5,0)="T1b"
^ONCO(165.8,59,1,5,1)="Tumor limited to both ovaries (capsules intact) or fallopian tubes; no tumor on ovarian or fallopian tube surface; no malignant cells in ascites or peritoneal washings"
^ONCO(165.8,59,1,6,0)="T1c"
^ONCO(165.8,59,1,6,1)="Tumor limited to one or both ovaries or fallopian tubes, with any of the following:"
^ONCO(165.8,59,1,7,0)="T1c1"
^ONCO(165.8,59,1,7,1)="Surgical spill"
^ONCO(165.8,59,1,8,0)="T1c2"
^ONCO(165.8,59,1,8,1)="Capsule ruptured before surgery or tumor on ovarian or fallopian tube surface"
^ONCO(165.8,59,1,9,0)="T2"
^ONCO(165.8,59,1,9,1)="Tumor involves one or both ovaries or fallopian tubes with pelvic extension below pelvic brim or primary peritoneal cancer"
^ONCO(165.8,59,1,10,0)="T2a"
^ONCO(165.8,59,1,10,1)="Extension and/or implants on the uterus and/or fallopian tube(s) and/or ovaries"
^ONCO(165.8,59,1,11,0)="T2b"
^ONCO(165.8,59,1,11,1)="Extension to and/or implants on other pelvic tissues"
^ONCO(165.8,59,1,12,0)="T3"
^ONCO(165.8,59,1,12,1)="Tumor involves one or both ovaries or fallopian tubes, or primary peritoneal cancer, with microscopically confirmed peritoneal metastasis outside the pelvis and/or metastasis to the retroperitoneal (pelvic and/or para-aortic) lymph nodes"
^ONCO(165.8,59,1,13,0)="T3a"
^ONCO(165.8,59,1,13,1)="Microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes"
^ONCO(165.8,59,1,14,0)="T3b"
^ONCO(165.8,59,1,14,1)="Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension with or without metastasis to the retroperitoneal lymph nodes"
^ONCO(165.8,59,1,15,0)="T3c"
^ONCO(165.8,59,1,15,1)="Macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ)"
^ONCO(165.8,59,1,16,0)="T1c3"
^ONCO(165.8,59,1,16,1)="Malignant cells in ascites or peritoneal washings"
^ONCO(165.8,59,1,"B","T0",2)=""
^ONCO(165.8,59,1,"B","T1",3)=""
^ONCO(165.8,59,1,"B","T1a",4)=""
^ONCO(165.8,59,1,"B","T1b",5)=""
^ONCO(165.8,59,1,"B","T1c",6)=""
^ONCO(165.8,59,1,"B","T1c1",7)=""
^ONCO(165.8,59,1,"B","T1c2",8)=""
^ONCO(165.8,59,1,"B","T1c3",16)=""
^ONCO(165.8,59,1,"B","T2",9)=""
^ONCO(165.8,59,1,"B","T2a",10)=""
^ONCO(165.8,59,1,"B","T2b",11)=""
^ONCO(165.8,59,1,"B","T3",12)=""
^ONCO(165.8,59,1,"B","T3a",13)=""
^ONCO(165.8,59,1,"B","T3b",14)=""
^ONCO(165.8,59,1,"B","T3c",15)=""
^ONCO(165.8,59,1,"B","TX",1)=""
^ONCO(165.8,59,2,0)="^165.83IA^6^6"
^ONCO(165.8,59,2,1,0)="NX"
^ONCO(165.8,59,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,59,2,2,0)="N0"
^ONCO(165.8,59,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,59,2,3,0)="N0(i+)"
^ONCO(165.8,59,2,3,1)="Isolated tumor cells in regional lymph node(s) no greater than 0.2mm"
^ONCO(165.8,59,2,4,0)="N1"
^ONCO(165.8,59,2,4,1)="Positive retroperitoneal lymph nodes only (histologically confirmed)"
^ONCO(165.8,59,2,5,0)="N1a"
^ONCO(165.8,59,2,5,1)="Metastasis up to and including 10m in greatest dimension"
^ONCO(165.8,59,2,6,0)="N1b"
^ONCO(165.8,59,2,6,1)="Metastasis more than 10mm in greatest dimension"
^ONCO(165.8,59,2,"B","N0",2)=""
^ONCO(165.8,59,2,"B","N0(i+)",3)=""
^ONCO(165.8,59,2,"B","N1",4)=""
^ONCO(165.8,59,2,"B","N1a",5)=""
^ONCO(165.8,59,2,"B","N1b",6)=""
^ONCO(165.8,59,2,"B","NX",1)=""
^ONCO(165.8,59,3,0)="^165.84IA^7^6"
^ONCO(165.8,59,3,1,0)="cM0"
^ONCO(165.8,59,3,1,1)="No distant metastasis"
^ONCO(165.8,59,3,2,0)="cM1"
^ONCO(165.8,59,3,2,1)="Distant metastasis, including pleural effusion with positive cytology; liver or splenic parenchymal metastasis; metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); and transmural involvement of intestine"
^ONCO(165.8,59,3,4,0)="cM1b"
^ONCO(165.8,59,3,4,1)="Liver or splenic parenchymal metastases; metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); transmural involvement of intestine"
^ONCO(165.8,59,3,5,0)="pM1"
^ONCO(165.8,59,3,5,1)="Distant metastasis, including pleural effusion with positive cytology; liver or splenic parenchymal metastasis; metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); and transmural involvement of intestine, microscopically confirmed"
^ONCO(165.8,59,3,6,0)="pM1a"
^ONCO(165.8,59,3,6,1)="Pleural effusion with positive cytology, microscopically confirmed"
^ONCO(165.8,59,3,7,0)="pM1b"
^ONCO(165.8,59,3,7,1)="Liver or splenic parenchymal metastases; metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); transmural involvement of intestine, microscopically confirmed"
^ONCO(165.8,59,3,"B","cM0",1)=""
^ONCO(165.8,59,3,"B","cM1",2)=""
^ONCO(165.8,59,3,"B","cM1b",4)=""
^ONCO(165.8,59,3,"B","pM1",5)=""
^ONCO(165.8,59,3,"B","pM1a",6)=""
^ONCO(165.8,59,3,"B","pM1b",7)=""
^ONCO(165.8,60,0)="56^Gestational Trophoblastic Neoplasms"
^ONCO(165.8,60,1,0)="^165.82IA^4^4"
^ONCO(165.8,60,1,1,0)="TX"
^ONCO(165.8,60,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,60,1,2,0)="T0"
^ONCO(165.8,60,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,60,1,3,0)="T1"
^ONCO(165.8,60,1,3,1)="Tumor confined to uterus"
^ONCO(165.8,60,1,4,0)="T2"
^ONCO(165.8,60,1,4,1)="Tumor extends to other genital structures (ovary, tube, vagina, broad ligaments) by metastasis or direct extension"
^ONCO(165.8,60,1,"B","T0",2)=""
^ONCO(165.8,60,1,"B","T1",3)=""
^ONCO(165.8,60,1,"B","T2",4)=""
^ONCO(165.8,60,1,"B","TX",1)=""
^ONCO(165.8,60,3,0)="^165.84IA^7^7"
^ONCO(165.8,60,3,1,0)="cM0"
^ONCO(165.8,60,3,1,1)="No distant metastasis"
^ONCO(165.8,60,3,2,0)="cM1"
^ONCO(165.8,60,3,2,1)="Distant metastasis"
^ONCO(165.8,60,3,3,0)="cM1a"
^ONCO(165.8,60,3,3,1)="Lung metastasis"
^ONCO(165.8,60,3,4,0)="cM1b"
^ONCO(165.8,60,3,4,1)="All other distant metastases"
^ONCO(165.8,60,3,5,0)="pM1"
^ONCO(165.8,60,3,5,1)="Distant metastasis, microscopically confirmed"
^ONCO(165.8,60,3,6,0)="pM1a"
^ONCO(165.8,60,3,6,1)="Lung metastasis, microscopically confirmed"
^ONCO(165.8,60,3,7,0)="pM1b"
^ONCO(165.8,60,3,7,1)="All other distant metastases, microscopically confirmed"
^ONCO(165.8,60,3,"B","cM0",1)=""
^ONCO(165.8,60,3,"B","cM1",2)=""
^ONCO(165.8,60,3,"B","cM1a",3)=""
^ONCO(165.8,60,3,"B","cM1b",4)=""
^ONCO(165.8,60,3,"B","pM1",5)=""
^ONCO(165.8,60,3,"B","pM1a",6)=""
^ONCO(165.8,60,3,"B","pM1b",7)=""
^ONCO(165.8,61,0)="57^Penis^^^6"
^ONCO(165.8,61,1,0)="^165.82IA^10^10"
^ONCO(165.8,61,1,1,0)="TX"
^ONCO(165.8,61,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,61,1,2,0)="T0"
^ONCO(165.8,61,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,61,1,3,0)="Tis"
^ONCO(165.8,61,1,3,1)="Carcinoma in situ (Penile intraepithelial neoplasia [PeIN])"
^ONCO(165.8,61,1,4,0)="Ta"
^ONCO(165.8,61,1,4,1)="Noninvasive localized squamous cell carcinoma"
^ONCO(165.8,61,1,5,0)="T1"
^ONCO(165.8,61,1,5,1)="Glans: Tumor invades lamina propria; Foreskin: Tumor invades dermis, lamina propria, or dartos fascia; Shaft: Tumor invades connective tissue between epidermis and corpora regardless of location; All sites with or without lymphovascular invasion or perineural invasion and is or is not high grade"
^ONCO(165.8,61,1,6,0)="T1a"
^ONCO(165.8,61,1,6,1)="Tumor is without lymphovascular invasion or perineural invasion and is not high grade (i.e., grade 3 or sarcomatoid)"
^ONCO(165.8,61,1,7,0)="T1b"
^ONCO(165.8,61,1,7,1)="Tumor exhibits lymphovascular invasion and/or perineural invasion or is high grade (i.e., grade 3 or sarcomatoid)"
^ONCO(165.8,61,1,8,0)="T2"
^ONCO(165.8,61,1,8,1)="Tumor invades into corpus spongiosum (either glans or ventral shaft) with or without urethral invasion"
^ONCO(165.8,61,1,9,0)="T3"
^ONCO(165.8,61,1,9,1)="Tumor invades into corpora cavernosum (including tunica albuginea) with or without urethral invasion"
^ONCO(165.8,61,1,10,0)="T4"
^ONCO(165.8,61,1,10,1)="Tumor invades into adjacent structures (i.e., scrotum, prostate, pubic bone)"
^ONCO(165.8,61,1,"B","T0",2)=""
^ONCO(165.8,61,1,"B","T1",5)=""
^ONCO(165.8,61,1,"B","T1a",6)=""
^ONCO(165.8,61,1,"B","T1b",7)=""
^ONCO(165.8,61,1,"B","T2",8)=""
^ONCO(165.8,61,1,"B","T3",9)=""
^ONCO(165.8,61,1,"B","T4",10)=""
^ONCO(165.8,61,1,"B","TX",1)=""
^ONCO(165.8,61,1,"B","Ta",4)=""
^ONCO(165.8,61,1,"B","Tis",3)=""
^ONCO(165.8,61,2,0)="^165.83IA^5^5"
^ONCO(165.8,61,2,1,0)="NX"
^ONCO(165.8,61,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,61,2,2,0)="N0"
^ONCO(165.8,61,2,2,1)="No palpable or visibly enlarged inguinal lymph nodes"
^ONCO(165.8,61,2,3,0)="N1"
^ONCO(165.8,61,2,3,1)="Palpable mobile unilateral inguinal lymph node"
^ONCO(165.8,61,2,4,0)="N2"
^ONCO(165.8,61,2,4,1)="Palpable mobile >= 2 unilateral inguinal nodes or bilateral inguinal lymph nodes"
^ONCO(165.8,61,2,5,0)="N3"
^ONCO(165.8,61,2,5,1)="Palpable fixed inguinal nodal mass or pelvic lymphadenopathy unilateral or bilateral"
^ONCO(165.8,61,2,"B","N0",2)=""
^ONCO(165.8,61,2,"B","N1",3)=""
^ONCO(165.8,61,2,"B","N2",4)=""
^ONCO(165.8,61,2,"B","N3",5)=""
^ONCO(165.8,61,2,"B","NX",1)=""
^ONCO(165.8,61,7,0)="^165.88AI^5^5"
^ONCO(165.8,61,7,1,0)="NX"
^ONCO(165.8,61,7,1,1)="Lymph node metastasis cannot be established"
^ONCO(165.8,61,7,2,0)="N0"
^ONCO(165.8,61,7,2,1)="No lymph node metastasis"
^ONCO(165.8,61,7,3,0)="N1"
^ONCO(165.8,61,7,3,1)="<= 2 unilateral inguinal metastases, no ENE"
^ONCO(165.8,61,7,4,0)="N2"
^ONCO(165.8,61,7,4,1)=">= 3 unilateral inguinal metastases or bilateral metastases, no ENE"
^ONCO(165.8,61,7,5,0)="N3"
^ONCO(165.8,61,7,5,1)="ENE of lymph node metastases or pelvic node metastases"
^ONCO(165.8,61,7,"B","N0",2)=""
^ONCO(165.8,61,7,"B","N1",3)=""
^ONCO(165.8,61,7,"B","N2",4)=""
^ONCO(165.8,61,7,"B","N3",5)=""
^ONCO(165.8,61,7,"B","NX",1)=""
^ONCO(165.8,62,0)="58^Prostate"
^ONCO(165.8,62,1,0)="^165.82IA^14^14"
^ONCO(165.8,62,1,1,0)="TX"
^ONCO(165.8,62,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,62,1,2,0)="T0"
^ONCO(165.8,62,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,62,1,3,0)="T1"
^ONCO(165.8,62,1,3,1)="Clinically inapparent tumor that is not palpable"
^ONCO(165.8,62,1,4,0)="T1a"
^ONCO(165.8,62,1,4,1)="Tumor incidental histologic finding in 5% or less of tissue resected"
^ONCO(165.8,62,1,5,0)="T1b"
^ONCO(165.8,62,1,5,1)="Tumor incidental histologic finding in more than 5% of tissue resected"
^ONCO(165.8,62,1,6,0)="T1c"
^ONCO(165.8,62,1,6,1)="Tumor identified by needle biopsy found in one or both sides, but not palpable"
^ONCO(165.8,62,1,7,0)="T2"
^ONCO(165.8,62,1,7,1)="Tumor is palpable and confined within prostate"
^ONCO(165.8,62,1,8,0)="T2a"
^ONCO(165.8,62,1,8,1)="Tumor involves one-half of one side or less"
^ONCO(165.8,62,1,9,0)="T2b"
^ONCO(165.8,62,1,9,1)="Tumor involves more than one-half of one side but not both sides"
^ONCO(165.8,62,1,10,0)="T2c"
^ONCO(165.8,62,1,10,1)="Tumor involves both sides"
^ONCO(165.8,62,1,11,0)="T3"
^ONCO(165.8,62,1,11,1)="Extraprostatic tumor that is not fixed or does not invade adjacent structures"
^ONCO(165.8,62,1,12,0)="T3a"
^ONCO(165.8,62,1,12,1)="Extraprostatic extension (unilateral or bilateral)"
^ONCO(165.8,62,1,13,0)="T3b"
^ONCO(165.8,62,1,13,1)="Tumor invades seminal vesicle(s)"
^ONCO(165.8,62,1,14,0)="T4"
^ONCO(165.8,62,1,14,1)="Tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles and/or pelvic wall"
^ONCO(165.8,62,1,"B","T0",2)=""
^ONCO(165.8,62,1,"B","T1",3)=""
^ONCO(165.8,62,1,"B","T1a",4)=""
^ONCO(165.8,62,1,"B","T1b",5)=""
^ONCO(165.8,62,1,"B","T1c",6)=""
^ONCO(165.8,62,1,"B","T2",7)=""
^ONCO(165.8,62,1,"B","T2a",8)=""
^ONCO(165.8,62,1,"B","T2b",9)=""
^ONCO(165.8,62,1,"B","T2c",10)=""
^ONCO(165.8,62,1,"B","T3",11)=""
^ONCO(165.8,62,1,"B","T3a",12)=""
^ONCO(165.8,62,1,"B","T3b",13)=""
^ONCO(165.8,62,1,"B","T4",14)=""
^ONCO(165.8,62,1,"B","TX",1)=""
^ONCO(165.8,62,2,0)="^165.83IA^3^3"
^ONCO(165.8,62,2,1,0)="NX"
^ONCO(165.8,62,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,62,2,2,0)="N0"
^ONCO(165.8,62,2,2,1)="No positive regional nodes"
^ONCO(165.8,62,2,3,0)="N1"
^ONCO(165.8,62,2,3,1)="Metastases in regional node(s)"
^ONCO(165.8,62,2,"B","N0",2)=""
^ONCO(165.8,62,2,"B","N1",3)=""
^ONCO(165.8,62,2,"B","NX",1)=""
^ONCO(165.8,62,3,0)="^165.84IA^9^9"
^ONCO(165.8,62,3,1,0)="cM0"
^ONCO(165.8,62,3,1,1)="No distant metastasis"
^ONCO(165.8,62,3,2,0)="cM1"
^ONCO(165.8,62,3,2,1)="Distant metastasis"
^ONCO(165.8,62,3,3,0)="cM1a"
^ONCO(165.8,62,3,3,1)="Nonregional lymph node(s)"
^ONCO(165.8,62,3,4,0)="cM1b"
^ONCO(165.8,62,3,4,1)="Bone(s)"
^ONCO(165.8,62,3,5,0)="cM1c"
^ONCO(165.8,62,3,5,1)="Other site(s) with or without bone disease"
^ONCO(165.8,62,3,6,0)="pM1"
^ONCO(165.8,62,3,6,1)="Distant metastasis, microscopically confirmed"
^ONCO(165.8,62,3,7,0)="pM1a"
^ONCO(165.8,62,3,7,1)="Nonregional lymph node(s), microscopically confirmed"
^ONCO(165.8,62,3,8,0)="pM1b"
^ONCO(165.8,62,3,8,1)="Bone(s), microscopically confirmed"
^ONCO(165.8,62,3,9,0)="pM1c"
^ONCO(165.8,62,3,9,1)="Other site(s) with or without bone disease, microscopically confirmed"
^ONCO(165.8,62,3,"B","cM0",1)=""
^ONCO(165.8,62,3,"B","cM1",2)=""
^ONCO(165.8,62,3,"B","cM1a",3)=""
^ONCO(165.8,62,3,"B","cM1b",4)=""
^ONCO(165.8,62,3,"B","cM1c",5)=""
^ONCO(165.8,62,3,"B","pM1",6)=""
^ONCO(165.8,62,3,"B","pM1a",7)=""
^ONCO(165.8,62,3,"B","pM1b",8)=""
^ONCO(165.8,62,3,"B","pM1c",9)=""
^ONCO(165.8,62,6,0)="^165.87IA^5^5"
^ONCO(165.8,62,6,1,0)="T2"
^ONCO(165.8,62,6,1,1)="Organ confined"
^ONCO(165.8,62,6,2,0)="T3"
^ONCO(165.8,62,6,2,1)="Extraprostatic extension"
^ONCO(165.8,62,6,3,0)="T3a"
^ONCO(165.8,62,6,3,1)="Extraprostatic extension (unilateral or bilateral) or microscopic invasion of bladder neck"
^ONCO(165.8,62,6,4,0)="T3b"
^ONCO(165.8,62,6,4,1)="Tumor invades seminal vesicle(s)"
^ONCO(165.8,62,6,5,0)="T4"
^ONCO(165.8,62,6,5,1)="Tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscle, and/or pelvic wall"
^ONCO(165.8,62,6,"B","T2",1)=""
^ONCO(165.8,62,6,"B","T3",2)=""
^ONCO(165.8,62,6,"B","T3a",3)=""
^ONCO(165.8,62,6,"B","T3b",4)=""
^ONCO(165.8,62,6,"B","T4",5)=""
^ONCO(165.8,63,0)="59^Testis"
^ONCO(165.8,63,1,0)="^165.82IA^4^4"
^ONCO(165.8,63,1,1,0)="TX"
^ONCO(165.8,63,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,63,1,2,0)="T0"
^ONCO(165.8,63,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,63,1,3,0)="Tis"
^ONCO(165.8,63,1,3,1)="Germ cell neoplasia in situ"
^ONCO(165.8,63,1,4,0)="T4"
^ONCO(165.8,63,1,4,1)="Tumor invades scrotum with or without vascular/lymphatic invasion"
^ONCO(165.8,63,1,"B","T0",2)=""
^ONCO(165.8,63,1,"B","T4",4)=""
^ONCO(165.8,63,1,"B","TX",1)=""
^ONCO(165.8,63,1,"B","Tis",3)=""
^ONCO(165.8,63,2,0)="^165.83IA^5^5"
^ONCO(165.8,63,2,1,0)="NX"
^ONCO(165.8,63,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,63,2,2,0)="N0"
^ONCO(165.8,63,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,63,2,3,0)="N1"
^ONCO(165.8,63,2,3,1)="Metastasis with a lymph node mass 2cm or smaller in greatest dimension OR Multiple lymph nodes, none larger than 2cm in greatest dimension"
^ONCO(165.8,63,2,4,0)="N2"
^ONCO(165.8,63,2,4,1)="Metastasis with a lymph node mass larger than 2 cm but not larger than 5cm in greatest dimension OR Multiple lymph nodes, any one mass larger than 2 cm but not larger than 5cm in greatest dimension"
^ONCO(165.8,63,2,5,0)="N3"
^ONCO(165.8,63,2,5,1)="Metastasis with a lymph node mass larger than 5cm in greatest dimension"
^ONCO(165.8,63,2,"B","N0",2)=""
^ONCO(165.8,63,2,"B","N1",3)=""
^ONCO(165.8,63,2,"B","N2",4)=""
^ONCO(165.8,63,2,"B","N3",5)=""
^ONCO(165.8,63,2,"B","NX",1)=""
^ONCO(165.8,63,3,0)="^165.84IA^7^7"
^ONCO(165.8,63,3,1,0)="cM0"
^ONCO(165.8,63,3,1,1)="No distant metastasis"
^ONCO(165.8,63,3,2,0)="cM1"
^ONCO(165.8,63,3,2,1)="Distant metastasis"
^ONCO(165.8,63,3,3,0)="cM1a"
^ONCO(165.8,63,3,3,1)="Non-retroperitoneal nodal or pulmonary metastases"
^ONCO(165.8,63,3,4,0)="cM1b"
^ONCO(165.8,63,3,4,1)="Non-pulmonary visceral metastases"
^ONCO(165.8,63,3,5,0)="pM1"
^ONCO(165.8,63,3,5,1)="Distant metastasis, microscopically confirmed"
^ONCO(165.8,63,3,6,0)="pM1a"
^ONCO(165.8,63,3,6,1)="Non-retroperitoneal nodal or pulmonary metastases, microscopically confirmed"
^ONCO(165.8,63,3,7,0)="pM1b"
^ONCO(165.8,63,3,7,1)="Non-pulmonary visceral metastases, microscopically confirmed"
^ONCO(165.8,63,3,"B","cM0",1)=""
^ONCO(165.8,63,3,"B","cM1",2)=""
^ONCO(165.8,63,3,"B","cM1a",3)=""
^ONCO(165.8,63,3,"B","cM1b",4)=""
^ONCO(165.8,63,3,"B","pM1",5)=""
^ONCO(165.8,63,3,"B","pM1a",6)=""
^ONCO(165.8,63,3,"B","pM1b",7)=""
^ONCO(165.8,63,6,0)="^165.87IA^9^9"
^ONCO(165.8,63,6,1,0)="TX"
^ONCO(165.8,63,6,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,63,6,2,0)="T0"
^ONCO(165.8,63,6,2,1)="No evidence of primary tumor"
^ONCO(165.8,63,6,3,0)="Tis"
^ONCO(165.8,63,6,3,1)="Germ cell neoplasia in situ"
^ONCO(165.8,63,6,4,0)="T1"
^ONCO(165.8,63,6,4,1)="Tumor limited to testis (including rete testis invasion) without lymphovascular invasion"
^ONCO(165.8,63,6,5,0)="T1a"
^ONCO(165.8,63,6,5,1)="Tumor smaller than 3cm in size"
^ONCO(165.8,63,6,6,0)="T1b"
^ONCO(165.8,63,6,6,1)="Tumor 3cm or larger in size"
^ONCO(165.8,63,6,7,0)="T2"
^ONCO(165.8,63,6,7,1)="Tumor limited to testis (including rete testis invasion) with lymphovascular invasion OR Tumor invading hilar soft tissue or epididymis or penetrating visceral mesothelial layer covering the external surface of tunica albuginea with or without lymphovascular invasion"
^ONCO(165.8,63,6,8,0)="T3"
^ONCO(165.8,63,6,8,1)="Tumor directly invades spermatic cord soft tissue with or without lymphovascular invasion"
^ONCO(165.8,63,6,9,0)="T4"
^ONCO(165.8,63,6,9,1)="Tumor invades scrotum with or without lymphovascular invasion"
^ONCO(165.8,63,6,"B","T0",2)=""
^ONCO(165.8,63,6,"B","T1",4)=""
^ONCO(165.8,63,6,"B","T1a",5)=""
^ONCO(165.8,63,6,"B","T1b",6)=""
^ONCO(165.8,63,6,"B","T2",7)=""
^ONCO(165.8,63,6,"B","T3",8)=""
^ONCO(165.8,63,6,"B","T4",9)=""
^ONCO(165.8,63,6,"B","TX",1)=""
^ONCO(165.8,63,6,"B","Tis",3)=""
^ONCO(165.8,63,7,0)="^165.88AI^5^5"
^ONCO(165.8,63,7,1,0)="NX"
^ONCO(165.8,63,7,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,63,7,2,0)="N0"
^ONCO(165.8,63,7,2,1)="No regional lymph node metastasis"
^ONCO(165.8,63,7,3,0)="N1"
^ONCO(165.8,63,7,3,1)="Metastasis with a lymph node mass 2cm or smaller in greatest dimension and less than or equal to five nodes positive, none larger than 2cm in greatest dimension"
^ONCO(165.8,63,7,4,0)="N2"
^ONCO(165.8,63,7,4,1)="Metastasis with a lymph node mass larger than 2cm but not larger than 5cm in greatest dimension; or more than five nodes positive, none larger than 5cm; or evidence of extranodal extension of tumor"
^ONCO(165.8,63,7,5,0)="N3"
^ONCO(165.8,63,7,5,1)="Metastasis with a lymph node mass larger than 5cm in greatest dimension"
^ONCO(165.8,63,7,"B","N0",2)=""
^ONCO(165.8,63,7,"B","N1",3)=""
^ONCO(165.8,63,7,"B","N2",4)=""
^ONCO(165.8,63,7,"B","N3",5)=""
^ONCO(165.8,63,7,"B","NX",1)=""
^ONCO(165.8,64,0)="60^Kidney^^14^6"
^ONCO(165.8,64,1,0)="^165.82IA^13^13"
^ONCO(165.8,64,1,1,0)="TX"
^ONCO(165.8,64,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,64,1,2,0)="T0"
^ONCO(165.8,64,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,64,1,3,0)="T1"
^ONCO(165.8,64,1,3,1)="Tumor <= 7cm in greatest dimension, limited to the kidney"
^ONCO(165.8,64,1,4,0)="T1a"
^ONCO(165.8,64,1,4,1)="Tumor <= 4cm in greatest dimension, limited to the kidney"
^ONCO(165.8,64,1,5,0)="T1b"
^ONCO(165.8,64,1,5,1)="Tumor >4 cm but <= 7cm in greatest dimension, limited to the kidney"
^ONCO(165.8,64,1,6,0)="T2"
^ONCO(165.8,64,1,6,1)="Tumor > 7cm in greatest dimension, limited to the kidney"
^ONCO(165.8,64,1,7,0)="T2a"
^ONCO(165.8,64,1,7,1)="Tumor > 7cm but <= 10cm in greatest dimension, limited to the kidney"
^ONCO(165.8,64,1,8,0)="T2b"
^ONCO(165.8,64,1,8,1)="Tumor > 10cm, limited to the kidney"
^ONCO(165.8,64,1,9,0)="T3"
^ONCO(165.8,64,1,9,1)="Tumor extends into major veins or perinephric tissues, but not into the ipsilateral adrenal gland and not beyond Gerota fascia"
^ONCO(165.8,64,1,10,0)="T3a"
^ONCO(165.8,64,1,10,1)="Tumor extends into the renal vein or its segmental branches, or invades the pelvicalyceal system, or invades perirenal and/or renal sinus fat but not beyond the Gerota's fascia"
^ONCO(165.8,64,1,11,0)="T3b"
^ONCO(165.8,64,1,11,1)="Tumor extends into the vena cava below the diaphragm"
^ONCO(165.8,64,1,12,0)="T3c"
^ONCO(165.8,64,1,12,1)="Tumor extends into the vena cava above the diaphragm or invades the wall of the vena cava"
^ONCO(165.8,64,1,13,0)="T4"
^ONCO(165.8,64,1,13,1)="Tumor invades beyond Gerota's fascia (including contiguous extension into the ipsilateral adrenal gland)"
^ONCO(165.8,64,1,"B","T0",2)=""
^ONCO(165.8,64,1,"B","T1",3)=""
^ONCO(165.8,64,1,"B","T1a",4)=""
^ONCO(165.8,64,1,"B","T1b",5)=""
^ONCO(165.8,64,1,"B","T2",6)=""
^ONCO(165.8,64,1,"B","T2a",7)=""
^ONCO(165.8,64,1,"B","T2b",8)=""
^ONCO(165.8,64,1,"B","T3",9)=""
^ONCO(165.8,64,1,"B","T3a",10)=""
^ONCO(165.8,64,1,"B","T3b",11)=""
^ONCO(165.8,64,1,"B","T3c",12)=""
^ONCO(165.8,64,1,"B","T4",13)=""
^ONCO(165.8,64,1,"B","TX",1)=""
^ONCO(165.8,65,0)="61.1^Renal Pelvis and Ureter: Urothelial Carcinomas^^^6"
^ONCO(165.8,65,1,0)="^165.82IA^8^8"
^ONCO(165.8,65,1,1,0)="TX"
^ONCO(165.8,65,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,65,1,2,0)="T0"
^ONCO(165.8,65,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,65,1,3,0)="Ta"
^ONCO(165.8,65,1,3,1)="Papillary noninvasive carcinoma"
^ONCO(165.8,65,1,4,0)="Tis"
^ONCO(165.8,65,1,4,1)="Carcinoma in situ"
^ONCO(165.8,65,1,5,0)="T1"
^ONCO(165.8,65,1,5,1)="Tumor invades subepithelial connective tissue"
^ONCO(165.8,65,1,6,0)="T2"
^ONCO(165.8,65,1,6,1)="Tumor invades the muscularis"
^ONCO(165.8,65,1,7,0)="T3"
^ONCO(165.8,65,1,7,1)="For renal pelvis only: Tumor invades beyond muscularis into peripelvic fat or into the renal parenchyma for ureter only; Tumor invades beyond muscularis into periureteric fat"
^ONCO(165.8,65,1,8,0)="T4"
^ONCO(165.8,65,1,8,1)="Tumor invades adjacent organs, or through the kidney into the perinephric fat"
^ONCO(165.8,65,1,"B","T0",2)=""
^ONCO(165.8,65,1,"B","T1",5)=""
^ONCO(165.8,65,1,"B","T2",6)=""
^ONCO(165.8,65,1,"B","T3",7)=""
^ONCO(165.8,65,1,"B","T4",8)=""
^ONCO(165.8,65,1,"B","TX",1)=""
^ONCO(165.8,65,1,"B","Ta",3)=""
^ONCO(165.8,65,1,"B","Tis",4)=""
^ONCO(165.8,65,2,0)="^165.83IA^4^4"
^ONCO(165.8,65,2,1,0)="NX"
^ONCO(165.8,65,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,65,2,2,0)="N0"
^ONCO(165.8,65,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,65,2,3,0)="N1"
^ONCO(165.8,65,2,3,1)="Metastasis <= 2cm in greatest dimension, in a single lymph node"
^ONCO(165.8,65,2,4,0)="N2"
^ONCO(165.8,65,2,4,1)="Metastasis > 2cm, in a single lymph node; or multiple lymph nodes"
^ONCO(165.8,65,2,"B","N0",2)=""
^ONCO(165.8,65,2,"B","N1",3)=""
^ONCO(165.8,65,2,"B","N2",4)=""
^ONCO(165.8,65,2,"B","NX",1)=""
^ONCO(165.8,66,0)="61.2^Renal Pelvis and Ureter: Squamous Cell Carcinoma and Adenocarcinoma^61.1^61.1^6"
^ONCO(165.8,67,0)="62.1^Urinary Bladder: Urothelial Carcinomas"
^ONCO(165.8,67,1,0)="^165.82IA^14^14"
^ONCO(165.8,67,1,1,0)="TX"
^ONCO(165.8,67,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,67,1,2,0)="T0"
^ONCO(165.8,67,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,67,1,3,0)="Ta"
^ONCO(165.8,67,1,3,1)="Papillary noninvasive carcinoma"
^ONCO(165.8,67,1,4,0)="Tis"
^ONCO(165.8,67,1,4,1)="Urothelial carcinoma in situ: ""flat tumor"""
^ONCO(165.8,67,1,5,0)="T1"
^ONCO(165.8,67,1,5,1)="Tumor invades lamina propria (subepithelial connective tissue)"
^ONCO(165.8,67,1,6,0)="T2"
^ONCO(165.8,67,1,6,1)="Tumor invades muscularis propria"
^ONCO(165.8,67,1,7,0)="T2a"
^ONCO(165.8,67,1,7,1)="Tumor invades superficial muscularis propria (inner half)"
^ONCO(165.8,67,1,8,0)="T2b"
^ONCO(165.8,67,1,8,1)="Tumor invades deep muscularis propria (outer half)"
^ONCO(165.8,67,1,9,0)="T3"
^ONCO(165.8,67,1,9,1)="Tumor invades perivesical soft tissue"
^ONCO(165.8,67,1,10,0)="T3a"
^ONCO(165.8,67,1,10,1)="Tumor invades perivesical soft tissue microscopically"
^ONCO(165.8,67,1,11,0)="T3b"
^ONCO(165.8,67,1,11,1)="Tumor invades perivesical soft tissue macroscopically (extravesical mass)"
^ONCO(165.8,67,1,12,0)="T4"
^ONCO(165.8,67,1,12,1)="Extravesical tumor directly invades any of the following: prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, abdominal wall"
^ONCO(165.8,67,1,13,0)="T4a"
^ONCO(165.8,67,1,13,1)="Extravesical tumor invades directly into prostatic stroma, seminal vesicles, uterus, vagina"
^ONCO(165.8,67,1,14,0)="T4b"
^ONCO(165.8,67,1,14,1)="Extravesical tumor invades pelvic wall, abdominal wall"
^ONCO(165.8,67,1,"B","T0",2)=""
^ONCO(165.8,67,1,"B","T1",5)=""
^ONCO(165.8,67,1,"B","T2",6)=""
^ONCO(165.8,67,1,"B","T2a",7)=""
^ONCO(165.8,67,1,"B","T2b",8)=""
^ONCO(165.8,67,1,"B","T3",9)=""
^ONCO(165.8,67,1,"B","T3a",10)=""
^ONCO(165.8,67,1,"B","T3b",11)=""
^ONCO(165.8,67,1,"B","T4",12)=""
^ONCO(165.8,67,1,"B","T4a",13)=""
^ONCO(165.8,67,1,"B","T4b",14)=""
^ONCO(165.8,67,1,"B","TX",1)=""
^ONCO(165.8,67,1,"B","Ta",3)=""
^ONCO(165.8,67,1,"B","Tis",4)=""
^ONCO(165.8,67,2,0)="^165.83IA^5^5"
^ONCO(165.8,67,2,1,0)="NX"
^ONCO(165.8,67,2,1,1)="Lymph nodes cannot be assessed"
^ONCO(165.8,67,2,2,0)="N0"
^ONCO(165.8,67,2,2,1)="No lymph node metastasis"
^ONCO(165.8,67,2,3,0)="N1"
^ONCO(165.8,67,2,3,1)="Single regional lymph node metastasis in the true pelvis (perivesical, obturator, internal and external iliac, or sacral lymph node)"
^ONCO(165.8,67,2,4,0)="N2"
^ONCO(165.8,67,2,4,1)="Multiple regional lymph node metastasis in the true pelvis (perivesical, obturator, internal and external iliac, or sacral lymph node metastasis)"
^ONCO(165.8,67,2,5,0)="N3"
^ONCO(165.8,67,2,5,1)="Lymph node metastasis to the common iliac lymph nodes"
^ONCO(165.8,67,2,"B","N0",2)=""
^ONCO(165.8,67,2,"B","N1",3)=""
^ONCO(165.8,67,2,"B","N2",4)=""
^ONCO(165.8,67,2,"B","N3",5)=""
^ONCO(165.8,67,2,"B","NX",1)=""
^ONCO(165.8,67,3,0)="^165.84IA^7^7"
^ONCO(165.8,67,3,1,0)="cM0"
^ONCO(165.8,67,3,1,1)="No distant metastasis"
^ONCO(165.8,67,3,2,0)="cM1"
^ONCO(165.8,67,3,2,1)="Distant metastasis"
^ONCO(165.8,67,3,3,0)="cM1a"
^ONCO(165.8,67,3,3,1)="Distant metastasis limited to lymph nodes beyond the common iliacs"
^ONCO(165.8,67,3,4,0)="cM1b"
^ONCO(165.8,67,3,4,1)="Non-lymph-node distant metastases"
^ONCO(165.8,67,3,5,0)="pM1"
^ONCO(165.8,67,3,5,1)="Distant metastasis, microscopically confirmed"
^ONCO(165.8,67,3,6,0)="pM1a"
^ONCO(165.8,67,3,6,1)="Distant metastasis limited to lymph nodes beyond the common iliacs, microscopically confirmed"
^ONCO(165.8,67,3,7,0)="pM1b"
^ONCO(165.8,67,3,7,1)="Non-lymph-node distant metastases, microscopically confirmed"
^ONCO(165.8,67,3,"B","cM0",1)=""
^ONCO(165.8,67,3,"B","cM1",2)=""
^ONCO(165.8,67,3,"B","cM1a",3)=""
^ONCO(165.8,67,3,"B","cM1b",4)=""
^ONCO(165.8,67,3,"B","pM1",5)=""
^ONCO(165.8,67,3,"B","pM1a",6)=""
^ONCO(165.8,67,3,"B","pM1b",7)=""
^ONCO(165.8,68,0)="62.2^Urinary Bladder: Squamous Cell Carcinoma and Adenocarcinoma^62.1^^62.1"
^ONCO(165.8,69,0)="63.1^Male Penile Urethra and Female Urethra: Urothelial Carcinomas^^^6"
^ONCO(165.8,69,1,0)="^165.82IA^8^8"
^ONCO(165.8,69,1,1,0)="TX"
^ONCO(165.8,69,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,69,1,2,0)="T0"
^ONCO(165.8,69,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,69,1,3,0)="Ta"
^ONCO(165.8,69,1,3,1)="Non-invasive papillary carcinoma"
^ONCO(165.8,69,1,4,0)="Tis"
^ONCO(165.8,69,1,4,1)="Carcinoma in situ"
^ONCO(165.8,69,1,5,0)="T1"
^ONCO(165.8,69,1,5,1)="Tumor invades subepithelial connective tissue"
^ONCO(165.8,69,1,6,0)="T2"
^ONCO(165.8,69,1,6,1)="Tumor invades any of the following: corpus spongiosum, periurethral muscle"
^ONCO(165.8,69,1,7,0)="T3"
^ONCO(165.8,69,1,7,1)="Tumor invades any of the following: corpus cavernosum, anterior vagina"
^ONCO(165.8,69,1,8,0)="T4"
^ONCO(165.8,69,1,8,1)="Tumor invades other adjacent organs (e.g., invasion of the bladder wall)"
^ONCO(165.8,69,1,"B","T0",2)=""
^ONCO(165.8,69,1,"B","T1",5)=""
^ONCO(165.8,69,1,"B","T2",6)=""
^ONCO(165.8,69,1,"B","T3",7)=""
^ONCO(165.8,69,1,"B","T4",8)=""
^ONCO(165.8,69,1,"B","TX",1)=""
^ONCO(165.8,69,1,"B","Ta",3)=""
^ONCO(165.8,69,1,"B","Tis",4)=""
^ONCO(165.8,69,2,0)="^165.83IA^4^4"
^ONCO(165.8,69,2,1,0)="NX"
^ONCO(165.8,69,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,69,2,2,0)="N0"
^ONCO(165.8,69,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,69,2,3,0)="N1"
^ONCO(165.8,69,2,3,1)="Single regional lymph node metastasis in the inguinal region or true pelvis [perivesical, obturator, internal (hypogastric) and external iliac], or presacral lymph node"
^ONCO(165.8,69,2,4,0)="N2"
^ONCO(165.8,69,2,4,1)="Multiple regional lymph node metastasis in the inguinal region or true pelvis (perivesical, hypogastric, obturator, internal and external iliac, or presacral lymph node)"
^ONCO(165.8,69,2,"B","N0",2)=""
^ONCO(165.8,69,2,"B","N1",3)=""
^ONCO(165.8,69,2,"B","N2",4)=""
^ONCO(165.8,69,2,"B","NX",1)=""
^ONCO(165.8,70,0)="63.2^Male Penile and Female Urethra: Squamous Cell Carcinoma and Adenocarcinoma^63.1^63.1^6"
^ONCO(165.8,71,0)="63.3^Prostatic Urethra: Urothelial Carcinomas^^63.1^6"
^ONCO(165.8,71,1,0)="^165.82IA^8^8"
^ONCO(165.8,71,1,1,0)="TX"
^ONCO(165.8,71,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,71,1,2,0)="T0"
^ONCO(165.8,71,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,71,1,3,0)="Ta"
^ONCO(165.8,71,1,3,1)="Non-invasive papillary carcinoma"
^ONCO(165.8,71,1,4,0)="Tis"
^ONCO(165.8,71,1,4,1)="Carcinoma in situ involving the prostatic urethra or periurethral or prostatic ducts without stromal invasion"
^ONCO(165.8,71,1,5,0)="T1"
^ONCO(165.8,71,1,5,1)="Tumor invades urethral subepithelial connective tissue immediately underlying the urothelium"
^ONCO(165.8,71,1,6,0)="T2"
^ONCO(165.8,71,1,6,1)="Tumor invades the prostatic stroma surrounding ducts either by direct extension from the urothelial surface or by invasion from prostatic ducts"
^ONCO(165.8,71,1,7,0)="T3"
^ONCO(165.8,71,1,7,1)="Tumor invades the periprostatic fat"
^ONCO(165.8,71,1,8,0)="T4"
^ONCO(165.8,71,1,8,1)="Tumor invades other adjacent organs (e.g., extraprostatic invasion of the bladder wall, rectal wall)"
^ONCO(165.8,71,1,"B","T0",2)=""
^ONCO(165.8,71,1,"B","T1",5)=""
^ONCO(165.8,71,1,"B","T2",6)=""
^ONCO(165.8,71,1,"B","T3",7)=""
^ONCO(165.8,71,1,"B","T4",8)=""
^ONCO(165.8,71,1,"B","TX",1)=""
^ONCO(165.8,71,1,"B","Ta",3)=""
^ONCO(165.8,71,1,"B","Tis",4)=""
^ONCO(165.8,72,0)="63.4^Prostatic Urethra: Squamous Cell Carcinoma and Adenocarcinoma^63.3^63.1^6"
^ONCO(165.8,73,0)="64^Eyelid Carcinoma^^^6"
^ONCO(165.8,73,1,0)="^165.82IA^18^18"
^ONCO(165.8,73,1,1,0)="TX"
^ONCO(165.8,73,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,73,1,2,0)="T0"
^ONCO(165.8,73,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,73,1,3,0)="Tis"
^ONCO(165.8,73,1,3,1)="Carcinoma in situ"
^ONCO(165.8,73,1,4,0)="T1"
^ONCO(165.8,73,1,4,1)="Tumor <= 10mm in greatest dimension"
^ONCO(165.8,73,1,5,0)="T1a"
^ONCO(165.8,73,1,5,1)="Tumor does not invade the tarsal plate or eyelid margin"
^ONCO(165.8,73,1,6,0)="T1b"
^ONCO(165.8,73,1,6,1)="Tumor invades the tarsal plate or eyelid margin"
^ONCO(165.8,73,1,7,0)="T1c"
^ONCO(165.8,73,1,7,1)="Tumor involves full thickness of the eyelid"
^ONCO(165.8,73,1,8,0)="T2"
^ONCO(165.8,73,1,8,1)="Tumor > 10mm but <= 20mm in greatest dimension"
^ONCO(165.8,73,1,9,0)="T2a"
^ONCO(165.8,73,1,9,1)="Tumor does not invade the tarsal plate or eyelid margin"
^ONCO(165.8,73,1,10,0)="T2b"
^ONCO(165.8,73,1,10,1)="Tumor invades the tarsal plate or eyelid margin"
^ONCO(165.8,73,1,11,0)="T2c"
^ONCO(165.8,73,1,11,1)="Tumor involves full thickness of the eyelid"
^ONCO(165.8,73,1,12,0)="T3"
^ONCO(165.8,73,1,12,1)="Tumor > 20mm but <= 30mm in greatest dimension"
^ONCO(165.8,73,1,13,0)="T3a"
^ONCO(165.8,73,1,13,1)="Tumor does not invade the tarsal plate or eyelid margin"
^ONCO(165.8,73,1,14,0)="T3b"
^ONCO(165.8,73,1,14,1)="Tumor invades the tarsal plate or eyelid margin"
^ONCO(165.8,73,1,15,0)="T3c"
^ONCO(165.8,73,1,15,1)="Tumor involves full thickness of the eyelid"
^ONCO(165.8,73,1,16,0)="T4"
^ONCO(165.8,73,1,16,1)="Any eyelid tumor that invades adjacent ocular, orbital, or facial structures"
^ONCO(165.8,73,1,17,0)="T4a"
^ONCO(165.8,73,1,17,1)="Tumor invades ocular or intraorbital structures"
^ONCO(165.8,73,1,18,0)="T4b"
^ONCO(165.8,73,1,18,1)="Tumor invades (or erodes through) the bony walls of the orbit or extends to the paranasal sinuses or invades the lacrimal sac/nasolacrimal duct or brain"
^ONCO(165.8,73,1,"B","T0",2)=""
^ONCO(165.8,73,1,"B","T1",4)=""
^ONCO(165.8,73,1,"B","T1a",5)=""
^ONCO(165.8,73,1,"B","T1b",6)=""
^ONCO(165.8,73,1,"B","T1c",7)=""
^ONCO(165.8,73,1,"B","T2",8)=""
^ONCO(165.8,73,1,"B","T2a",9)=""
^ONCO(165.8,73,1,"B","T2b",10)=""
^ONCO(165.8,73,1,"B","T2c",11)=""
^ONCO(165.8,73,1,"B","T3",12)=""
^ONCO(165.8,73,1,"B","T3a",13)=""
^ONCO(165.8,73,1,"B","T3b",14)=""
^ONCO(165.8,73,1,"B","T3c",15)=""
^ONCO(165.8,73,1,"B","T4",16)=""
^ONCO(165.8,73,1,"B","T4a",17)=""
^ONCO(165.8,73,1,"B","T4b",18)=""
^ONCO(165.8,73,1,"B","TX",1)=""
^ONCO(165.8,73,1,"B","Tis",3)=""
^ONCO(165.8,73,2,0)="^165.83IA^8^8"
^ONCO(165.8,73,2,1,0)="NX"
^ONCO(165.8,73,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,73,2,2,0)="N0"
^ONCO(165.8,73,2,2,1)="No evidence of lymph node involvement"
^ONCO(165.8,73,2,3,0)="N1"
^ONCO(165.8,73,2,3,1)="Metastasis in a single ipsilateral regional lymph node, =3 cm in greatest dimension"
^ONCO(165.8,73,2,4,0)="N1a"
^ONCO(165.8,73,2,4,1)="Metastasis in a single ipsilateral lymph node based on clinical evaluation or imaging findings"
^ONCO(165.8,73,2,5,0)="N1b"
^ONCO(165.8,73,2,5,1)="Metastasis in a single ipsilateral lymph node based on lymph node biopsy"
^ONCO(165.8,73,2,6,0)="N2"
^ONCO(165.8,73,2,6,1)="Metastasis in a single ipsilateral lymph node, >3 cm in greatest dimension, or in bilateral or contralateral lymph nodes"
^ONCO(165.8,73,2,7,0)="N2a"
^ONCO(165.8,73,2,7,1)="Metastasis documented based on clinical evaluation or imaging findings"
^ONCO(165.8,73,2,8,0)="N2b"
^ONCO(165.8,73,2,8,1)="Metastasis documented based on microscopic findings on lymph node biopsyclinical evaluation or imaging findings"
^ONCO(165.8,73,2,"B","N0",2)=""
^ONCO(165.8,73,2,"B","N1",3)=""
^ONCO(165.8,73,2,"B","N1a",4)=""
^ONCO(165.8,73,2,"B","N1b",5)=""
^ONCO(165.8,73,2,"B","N2",6)=""
^ONCO(165.8,73,2,"B","N2a",7)=""
^ONCO(165.8,73,2,"B","N2b",8)=""
^ONCO(165.8,73,2,"B","NX",1)=""
^ONCO(165.8,74,0)="65^Conjunctival Carcinoma^^14^6"
^ONCO(165.8,74,1,0)="^165.82IA^11^11"
^ONCO(165.8,74,1,1,0)="TX"
^ONCO(165.8,74,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,74,1,2,0)="T0"
^ONCO(165.8,74,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,74,1,3,0)="Tis"
^ONCO(165.8,74,1,3,1)="Carcinoma in situ"
^ONCO(165.8,74,1,4,0)="T1"
^ONCO(165.8,74,1,4,1)="Tumor (<= 5mm in greatest dimension) invades through the conjunctival basement membrane without invasion of adjacent structures"
^ONCO(165.8,74,1,5,0)="T2"
^ONCO(165.8,74,1,5,1)="Tumor (> 5mm in greatest dimension) invades through the conjunctival basement membrane without invasion of adjacent structures"
^ONCO(165.8,74,1,6,0)="T3"
^ONCO(165.8,74,1,6,1)="Tumor invades adjacent structures (excluding the orbit)"
^ONCO(165.8,74,1,7,0)="T4"
^ONCO(165.8,74,1,7,1)="Tumor invades the orbit with or without further extension"
^ONCO(165.8,74,1,8,0)="T4a"
^ONCO(165.8,74,1,8,1)="Tumor invades orbital soft tissues without bone invasion"
^ONCO(165.8,74,1,9,0)="T4b"
^ONCO(165.8,74,1,9,1)="Tumor invades bone"
^ONCO(165.8,74,1,10,0)="T4c"
^ONCO(165.8,74,1,10,1)="Tumor invades adjacent paranasal sinuses"
^ONCO(165.8,74,1,11,0)="T4d"
^ONCO(165.8,74,1,11,1)="Tumor invades brain"
^ONCO(165.8,74,1,"B","T0",2)=""
^ONCO(165.8,74,1,"B","T1",4)=""
^ONCO(165.8,74,1,"B","T2",5)=""
^ONCO(165.8,74,1,"B","T3",6)=""
^ONCO(165.8,74,1,"B","T4",7)=""
^ONCO(165.8,74,1,"B","T4a",8)=""
^ONCO(165.8,74,1,"B","T4b",9)=""
^ONCO(165.8,74,1,"B","T4c",10)=""
^ONCO(165.8,74,1,"B","T4d",11)=""
^ONCO(165.8,74,1,"B","TX",1)=""
^ONCO(165.8,74,1,"B","Tis",3)=""
^ONCO(165.8,75,0)="66^Conjunctival Melanoma^^14^6"
^ONCO(165.8,75,1,0)="^165.82IA^18^18"
^ONCO(165.8,75,1,1,0)="TX"
^ONCO(165.8,75,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,75,1,2,0)="T0"
^ONCO(165.8,75,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,75,1,3,0)="T1"
^ONCO(165.8,75,1,3,1)="Tumor of the bulbar conjunctiva"
^ONCO(165.8,75,1,4,0)="T1a"
^ONCO(165.8,75,1,4,1)="< 1 quadrant"
^ONCO(165.8,75,1,5,0)="T1b"
^ONCO(165.8,75,1,5,1)=">= 1 to < 2 quadrants"
^ONCO(165.8,75,1,6,0)="T1c"
^ONCO(165.8,75,1,6,1)=">= 2 to < 3 quadrants"
^ONCO(165.8,75,1,7,0)="T1d"
^ONCO(165.8,75,1,7,1)=">= 3 quadrants"
^ONCO(165.8,75,1,8,0)="T2"
^ONCO(165.8,75,1,8,1)="Tumor of the nonbulbar (forniceal, palpebral, tarsal) conjunctiva, and tumor involving the caruncle"
^ONCO(165.8,75,1,9,0)="T2a"
^ONCO(165.8,75,1,9,1)="Noncaruncular, and <= 1 quadrant of the nonbulbar conjunctiva involved"
^ONCO(165.8,75,1,10,0)="T2b"
^ONCO(165.8,75,1,10,1)="Noncaruncular, and > 1 quadrant of the nonbulbar conjunctiva involved"
^ONCO(165.8,75,1,11,0)="T2c"
^ONCO(165.8,75,1,11,1)="Caruncular, and <= 1 quadrant of the nonbulbar conjunctiva involved"
^ONCO(165.8,75,1,12,0)="T2d"
^ONCO(165.8,75,1,12,1)="Caruncular, and > 1 quadrant of the nonbulbar conjunctiva involved"
^ONCO(165.8,75,1,13,0)="T3"
^ONCO(165.8,75,1,13,1)="Tumor of any size with local invasion"
^ONCO(165.8,75,1,14,0)="T3a"
^ONCO(165.8,75,1,14,1)="Globe"
^ONCO(165.8,75,1,15,0)="T3b"
^ONCO(165.8,75,1,15,1)="Eyelid"
^ONCO(165.8,75,1,16,0)="T3c"
^ONCO(165.8,75,1,16,1)="Orbit"
^ONCO(165.8,75,1,17,0)="T3d"
^ONCO(165.8,75,1,17,1)="Nasolacrimal duct and/or lacrimal sac and/or paranasal sinuses"
^ONCO(165.8,75,1,18,0)="T4"
^ONCO(165.8,75,1,18,1)="Tumor of any size with invasion of the central nervous system"
^ONCO(165.8,75,1,"B","T0",2)=""
^ONCO(165.8,75,1,"B","T1",3)=""
^ONCO(165.8,75,1,"B","T1a",4)=""
^ONCO(165.8,75,1,"B","T1b",5)=""
^ONCO(165.8,75,1,"B","T1c",6)=""
^ONCO(165.8,75,1,"B","T1d",7)=""
^ONCO(165.8,75,1,"B","T2",8)=""
^ONCO(165.8,75,1,"B","T2a",9)=""
^ONCO(165.8,75,1,"B","T2b",10)=""
^ONCO(165.8,75,1,"B","T2c",11)=""
^ONCO(165.8,75,1,"B","T2d",12)=""
^ONCO(165.8,75,1,"B","T3",13)=""
^ONCO(165.8,75,1,"B","T3a",14)=""
^ONCO(165.8,75,1,"B","T3b",15)=""
^ONCO(165.8,75,1,"B","T3c",16)=""
^ONCO(165.8,75,1,"B","T3d",17)=""
^ONCO(165.8,75,1,"B","T4",18)=""
^ONCO(165.8,75,1,"B","TX",1)=""
^ONCO(165.8,75,6,0)="^165.87IA^15^15"
^ONCO(165.8,75,6,1,0)="TX"
^ONCO(165.8,75,6,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,75,6,2,0)="T0"
^ONCO(165.8,75,6,2,1)="No evidence of primary tumor"
^ONCO(165.8,75,6,3,0)="Tis"
^ONCO(165.8,75,6,3,1)="Melanoma confined to the conjunctival epithelium"
^ONCO(165.8,75,6,4,0)="T1"
^ONCO(165.8,75,6,4,1)="Tumor of the bulbar conjunctiva"
^ONCO(165.8,75,6,5,0)="T1a"
^ONCO(165.8,75,6,5,1)="Tumor of the bulbar conjunctiva with invasion of the substantia propria, not more than 2.0mm in thickness"
^ONCO(165.8,75,6,6,0)="T1b"
^ONCO(165.8,75,6,6,1)="Tumor of the bulbar conjunctiva with invasion of the substantia propria, more than 2.0mm in thickness"
^ONCO(165.8,75,6,7,0)="T2"
^ONCO(165.8,75,6,7,1)="Tumor of the nonbulbar (forniceal, palpebral, tarsal) conjunctiva, and tumor involving the caruncle"
^ONCO(165.8,75,6,8,0)="T2a"
^ONCO(165.8,75,6,8,1)="Tumor of the nonbulbar conjunctiva with invasion of the substantia propria, not more than 2.0mm in thickness"
^ONCO(165.8,75,6,9,0)="T2b"
^ONCO(165.8,75,6,9,1)="Tumor of the nonbulbar conjunctiva with invasion of the substantia propria, more than 2.0mm in thickness"
^ONCO(165.8,75,6,10,0)="T3"
^ONCO(165.8,75,6,10,1)="Tumor of any size with local invasion"
^ONCO(165.8,75,6,11,0)="T3a"
^ONCO(165.8,75,6,11,1)="Globe"
^ONCO(165.8,75,6,12,0)="T3b"
^ONCO(165.8,75,6,12,1)="Eyelid"
^ONCO(165.8,75,6,13,0)="T3c"
^ONCO(165.8,75,6,13,1)="Orbit"
^ONCO(165.8,75,6,14,0)="T3d"
^ONCO(165.8,75,6,14,1)="Nasolacrimal duct and/or lacrimal sac and/or paranasal sinuses"
^ONCO(165.8,75,6,15,0)="T4"
^ONCO(165.8,75,6,15,1)="Tumor of any size with invasion of the central nervous system"
^ONCO(165.8,75,6,"B","T0",2)=""
^ONCO(165.8,75,6,"B","T1",4)=""
^ONCO(165.8,75,6,"B","T1a",5)=""
^ONCO(165.8,75,6,"B","T1b",6)=""
^ONCO(165.8,75,6,"B","T2",7)=""
^ONCO(165.8,75,6,"B","T2a",8)=""
^ONCO(165.8,75,6,"B","T2b",9)=""
^ONCO(165.8,75,6,"B","T3",10)=""
^ONCO(165.8,75,6,"B","T3a",11)=""
^ONCO(165.8,75,6,"B","T3b",12)=""
^ONCO(165.8,75,6,"B","T3c",13)=""
^ONCO(165.8,75,6,"B","T3d",14)=""
^ONCO(165.8,75,6,"B","T4",15)=""
^ONCO(165.8,75,6,"B","TX",1)=""
^ONCO(165.8,75,6,"B","Tis",3)=""
^ONCO(165.8,76,0)="67.1^Uveal Melanoma - Iris Melanoma"
^ONCO(165.8,76,1,0)="^165.82IA^14^14"
^ONCO(165.8,76,1,1,0)="TX"
^ONCO(165.8,76,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,76,1,2,0)="T0"
^ONCO(165.8,76,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,76,1,3,0)="T1"
^ONCO(165.8,76,1,3,1)="Tumor limited to the iris"
^ONCO(165.8,76,1,4,0)="T1a"
^ONCO(165.8,76,1,4,1)="Tumor limited to the iris, not more than 3 clock hours in size"
^ONCO(165.8,76,1,5,0)="T1b"
^ONCO(165.8,76,1,5,1)="Tumor limited to the iris, more than 3 clock hours in size"
^ONCO(165.8,76,1,6,0)="T1c"
^ONCO(165.8,76,1,6,1)="Tumor limited to the iris with secondary glaucomaot more than 3 clock hours "
^ONCO(165.8,76,1,7,0)="T2"
^ONCO(165.8,76,1,7,1)="Tumor confluent with or extending into the ciliary body, choroid, or both"
^ONCO(165.8,76,1,8,0)="T2a"
^ONCO(165.8,76,1,8,1)="Tumor confluent with or extending into the ciliary body, without secondary glaucoma"
^ONCO(165.8,76,1,9,0)="T2b"
^ONCO(165.8,76,1,9,1)="Tumor confluent with or extending into the ciliary body and choroid, without secondary glaucoma"
^ONCO(165.8,76,1,10,0)="T2c"
^ONCO(165.8,76,1,10,1)="Tumor confluent with or extending into the ciliary body, choroid, or both, with secondary glaucoma"
^ONCO(165.8,76,1,11,0)="T3"
^ONCO(165.8,76,1,11,1)="Tumor confluent with or extending into the ciliary body, choroid, or both, with scleral extension"
^ONCO(165.8,76,1,12,0)="T4"
^ONCO(165.8,76,1,12,1)="Tumor with extrascleral extension"
^ONCO(165.8,76,1,13,0)="T4a"
^ONCO(165.8,76,1,13,1)="Tumor with extrascleral extension <= 5mm in largest diameter"
^ONCO(165.8,76,1,14,0)="T4b"
^ONCO(165.8,76,1,14,1)="Tumor with extrascleral extension > 5mm in largest diameter"
^ONCO(165.8,76,1,"B","T0",2)=""
^ONCO(165.8,76,1,"B","T1",3)=""
^ONCO(165.8,76,1,"B","T1a",4)=""
^ONCO(165.8,76,1,"B","T1b",5)=""
^ONCO(165.8,76,1,"B","T1c",6)=""
^ONCO(165.8,76,1,"B","T2",7)=""
^ONCO(165.8,76,1,"B","T2a",8)=""
^ONCO(165.8,76,1,"B","T2b",9)=""
^ONCO(165.8,76,1,"B","T2c",10)=""
^ONCO(165.8,76,1,"B","T3",11)=""
^ONCO(165.8,76,1,"B","T4",12)=""
^ONCO(165.8,76,1,"B","T4a",13)=""
^ONCO(165.8,76,1,"B","T4b",14)=""
^ONCO(165.8,76,1,"B","TX",1)=""
^ONCO(165.8,76,2,0)="^165.83IA^5^5"
^ONCO(165.8,76,2,1,0)="NX"
^ONCO(165.8,76,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,76,2,2,0)="N0"
^ONCO(165.8,76,2,2,1)="No regional lymph node involvement"
^ONCO(165.8,76,2,3,0)="N1"
^ONCO(165.8,76,2,3,1)="Regional lymph node metastases or discrete tumor deposits in the orbit"
^ONCO(165.8,76,2,4,0)="N1a"
^ONCO(165.8,76,2,4,1)="Metastasis in one or more regional lymph node(s)"
^ONCO(165.8,76,2,5,0)="N1b"
^ONCO(165.8,76,2,5,1)="No regional lymph nodes are positive, but there are discrete tumor deposits in the orbit that are not contiguous to the eye. (choroidal and ciliary body melanoma only)"
^ONCO(165.8,76,2,"B","N0",2)=""
^ONCO(165.8,76,2,"B","N1",3)=""
^ONCO(165.8,76,2,"B","N1a",4)=""
^ONCO(165.8,76,2,"B","N1b",5)=""
^ONCO(165.8,76,2,"B","NX",1)=""
^ONCO(165.8,76,3,0)="^165.84IA^9^9"
^ONCO(165.8,76,3,1,0)="cM0"
^ONCO(165.8,76,3,1,1)="No distant metastasis by clinical classification"
^ONCO(165.8,76,3,2,0)="cM1"
^ONCO(165.8,76,3,2,1)="Distant metastasis"
^ONCO(165.8,76,3,3,0)="cM1a"
^ONCO(165.8,76,3,3,1)="Largest diameter of the largest metastasis <= 3.0cm"
^ONCO(165.8,76,3,4,0)="cM1b"
^ONCO(165.8,76,3,4,1)="Largest diameter of the largest metastasis 3.1-8.0cm"
^ONCO(165.8,76,3,5,0)="cM1c"
^ONCO(165.8,76,3,5,1)="Largest diameter of the largest metastasis >= 8.1cm"
^ONCO(165.8,76,3,6,0)="pM1"
^ONCO(165.8,76,3,6,1)="Distant metastasis, microscopically confirmed"
^ONCO(165.8,76,3,7,0)="pM1a"
^ONCO(165.8,76,3,7,1)="Largest diameter of the largest metastasis <= 3.0cm, microscopically confirmed"
^ONCO(165.8,76,3,8,0)="pM1b"
^ONCO(165.8,76,3,8,1)="Largest diameter of the largest metastasis 3.1-8.0cm, microscopically confirmed"
^ONCO(165.8,76,3,9,0)="pM1c"
^ONCO(165.8,76,3,9,1)="Largest diameter of the largest metastasis >= 8.1cm, microscopically confirmed"
^ONCO(165.8,76,3,"B","cM0",1)=""
^ONCO(165.8,76,3,"B","cM1",2)=""
^ONCO(165.8,76,3,"B","cM1a",3)=""
^ONCO(165.8,76,3,"B","cM1b",4)=""
^ONCO(165.8,76,3,"B","cM1c",5)=""
^ONCO(165.8,76,3,"B","pM1",6)=""
^ONCO(165.8,76,3,"B","pM1a",7)=""
^ONCO(165.8,76,3,"B","pM1b",8)=""
^ONCO(165.8,76,3,"B","pM1c",9)=""
^ONCO(165.8,77,0)="67.2^Uveal Melanoma - Choroidal and Ciliary Body Melanoma^^67.1^67.1"
^ONCO(165.8,77,1,0)="^165.82IA^23^23"
^ONCO(165.8,77,1,1,0)="TX"
^ONCO(165.8,77,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,77,1,2,0)="T0"
^ONCO(165.8,77,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,77,1,3,0)="T1"
^ONCO(165.8,77,1,3,1)="Tumor size category 1"
^ONCO(165.8,77,1,4,0)="T1a"
^ONCO(165.8,77,1,4,1)="Tumor size category 1 without ciliary body involvement and extraocular extension"
^ONCO(165.8,77,1,5,0)="T1b"
^ONCO(165.8,77,1,5,1)="Tumor size category 1 with ciliary body involvement"
^ONCO(165.8,77,1,6,0)="T1c"
^ONCO(165.8,77,1,6,1)="Tumor size category 1 without ciliary body involvement but with extraocular extension"
^ONCO(165.8,77,1,7,0)="T1d"
^ONCO(165.8,77,1,7,1)="Tumor size category 1 with ciliary body involvement and extraocular extension <= 5 mm in largest diameter"
^ONCO(165.8,77,1,8,0)="T2"
^ONCO(165.8,77,1,8,1)="Tumor size category 2"
^ONCO(165.8,77,1,9,0)="T2a"
^ONCO(165.8,77,1,9,1)="Tumor size category 2 without ciliary body involvement and extraocular extension"
^ONCO(165.8,77,1,10,0)="T2b"
^ONCO(165.8,77,1,10,1)="Tumor size category 2 with ciliary body involvement"
^ONCO(165.8,77,1,11,0)="T2c"
^ONCO(165.8,77,1,11,1)="Tumor size category 2 without ciliary body involvement but with extraocular extension <= 5mm in largest diameter"
^ONCO(165.8,77,1,12,0)="T2d"
^ONCO(165.8,77,1,12,1)="Tumor size category 2 with ciliary body involvement and extraocular extension <= 5mm in largest diameter"
^ONCO(165.8,77,1,13,0)="T3"
^ONCO(165.8,77,1,13,1)="Tumor size category 3"
^ONCO(165.8,77,1,14,0)="T3a"
^ONCO(165.8,77,1,14,1)="Tumor size category 3 without ciliary body involvement and extraocular extension"
^ONCO(165.8,77,1,15,0)="T3b"
^ONCO(165.8,77,1,15,1)="Tumor size category 3 with ciliary body involvement"
^ONCO(165.8,77,1,16,0)="T3c"
^ONCO(165.8,77,1,16,1)="Tumor size category 3 without ciliary body involvement but with extraocular extension <= 5mm in largest diameter"
^ONCO(165.8,77,1,17,0)="T3d"
^ONCO(165.8,77,1,17,1)="Tumor size category 3 with ciliary body involvement and extraocular extension <= 5mm in largest diameter"
^ONCO(165.8,77,1,18,0)="T4"
^ONCO(165.8,77,1,18,1)="Tumor size category 4"
^ONCO(165.8,77,1,19,0)="T4a"
^ONCO(165.8,77,1,19,1)="Tumor size category 4 without ciliary body involvement and extraocular extension"
^ONCO(165.8,77,1,20,0)="T4b"
^ONCO(165.8,77,1,20,1)="Tumor size category 4 with ciliary body involvement"
^ONCO(165.8,77,1,21,0)="T4c"
^ONCO(165.8,77,1,21,1)="Tumor size category 2 without ciliary body involvement but with extraocular extension <= 5mm in largest diameter"
^ONCO(165.8,77,1,22,0)="T4d"
^ONCO(165.8,77,1,22,1)="Tumor size category 4 with ciliary body involvement and extraocular extension <= 5mm in largest diameter"
^ONCO(165.8,77,1,23,0)="T4e"
^ONCO(165.8,77,1,23,1)="Any tumor size category with extraocular extension >5 mm in largest diameter"
^ONCO(165.8,77,1,"B","T0",2)=""
^ONCO(165.8,77,1,"B","T1",3)=""
^ONCO(165.8,77,1,"B","T1a",4)=""
^ONCO(165.8,77,1,"B","T1b",5)=""
^ONCO(165.8,77,1,"B","T1c",6)=""
^ONCO(165.8,77,1,"B","T1d",7)=""
^ONCO(165.8,77,1,"B","T2",8)=""
^ONCO(165.8,77,1,"B","T2a",9)=""
^ONCO(165.8,77,1,"B","T2b",10)=""
^ONCO(165.8,77,1,"B","T2c",11)=""
^ONCO(165.8,77,1,"B","T2d",12)=""
^ONCO(165.8,77,1,"B","T3",13)=""
^ONCO(165.8,77,1,"B","T3a",14)=""
^ONCO(165.8,77,1,"B","T3b",15)=""
^ONCO(165.8,77,1,"B","T3c",16)=""
^ONCO(165.8,77,1,"B","T3d",17)=""
^ONCO(165.8,77,1,"B","T4",18)=""
^ONCO(165.8,77,1,"B","T4a",19)=""
^ONCO(165.8,77,1,"B","T4b",20)=""
^ONCO(165.8,77,1,"B","T4c",21)=""
^ONCO(165.8,77,1,"B","T4d",22)=""
^ONCO(165.8,77,1,"B","T4e",23)=""
^ONCO(165.8,77,1,"B","TX",1)=""
^ONCO(165.8,78,0)="68^Retinoblastoma"
^ONCO(165.8,78,1,0)="^165.82IA^17^17"
^ONCO(165.8,78,1,1,0)="TX"
^ONCO(165.8,78,1,1,1)="Unknown evidence of intraocular tumor"
^ONCO(165.8,78,1,2,0)="T0"
^ONCO(165.8,78,1,2,1)="No evidence of intraocular tumor"
^ONCO(165.8,78,1,3,0)="T1"
^ONCO(165.8,78,1,3,1)="Intraretinal tumor(s) with subretinal fluid <= 5 mm from the base of any tumor"
^ONCO(165.8,78,1,4,0)="T1a"
^ONCO(165.8,78,1,4,1)="Tumors <= 3mm and further than 1.5mm from disc and fovea"
^ONCO(165.8,78,1,5,0)="T1b"
^ONCO(165.8,78,1,5,1)="Tumors > 3mm or closer than 1.5mm from disc and fovea"
^ONCO(165.8,78,1,6,0)="T2"
^ONCO(165.8,78,1,6,1)="Intraocular tumor(s) with retinal detachment, vitreous seeding or subretinal seeding"
^ONCO(165.8,78,1,7,0)="T2a"
^ONCO(165.8,78,1,7,1)="Subretinal fluid > 5mm from the base of any tumor"
^ONCO(165.8,78,1,8,0)="T2b"
^ONCO(165.8,78,1,8,1)="Vitreous seeding and/or subretinal seeding"
^ONCO(165.8,78,1,9,0)="T3"
^ONCO(165.8,78,1,9,1)="Advanced intraocular tumor(s)"
^ONCO(165.8,78,1,10,0)="T3a"
^ONCO(165.8,78,1,10,1)="Phthisis or pre-phthisis bulbi"
^ONCO(165.8,78,1,11,0)="T3b"
^ONCO(165.8,78,1,11,1)="Tumor invasion of choroid, pars plana, ciliary body, lens, zonules, iris, or anterior chamber"
^ONCO(165.8,78,1,12,0)="T3c"
^ONCO(165.8,78,1,12,1)="Raised intraocular pressure with neovascularization and/or buphthalmos"
^ONCO(165.8,78,1,13,0)="T3d"
^ONCO(165.8,78,1,13,1)="Hyphema and/or massive vitreous hemorrhage"
^ONCO(165.8,78,1,14,0)="T3e"
^ONCO(165.8,78,1,14,1)="Aseptic orbital cellulitis"
^ONCO(165.8,78,1,15,0)="T4"
^ONCO(165.8,78,1,15,1)="Extraocular tumor(s) involving orbit, including optic nerve"
^ONCO(165.8,78,1,16,0)="T4a"
^ONCO(165.8,78,1,16,1)="Radiologic evidence of retrobulbar optic nerve involvement or thickening of optic nerve or involvement of orbital tissues"
^ONCO(165.8,78,1,17,0)="T4b"
^ONCO(165.8,78,1,17,1)="Extraocular tumor clinically evident with proptosis and/or an orbital mass"
^ONCO(165.8,78,1,"B","T0",2)=""
^ONCO(165.8,78,1,"B","T1",3)=""
^ONCO(165.8,78,1,"B","T1a",4)=""
^ONCO(165.8,78,1,"B","T1b",5)=""
^ONCO(165.8,78,1,"B","T2",6)=""
^ONCO(165.8,78,1,"B","T2a",7)=""
^ONCO(165.8,78,1,"B","T2b",8)=""
^ONCO(165.8,78,1,"B","T3",9)=""
^ONCO(165.8,78,1,"B","T3a",10)=""
^ONCO(165.8,78,1,"B","T3b",11)=""
^ONCO(165.8,78,1,"B","T3c",12)=""
^ONCO(165.8,78,1,"B","T3d",13)=""
^ONCO(165.8,78,1,"B","T3e",14)=""
^ONCO(165.8,78,1,"B","T4",15)=""
^ONCO(165.8,78,1,"B","T4a",16)=""
^ONCO(165.8,78,1,"B","T4b",17)=""
^ONCO(165.8,78,1,"B","TX",1)=""
^ONCO(165.8,78,2,0)="^165.83IA^3^3"
^ONCO(165.8,78,2,1,0)="NX"
^ONCO(165.8,78,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,78,2,2,0)="N0"
^ONCO(165.8,78,2,2,1)="No regional lymph node involvement"
^ONCO(165.8,78,2,3,0)="N1"
^ONCO(165.8,78,2,3,1)="Evidence of preauricular, submandibular, and cervical lymph node involvement"
^ONCO(165.8,78,2,"B","N0",2)=""
^ONCO(165.8,78,2,"B","N1",3)=""
^ONCO(165.8,78,2,"B","NX",1)=""
^ONCO(165.8,78,3,0)="^165.84IA^7^7"
^ONCO(165.8,78,3,1,0)="cM0"
^ONCO(165.8,78,3,1,1)="No signs or symptoms of intracranial or distant metastasis"
^ONCO(165.8,78,3,2,0)="cM1"
^ONCO(165.8,78,3,2,1)="Distant metastasis without microscopic confirmation"
^ONCO(165.8,78,3,3,0)="cM1a"
^ONCO(165.8,78,3,3,1)="Tumor(s) involving any distant site (e.g., bone marrow, liver) on clinical or radiologic tests"
^ONCO(165.8,78,3,4,0)="cM1b"
^ONCO(165.8,78,3,4,1)="Tumor involving the CNS on radiologic imaging (not including trilateral retinoblastoma)"
^ONCO(165.8,78,3,5,0)="pM1"
^ONCO(165.8,78,3,5,1)="Distant metastasis with histopathologic confirmation"
^ONCO(165.8,78,3,6,0)="pM1a"
^ONCO(165.8,78,3,6,1)="Histopathologic confirmation of tumor at any distant site (e.g., bone marrow, liver, or other)"
^ONCO(165.8,78,3,7,0)="pM1b"
^ONCO(165.8,78,3,7,1)="Histopathologic confirmation of tumor in the cerebrospinal fluid or CNS parenchyma"
^ONCO(165.8,78,3,"B","cM0",1)=""
^ONCO(165.8,78,3,"B","cM1",2)=""
^ONCO(165.8,78,3,"B","cM1a",3)=""
^ONCO(165.8,78,3,"B","cM1b",4)=""
^ONCO(165.8,78,3,"B","pM1",5)=""
^ONCO(165.8,78,3,"B","pM1a",6)=""
^ONCO(165.8,78,3,"B","pM1b",7)=""
^ONCO(165.8,78,6,0)="^165.87IA^12^12"
^ONCO(165.8,78,6,1,0)="TX"
^ONCO(165.8,78,6,1,1)="Unknown evidence of intraocular tumor"
^ONCO(165.8,78,6,2,0)="T0"
^ONCO(165.8,78,6,2,1)="No evidence of intraocular tumor"
^ONCO(165.8,78,6,3,0)="T1"
^ONCO(165.8,78,6,3,1)="Intraocular tumor(s) without any local invasion, focal choroidal invasion, or pre or intralaminar involvement of the optic nerve head"
^ONCO(165.8,78,6,4,0)="T2"
^ONCO(165.8,78,6,4,1)="Intraocular tumor(s) with local invasion"
^ONCO(165.8,78,6,5,0)="T2a"
^ONCO(165.8,78,6,5,1)="Concomitant focal choroidal invasion and pre- or intralaminar involvement of the optic nerve head"
^ONCO(165.8,78,6,6,0)="T2b"
^ONCO(165.8,78,6,6,1)="Tumor invasion of stroma of iris and/or trabecular meshwork and/or Schlemm's canal"
^ONCO(165.8,78,6,7,0)="T3"
^ONCO(165.8,78,6,7,1)="Intraocular tumor(s) with significant local invasion"
^ONCO(165.8,78,6,8,0)="T3a"
^ONCO(165.8,78,6,8,1)="Massive choroidal invasion (>3mm in largest diameter, or multiple foci of focal choroidal involvement totaling >3mm, or any full-thickness choroidal involvement)"
^ONCO(165.8,78,6,9,0)="T3b"
^ONCO(165.8,78,6,9,1)="Retrolaminar invasion of the optic nerve head, not involving the transected end of the optic nerve"
^ONCO(165.8,78,6,10,0)="T3c"
^ONCO(165.8,78,6,10,1)="Any partial-thickness involvement of the sclera within the inner two thirds"
^ONCO(165.8,78,6,11,0)="T3d"
^ONCO(165.8,78,6,11,1)="Full-thickness invasion into the outer third of the sclera and/or invasion into or around emissary channels"
^ONCO(165.8,78,6,12,0)="T4"
^ONCO(165.8,78,6,12,1)="Evidence of extraocular tumor: tumor at the transected end of the optic nerve, tumor in the meningeal spaces around the optic nerve, full-thickness invasion of the sclera with invasion of the episclera, adjacent adipose tissue, extraocular muscle, bone, conjunctiva, or eyelids"
^ONCO(165.8,78,6,"B","T0",2)=""
^ONCO(165.8,78,6,"B","T1",3)=""
^ONCO(165.8,78,6,"B","T2",4)=""
^ONCO(165.8,78,6,"B","T2a",5)=""
^ONCO(165.8,78,6,"B","T2b",6)=""
^ONCO(165.8,78,6,"B","T3",7)=""
^ONCO(165.8,78,6,"B","T3a",8)=""
^ONCO(165.8,78,6,"B","T3b",9)=""
^ONCO(165.8,78,6,"B","T3c",10)=""
^ONCO(165.8,78,6,"B","T3d",11)=""
^ONCO(165.8,78,6,"B","T4",12)=""
^ONCO(165.8,78,6,"B","TX",1)=""
^ONCO(165.8,78,7,0)="^165.88AI^3^3"
^ONCO(165.8,78,7,1,0)="NX"
^ONCO(165.8,78,7,1,1)="Regional lymph node involvement cannot be assessed"
^ONCO(165.8,78,7,2,0)="N0"
^ONCO(165.8,78,7,2,1)="No lymph node involvement"
^ONCO(165.8,78,7,3,0)="N1"
^ONCO(165.8,78,7,3,1)="Regional lymph node involvement"
^ONCO(165.8,78,7,"B","N0",2)=""
^ONCO(165.8,78,7,"B","N1",3)=""
^ONCO(165.8,78,7,"B","NX",1)=""
^ONCO(165.8,79,0)="69^Lacrimal Gland Carcinoma^^14^6"
^ONCO(165.8,79,1,0)="^165.82IA^18^18"
^ONCO(165.8,79,1,1,0)="TX"
^ONCO(165.8,79,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,79,1,2,0)="T0"
^ONCO(165.8,79,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,79,1,3,0)="T1"
^ONCO(165.8,79,1,3,1)="Tumor <= 2cm in greatest dimension with or without extraglandular extension into the orbital soft tissue"
^ONCO(165.8,79,1,4,0)="T1a"
^ONCO(165.8,79,1,4,1)="No periosteal or bone involvement"
^ONCO(165.8,79,1,5,0)="T1b"
^ONCO(165.8,79,1,5,1)="Periosteal involvement only"
^ONCO(165.8,79,1,6,0)="T1c"
^ONCO(165.8,79,1,6,1)="Periosteal and bone involvement"
^ONCO(165.8,79,1,7,0)="T2"
^ONCO(165.8,79,1,7,1)="Tumor > 2cm and <= 4cm in greatest dimension"
^ONCO(165.8,79,1,8,0)="T2a"
^ONCO(165.8,79,1,8,1)="No periosteal or bone involvement"
^ONCO(165.8,79,1,9,0)="T2b"
^ONCO(165.8,79,1,9,1)="Periosteal involvement only"
^ONCO(165.8,79,1,10,0)="T2c"
^ONCO(165.8,79,1,10,1)="Periosteal and bone involvement"
^ONCO(165.8,79,1,11,0)="T3"
^ONCO(165.8,79,1,11,1)="Tumor > 4cm in greatest dimension"
^ONCO(165.8,79,1,12,0)="T3a"
^ONCO(165.8,79,1,12,1)="No periosteal or bone involvement"
^ONCO(165.8,79,1,13,0)="T3b"
^ONCO(165.8,79,1,13,1)="Periosteal involvement only"
^ONCO(165.8,79,1,14,0)="T3c"
^ONCO(165.8,79,1,14,1)="Periosteal and bone involvement"
^ONCO(165.8,79,1,15,0)="T4"
^ONCO(165.8,79,1,15,1)="Involvement of adjacent structures, including sinuses, temporal fossa, pterygoid fossa, superior orbital fissure, cavernous sinus or brain"
^ONCO(165.8,79,1,16,0)="T4a"
^ONCO(165.8,79,1,16,1)="Tumor <= 2cm in greatest dimension"
^ONCO(165.8,79,1,17,0)="T4b"
^ONCO(165.8,79,1,17,1)="Tumor > 2cm and <= 4cm in greatest dimension"
^ONCO(165.8,79,1,18,0)="T4c"
^ONCO(165.8,79,1,18,1)="Tumor > 4cm in greatest dimension"
^ONCO(165.8,79,1,"B","T0",2)=""
^ONCO(165.8,79,1,"B","T1",3)=""
^ONCO(165.8,79,1,"B","T1a",4)=""
^ONCO(165.8,79,1,"B","T1b",5)=""
^ONCO(165.8,79,1,"B","T1c",6)=""
^ONCO(165.8,79,1,"B","T2",7)=""
^ONCO(165.8,79,1,"B","T2a",8)=""
^ONCO(165.8,79,1,"B","T2b",9)=""
^ONCO(165.8,79,1,"B","T2c",10)=""
^ONCO(165.8,79,1,"B","T3",11)=""
^ONCO(165.8,79,1,"B","T3a",12)=""
^ONCO(165.8,79,1,"B","T3b",13)=""
^ONCO(165.8,79,1,"B","T3c",14)=""
^ONCO(165.8,79,1,"B","T4",15)=""
^ONCO(165.8,79,1,"B","T4a",16)=""
^ONCO(165.8,79,1,"B","T4b",17)=""
^ONCO(165.8,79,1,"B","T4c",18)=""
^ONCO(165.8,79,1,"B","TX",1)=""
^ONCO(165.8,80,0)="70^Orbital Sarcoma^^14^6"
^ONCO(165.8,80,1,0)="^165.82IA^6^6"
^ONCO(165.8,80,1,1,0)="TX"
^ONCO(165.8,80,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,80,1,2,0)="T0"
^ONCO(165.8,80,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,80,1,3,0)="T1"
^ONCO(165.8,80,1,3,1)="Tumor <= 2cm in greatest dimension"
^ONCO(165.8,80,1,4,0)="T2"
^ONCO(165.8,80,1,4,1)="Tumor > 2cm in greatest diameter without invasion of bony walls or globe"
^ONCO(165.8,80,1,5,0)="T3"
^ONCO(165.8,80,1,5,1)="Tumor of any size with invasion of bony walls"
^ONCO(165.8,80,1,6,0)="T4"
^ONCO(165.8,80,1,6,1)="Tumor of any size with invasion of globe or periorbital structures, including eyelid, conjunctiva, temporal fossa, nasal cavity, paranasal sinuses, and/or central nervous system"
^ONCO(165.8,80,1,"B","T0",2)=""
^ONCO(165.8,80,1,"B","T1",3)=""
^ONCO(165.8,80,1,"B","T2",4)=""
^ONCO(165.8,80,1,"B","T3",5)=""
^ONCO(165.8,80,1,"B","T4",6)=""
^ONCO(165.8,80,1,"B","TX",1)=""
^ONCO(165.8,81,0)="71^Ocular Adnexal Lymphoma"
^ONCO(165.8,81,1,0)="^165.82IA^6^6"
^ONCO(165.8,81,1,1,0)="TX"
^ONCO(165.8,81,1,1,1)="Lymphoma extent not specified"
^ONCO(165.8,81,1,2,0)="T0"
^ONCO(165.8,81,1,2,1)="No evidence of lymphoma"
^ONCO(165.8,81,1,3,0)="T1"
^ONCO(165.8,81,1,3,1)="Lymphoma involving the conjunctiva alone without eyelid or orbital involvement"
^ONCO(165.8,81,1,4,0)="T2"
^ONCO(165.8,81,1,4,1)="Lymphoma with orbital involvement with or without conjunctival involvement"
^ONCO(165.8,81,1,5,0)="T3"
^ONCO(165.8,81,1,5,1)="Lymphoma with preseptal eyelid involvement with or without orbital involvement and with or without conjunctival involvement"
^ONCO(165.8,81,1,6,0)="T4"
^ONCO(165.8,81,1,6,1)="Orbital adnexal lymphoma and extraorbital lymphoma extending beyond the orbit to adjacent structures, such as bone, maxillofacial sinuses and brain"
^ONCO(165.8,81,1,"B","T0",2)=""
^ONCO(165.8,81,1,"B","T1",3)=""
^ONCO(165.8,81,1,"B","T2",4)=""
^ONCO(165.8,81,1,"B","T3",5)=""
^ONCO(165.8,81,1,"B","T4",6)=""
^ONCO(165.8,81,1,"B","TX",1)=""
^ONCO(165.8,81,2,0)="^165.83IA^7^7"
^ONCO(165.8,81,2,1,0)="NX"
^ONCO(165.8,81,2,1,1)="Involvement of lymph nodes not assessed"
^ONCO(165.8,81,2,2,0)="N0"
^ONCO(165.8,81,2,2,1)="No evidence of lymph node involvement"
^ONCO(165.8,81,2,3,0)="N1"
^ONCO(165.8,81,2,3,1)="Involvement of lymph node region or regions draining the ocular adnexal structures and superior to the mediastinum (preauricular, parotid, submandibular, and cervical nodes)"
^ONCO(165.8,81,2,4,0)="N1a"
^ONCO(165.8,81,2,4,1)="Involvement of a single lymph node region, superior to the mediastinum"
^ONCO(165.8,81,2,5,0)="N1b"
^ONCO(165.8,81,2,5,1)="Involvement of two or more lymph node regions, superior to the mediastinum"
^ONCO(165.8,81,2,6,0)="N2"
^ONCO(165.8,81,2,6,1)="Involvement of lymph node regions of the mediastinum"
^ONCO(165.8,81,2,7,0)="N3"
^ONCO(165.8,81,2,7,1)="Diffuse or disseminated involvement of peripheral and central lymph node regions"
^ONCO(165.8,81,2,"B","N0",2)=""
^ONCO(165.8,81,2,"B","N1",3)=""
^ONCO(165.8,81,2,"B","N1a",4)=""
^ONCO(165.8,81,2,"B","N1b",5)=""
^ONCO(165.8,81,2,"B","N2",6)=""
^ONCO(165.8,81,2,"B","N3",7)=""
^ONCO(165.8,81,2,"B","NX",1)=""
^ONCO(165.8,81,3,0)="^165.84IA^9^9"
^ONCO(165.8,81,3,1,0)="cM0"
^ONCO(165.8,81,3,1,1)="No evidence of involvement of other extranodal sites"
^ONCO(165.8,81,3,2,0)="cM1"
^ONCO(165.8,81,3,2,1)="Evidence of involvement of other extranodal sites"
^ONCO(165.8,81,3,3,0)="cM1a"
^ONCO(165.8,81,3,3,1)="Noncontiguous involvement of tissues or organs external to the ocular adnexa (e.g., parotid glands, submandibular gland, lung, lever, spleen, kidney, breast)"
^ONCO(165.8,81,3,4,0)="cM1b"
^ONCO(165.8,81,3,4,1)="Lymphomatous involvement of the bone marrow"
^ONCO(165.8,81,3,5,0)="cM1c"
^ONCO(165.8,81,3,5,1)="Both M1a and M1b involvement"
^ONCO(165.8,81,3,6,0)="pM1"
^ONCO(165.8,81,3,6,1)="Evidence of involvement of other extranodal sites, microscopically confirmed"
^ONCO(165.8,81,3,7,0)="pM1a"
^ONCO(165.8,81,3,7,1)="Noncontiguous involvement of tissues or organs external to the ocular adnexa (e.g., parotid glands, submandibular gland, lung, lever, spleen, kidney, breast)"
^ONCO(165.8,81,3,8,0)="pM1b"
^ONCO(165.8,81,3,8,1)="Lymphomatous involvement of the bone marrow"
^ONCO(165.8,81,3,9,0)="pM1c"
^ONCO(165.8,81,3,9,1)="Both M1a and M1b involvement"
^ONCO(165.8,81,3,"B","cM0",1)=""
^ONCO(165.8,81,3,"B","cM1",2)=""
^ONCO(165.8,81,3,"B","cM1a",3)=""
^ONCO(165.8,81,3,"B","cM1b",4)=""
^ONCO(165.8,81,3,"B","cM1c",5)=""
^ONCO(165.8,81,3,"B","pM1",6)=""
^ONCO(165.8,81,3,"B","pM1a",7)=""
^ONCO(165.8,81,3,"B","pM1b",8)=""
^ONCO(165.8,81,3,"B","pM1c",9)=""
^ONCO(165.8,82,0)="72^Brain and Spinal Cord"
^ONCO(165.8,83,0)="73.1^Thyroid - Differentiated^^^6"
^ONCO(165.8,83,1,0)="^165.82IA^12^12"
^ONCO(165.8,83,1,1,0)="TX"
^ONCO(165.8,83,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,83,1,2,0)="T0"
^ONCO(165.8,83,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,83,1,3,0)="T1"
^ONCO(165.8,83,1,3,1)="Tumor <= 2cm in greatest dimension limited to the thyroid"
^ONCO(165.8,83,1,4,0)="T1a"
^ONCO(165.8,83,1,4,1)="Tumor <= 1cm in greatest dimension limited to the thyroid"
^ONCO(165.8,83,1,5,0)="T1b"
^ONCO(165.8,83,1,5,1)="Tumor > 1cm but <= 2cm in greatest dimension limited to the thyroid"
^ONCO(165.8,83,1,6,0)="T2"
^ONCO(165.8,83,1,6,1)="Tumor > 2cm but <= 4cm in greatest dimension limited to the thyroid"
^ONCO(165.8,83,1,7,0)="T3"
^ONCO(165.8,83,1,7,1)="Tumor >4 cm limited to the thyroid, or gross extrathyroidal extension invading only strap muscles"
^ONCO(165.8,83,1,8,0)="T3a"
^ONCO(165.8,83,1,8,1)="Tumor >4 cm limited to the thyroid"
^ONCO(165.8,83,1,9,0)="T3b"
^ONCO(165.8,83,1,9,1)="Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size"
^ONCO(165.8,83,1,10,0)="T4"
^ONCO(165.8,83,1,10,1)="Includes gross extrathyroidal extension beyond the strap muscles"
^ONCO(165.8,83,1,11,0)="T4a"
^ONCO(165.8,83,1,11,1)="Gross extrathyroidal extension invading subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve from a tumor of any size"
^ONCO(165.8,83,1,12,0)="T4b"
^ONCO(165.8,83,1,12,1)="Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size"
^ONCO(165.8,83,1,"B","T0",2)=""
^ONCO(165.8,83,1,"B","T1",3)=""
^ONCO(165.8,83,1,"B","T1a",4)=""
^ONCO(165.8,83,1,"B","T1b",5)=""
^ONCO(165.8,83,1,"B","T2",6)=""
^ONCO(165.8,83,1,"B","T3",7)=""
^ONCO(165.8,83,1,"B","T3a",8)=""
^ONCO(165.8,83,1,"B","T3b",9)=""
^ONCO(165.8,83,1,"B","T4",10)=""
^ONCO(165.8,83,1,"B","T4a",11)=""
^ONCO(165.8,83,1,"B","T4b",12)=""
^ONCO(165.8,83,1,"B","TX",1)=""
^ONCO(165.8,83,2,0)="^165.83IA^7^7"
^ONCO(165.8,83,2,1,0)="NX"
^ONCO(165.8,83,2,1,1)="Regional lymph nodes cannot be assessed"
^ONCO(165.8,83,2,2,0)="N0"
^ONCO(165.8,83,2,2,1)="No evidence of locoregional lymph node metastasis"
^ONCO(165.8,83,2,3,0)="N0a"
^ONCO(165.8,83,2,3,1)="One or more cytologically or histologically confirmed benign lymph nodes"
^ONCO(165.8,83,2,4,0)="N0b"
^ONCO(165.8,83,2,4,1)="No radiologic or clinical evidence of locoregional lymph node metastasis"
^ONCO(165.8,83,2,5,0)="N1"
^ONCO(165.8,83,2,5,1)="Metastasis to regional nodes"
^ONCO(165.8,83,2,6,0)="N1a"
^ONCO(165.8,83,2,6,1)="Metastasis to level VI or VII (pretracheal, paratracheal, or prelaryngeal/Delphian, or upper mediastinal) lymph nodes. This can be unilateral or bilateral disease."
^ONCO(165.8,83,2,7,0)="N1b"
^ONCO(165.8,83,2,7,1)="Metastasis to unilateral, bilateral, or contralateral lateral neck lymph nodes (levels I, II, III, IV, or V) or retropharyngeal lymph nodes"
^ONCO(165.8,83,2,"B","N0",2)=""
^ONCO(165.8,83,2,"B","N0a",3)=""
^ONCO(165.8,83,2,"B","N0b",4)=""
^ONCO(165.8,83,2,"B","N1",5)=""
^ONCO(165.8,83,2,"B","N1a",6)=""
^ONCO(165.8,83,2,"B","N1b",7)=""
^ONCO(165.8,83,2,"B","NX",1)=""
^ONCO(165.8,83,4,0)="^165.85I^2^2"
^ONCO(165.8,83,4,1,0)="(s)^Select if solitary tumor"
^ONCO(165.8,83,4,2,0)="(m)^Select if multifocal tumor"
^ONCO(165.8,83,4,"B","(m)",2)=""
^ONCO(165.8,83,4,"B","(s)",1)=""
^ONCO(165.8,84,0)="73.2^Thyroid - Anaplastic^73.1^73.1^6"
^ONCO(165.8,85,0)="74^Thyroid - Medullary^^73.1^6"
^ONCO(165.8,85,1,0)="^165.82IA^12^12"
^ONCO(165.8,85,1,1,0)="TX"
^ONCO(165.8,85,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,85,1,2,0)="T0"
^ONCO(165.8,85,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,85,1,3,0)="T1"
^ONCO(165.8,85,1,3,1)="Tumor <= 2cm in greatest dimension limited to the thyroid"
^ONCO(165.8,85,1,4,0)="T1a"
^ONCO(165.8,85,1,4,1)="Tumor <= 1cm in greatest dimension limited to the thyroid"
^ONCO(165.8,85,1,5,0)="T1b"
^ONCO(165.8,85,1,5,1)="Tumor > 1cm but <= 2cm in greatest dimension limited to the thyroid"
^ONCO(165.8,85,1,6,0)="T2"
^ONCO(165.8,85,1,6,1)="Tumor > 2cm but <= 4cm in greatest dimension limited to the thyroid"
^ONCO(165.8,85,1,7,0)="T3"
^ONCO(165.8,85,1,7,1)="Tumor > 4cm or with extrathyroidal extension"
^ONCO(165.8,85,1,8,0)="T3a"
^ONCO(165.8,85,1,8,1)="Tumor > 4cm in greatest dimension limited to the thyroid"
^ONCO(165.8,85,1,9,0)="T3b"
^ONCO(165.8,85,1,9,1)="Tumor of any size with gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid or omohyoid muscles)"
^ONCO(165.8,85,1,10,0)="T4"
^ONCO(165.8,85,1,10,1)="Advanced disease"
^ONCO(165.8,85,1,11,0)="T4a"
^ONCO(165.8,85,1,11,1)="Moderately advanced disease; tumor of any size with gross extrathyroidal extension into the nearby tissues of the neck, including subcutaneous soft tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve"
^ONCO(165.8,85,1,12,0)="T4b"
^ONCO(165.8,85,1,12,1)="Very advanced disease; tumor of any size with extension toward the spine or into nearby large blood vessels, gross extrathyroidal extension invading the prevertebral fascia, or encasing the carotid artery or mediastinal vessels"
^ONCO(165.8,85,1,"B","T0",2)=""
^ONCO(165.8,85,1,"B","T1",3)=""
^ONCO(165.8,85,1,"B","T1a",4)=""
^ONCO(165.8,85,1,"B","T1b",5)=""
^ONCO(165.8,85,1,"B","T2",6)=""
^ONCO(165.8,85,1,"B","T3",7)=""
^ONCO(165.8,85,1,"B","T3a",8)=""
^ONCO(165.8,85,1,"B","T3b",9)=""
^ONCO(165.8,85,1,"B","T4",10)=""
^ONCO(165.8,85,1,"B","T4a",11)=""
^ONCO(165.8,85,1,"B","T4b",12)=""
^ONCO(165.8,85,1,"B","TX",1)=""
^ONCO(165.8,86,0)="75^Parathyroid^^^6"
^ONCO(165.8,86,1,0)="^165.82IA^7^7"
^ONCO(165.8,86,1,1,0)="TX"
^ONCO(165.8,86,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,86,1,2,0)="T0"
^ONCO(165.8,86,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,86,1,3,0)="Tis"
^ONCO(165.8,86,1,3,1)="Atypical parathyroid neoplasm (neoplasm of uncertain malignant potential)"
^ONCO(165.8,86,1,4,0)="T1"
^ONCO(165.8,86,1,4,1)="Localized to the parathyroid gland with extension limited to soft tissue"
^ONCO(165.8,86,1,5,0)="T2"
^ONCO(165.8,86,1,5,1)="Direct invasion into the thyroid gland"
^ONCO(165.8,86,1,6,0)="T3"
^ONCO(165.8,86,1,6,1)="Direct invasion into recurrent laryngeal nerve, esophagus, trachea, skeletal muscle, adjacent lymph nodes, or thymus"
^ONCO(165.8,86,1,7,0)="T4"
^ONCO(165.8,86,1,7,1)="Direct invasion into major blood vessel or spine"
^ONCO(165.8,86,1,"B","T0",2)=""
^ONCO(165.8,86,1,"B","T1",4)=""
^ONCO(165.8,86,1,"B","T2",5)=""
^ONCO(165.8,86,1,"B","T3",6)=""
^ONCO(165.8,86,1,"B","T4",7)=""
^ONCO(165.8,86,1,"B","TX",1)=""
^ONCO(165.8,86,1,"B","Tis",3)=""
^ONCO(165.8,86,2,0)="^165.83IA^5^5"
^ONCO(165.8,86,2,1,0)="NX"
^ONCO(165.8,86,2,1,1)="Regional nodes cannot be assessed"
^ONCO(165.8,86,2,2,0)="N0"
^ONCO(165.8,86,2,2,1)="No regional lymph node metastasis"
^ONCO(165.8,86,2,3,0)="N1"
^ONCO(165.8,86,2,3,1)="Regional lymph node metastasis"
^ONCO(165.8,86,2,4,0)="N1a"
^ONCO(165.8,86,2,4,1)="Metastasis to level VI (pretracheal, paratracheal, and prelaryngeal/Delphian lymph nodes) or superior mediastinal lymph nodes (level VII)"
^ONCO(165.8,86,2,5,0)="N1b"
^ONCO(165.8,86,2,5,1)="Metastasis to unilateral, bilateral, or contralateral cervical (level I, II, III, IV, or V) or retropharyngeal nodes"
^ONCO(165.8,86,2,"B","N0",2)=""
^ONCO(165.8,86,2,"B","N1",3)=""
^ONCO(165.8,86,2,"B","N1a",4)=""
^ONCO(165.8,86,2,"B","N1b",5)=""
^ONCO(165.8,86,2,"B","NX",1)=""
^ONCO(165.8,87,0)="76^Adrenal Cortical Carcinoma^^14^6"
^ONCO(165.8,87,1,0)="^165.82IA^6^6"
^ONCO(165.8,87,1,1,0)="TX"
^ONCO(165.8,87,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,87,1,2,0)="T0"
^ONCO(165.8,87,1,2,1)="No evidence of primary tumor"
^ONCO(165.8,87,1,3,0)="T1"
^ONCO(165.8,87,1,3,1)="Tumor <= 5cm in greatest dimension, no extra-adrenal invasion"
^ONCO(165.8,87,1,4,0)="T2"
^ONCO(165.8,87,1,4,1)="Tumor > 5cm, no extra-adrenal invasion"
^ONCO(165.8,87,1,5,0)="T3"
^ONCO(165.8,87,1,5,1)="Tumor of any size with local invasion but not invading adjacent organs"
^ONCO(165.8,87,1,6,0)="T4"
^ONCO(165.8,87,1,6,1)="Tumor of any size that invades adjacent organs (kidney, diaphragm, pancreas, spleen, or liver) or large blood vessels (renal vein or vena cava)"
^ONCO(165.8,87,1,"B","T0",2)=""
^ONCO(165.8,87,1,"B","T1",3)=""
^ONCO(165.8,87,1,"B","T2",4)=""
^ONCO(165.8,87,1,"B","T3",5)=""
^ONCO(165.8,87,1,"B","T4",6)=""
^ONCO(165.8,87,1,"B","TX",1)=""
^ONCO(165.8,88,0)="77^Adrenal - Neuroendocrine Tumors^^14"
^ONCO(165.8,88,1,0)="^165.82IA^4^4"
^ONCO(165.8,88,1,1,0)="TX"
^ONCO(165.8,88,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,88,1,2,0)="T1"
^ONCO(165.8,88,1,2,1)="PH < 5cm in greatest dimension, no extra-adrenal invasion"
^ONCO(165.8,88,1,3,0)="T2"
^ONCO(165.8,88,1,3,1)="PH >= 5cm or PG-sympathetic of any size, no extra-adrenal invasion"
^ONCO(165.8,88,1,4,0)="T3"
^ONCO(165.8,88,1,4,1)="Tumor of any size with invasion into surrounding tissues (e.g., liver, pancreas, spleen, kidneys)"
^ONCO(165.8,88,1,"B","T1",2)=""
^ONCO(165.8,88,1,"B","T2",3)=""
^ONCO(165.8,88,1,"B","T3",4)=""
^ONCO(165.8,88,1,"B","TX",1)=""
^ONCO(165.8,88,3,0)="^165.84IA^9^9"
^ONCO(165.8,88,3,1,0)="cM0"
^ONCO(165.8,88,3,1,1)="No distant metastasis"
^ONCO(165.8,88,3,2,0)="cM1"
^ONCO(165.8,88,3,2,1)="Distant metastasis"
^ONCO(165.8,88,3,3,0)="cM1a"
^ONCO(165.8,88,3,3,1)="Distant metastasis to only bone"
^ONCO(165.8,88,3,4,0)="cM1b"
^ONCO(165.8,88,3,4,1)="Distant metastasis to only distant lymph nodes/liver or lung"
^ONCO(165.8,88,3,5,0)="cM1c"
^ONCO(165.8,88,3,5,1)="Distant metastasis to bone plus multiple other sites"
^ONCO(165.8,88,3,6,0)="pM1"
^ONCO(165.8,88,3,6,1)="Distant metastasis, microscopically confirmed"
^ONCO(165.8,88,3,7,0)="pM1a"
^ONCO(165.8,88,3,7,1)="Distant metastasis to only bone, microscopically confirmed"
^ONCO(165.8,88,3,8,0)="pM1b"
^ONCO(165.8,88,3,8,1)="Distant metastasis to only distant lymph nodes/liver or lung, microscopically confirmed"
^ONCO(165.8,88,3,9,0)="pM1c"
^ONCO(165.8,88,3,9,1)="Distant metastasis to bone plus multiple other sites, microscopically confirmed"
^ONCO(165.8,88,3,"B","cM0",1)=""
^ONCO(165.8,88,3,"B","cM1",2)=""
^ONCO(165.8,88,3,"B","cM1a",3)=""
^ONCO(165.8,88,3,"B","cM1b",4)=""
^ONCO(165.8,88,3,"B","cM1c",5)=""
^ONCO(165.8,88,3,"B","pM1",6)=""
^ONCO(165.8,88,3,"B","pM1a",7)=""
^ONCO(165.8,88,3,"B","pM1b",8)=""
^ONCO(165.8,88,3,"B","pM1c",9)=""
^ONCO(165.8,89,0)="79^Non-Hodgkin Lymphomas: Unspecified or Other Type"
^ONCO(165.8,90,0)="79.1^Non-Hodgkin Lymphomas: Diffuse Large B Cell Lymphoma"
^ONCO(165.8,91,0)="79.2^Non-Hodgkin Lymphomas: Mantle Cell Lymphoma"
^ONCO(165.8,92,0)="79.3^Non-Hodgkin Lymphomas: Follicular Lymphoma"
^ONCO(165.8,93,0)="79.4^Non-Hodgkin Lymphomas: Marginal Zone Lymphoma"
^ONCO(165.8,94,0)="79.5^Non-Hodgkin Lymphomas: Chronic Lymphocytic Leukemia and Small Lymphocytic"
^ONCO(165.8,95,0)="79.6^Non-Hodgkin Lymphomas: Peripheral T-cell Lymphoma"
^ONCO(165.8,96,0)="79.7^Hodgkin Lymphoma"
^ONCO(165.8,97,0)="80.1^Pediatric Hodgkin Lymphoma"
^ONCO(165.8,98,0)="80.2^Pediatric Non-Hodgkin Lymphoma"
^ONCO(165.8,99,0)="81.1^Primary Cutaneous Lymphoma: Mycosis Fungoides and Szary Syndrome"
^ONCO(165.8,99,1,0)="^165.82IA^8^8"
^ONCO(165.8,99,1,1,0)="T1"
^ONCO(165.8,99,1,1,1)="Limited patches,* papules, and/or plaques** covering <10% of the skin surface"
^ONCO(165.8,99,1,2,0)="T1a"
^ONCO(165.8,99,1,2,1)="T1a (patch only)"
^ONCO(165.8,99,1,3,0)="T1b"
^ONCO(165.8,99,1,3,1)="T1b (plaque +/- patch)"
^ONCO(165.8,99,1,4,0)="T2"
^ONCO(165.8,99,1,4,1)="Patches, papules, or plaques covering =10% of the skin surface"
^ONCO(165.8,99,1,5,0)="T2a"
^ONCO(165.8,99,1,5,1)="T2a (patch only)"
^ONCO(165.8,99,1,6,0)="T2b"
^ONCO(165.8,99,1,6,1)="T2b (plaque +/- patch)"
^ONCO(165.8,99,1,7,0)="T3"
^ONCO(165.8,99,1,7,1)="One or more tumors*** (=1 cm in diameter)"
^ONCO(165.8,99,1,8,0)="T4"
^ONCO(165.8,99,1,8,1)="Confluence of erythema covering =80% of body surface area"
^ONCO(165.8,99,1,"B","T1",1)=""
^ONCO(165.8,99,1,"B","T1a",2)=""
^ONCO(165.8,99,1,"B","T1b",3)=""
^ONCO(165.8,99,1,"B","T2",4)=""
^ONCO(165.8,99,1,"B","T2a",5)=""
^ONCO(165.8,99,1,"B","T2b",6)=""
^ONCO(165.8,99,1,"B","T3",7)=""
^ONCO(165.8,99,1,"B","T4",8)=""
^ONCO(165.8,99,2,0)="^165.83IA^9^9"
^ONCO(165.8,99,2,1,0)="NX"
^ONCO(165.8,99,2,1,1)="Clinically abnormal peripheral lymph nodes; no histologic confirmation"
^ONCO(165.8,99,2,2,0)="N0"
^ONCO(165.8,99,2,2,1)="No clinically abnormal peripheral lymph nodes; biopsy not required"
^ONCO(165.8,99,2,3,0)="N1"
^ONCO(165.8,99,2,3,1)="Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or National Cancer Institute (NCI) LN0-2"
^ONCO(165.8,99,2,4,0)="N1a"
^ONCO(165.8,99,2,4,1)="Clone negative"
^ONCO(165.8,99,2,5,0)="N1b"
^ONCO(165.8,99,2,5,1)="Clone positive"
^ONCO(165.8,99,2,6,0)="N2"
^ONCO(165.8,99,2,6,1)="Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3"
^ONCO(165.8,99,2,7,0)="N2a"
^ONCO(165.8,99,2,7,1)="Clone negative"
^ONCO(165.8,99,2,8,0)="N2b"
^ONCO(165.8,99,2,8,1)="Clone positive"
^ONCO(165.8,99,2,9,0)="N3"
^ONCO(165.8,99,2,9,1)="Clinically abnormal peripheral lymph nodes; Histopathology Dutch grades 3-4 or NCI LN4; clone positive or negative"
^ONCO(165.8,99,2,"B","N0",2)=""
^ONCO(165.8,99,2,"B","N1",3)=""
^ONCO(165.8,99,2,"B","N1a",4)=""
^ONCO(165.8,99,2,"B","N1b",5)=""
^ONCO(165.8,99,2,"B","N2",6)=""
^ONCO(165.8,99,2,"B","N2a",7)=""
^ONCO(165.8,99,2,"B","N2b",8)=""
^ONCO(165.8,99,2,"B","N3",9)=""
^ONCO(165.8,99,2,"B","NX",1)=""
^ONCO(165.8,99,3,0)="^165.84IA^3^3"
^ONCO(165.8,99,3,1,0)="cM0"
^ONCO(165.8,99,3,1,1)="No visceral organ involvement"
^ONCO(165.8,99,3,2,0)="cM1"
^ONCO(165.8,99,3,2,1)="Visceral involvement (spleen and liver may be diagnosed by imaging criteria, and organ involved should be specified)"
^ONCO(165.8,99,3,3,0)="pM1"
^ONCO(165.8,99,3,3,1)="Visceral involvement (must have pathology confirmation, and organ involved should be specified)"
^ONCO(165.8,99,3,"B","cM0",1)=""
^ONCO(165.8,99,3,"B","cM1",2)=""
^ONCO(165.8,99,3,"B","pM1",3)=""
^ONCO(165.8,100,0)="81.2^Primary Cutaneous Lymphoma: Primary Cutaneous B-Cell/T-Cell (non-MF/SS)"
^ONCO(165.8,100,1,0)="^165.82IA^10^10"
^ONCO(165.8,100,1,1,0)="T1"
^ONCO(165.8,100,1,1,1)="Solitary skin involvement"
^ONCO(165.8,100,1,2,0)="T1a"
^ONCO(165.8,100,1,2,1)="Solitary lesion < 5cm"
^ONCO(165.8,100,1,3,0)="T1b"
^ONCO(165.8,100,1,3,1)="Solitary lesion >= 5cm"
^ONCO(165.8,100,1,4,0)="T2"
^ONCO(165.8,100,1,4,1)="Regional skin involvement: multiple lesions limited to one body region or two contiguous body regions"
^ONCO(165.8,100,1,5,0)="T2a"
^ONCO(165.8,100,1,5,1)="All disease encompassing in a < 15-cm circular area"
^ONCO(165.8,100,1,6,0)="T2b"
^ONCO(165.8,100,1,6,1)="All disease encompassing in a >= 15-cm and < 30-cm circular area"
^ONCO(165.8,100,1,7,0)="T2c"
^ONCO(165.8,100,1,7,1)="All disease encompassing in a >= 30-cm circular area"
^ONCO(165.8,100,1,8,0)="T3"
^ONCO(165.8,100,1,8,1)="Generalized skin involvement"
^ONCO(165.8,100,1,9,0)="T3a"
^ONCO(165.8,100,1,9,1)="Multiple lesions involving 2 noncontiguous body regions"
^ONCO(165.8,100,1,10,0)="T3b"
^ONCO(165.8,100,1,10,1)="Multiple lesions involving >= 3 body regions"
^ONCO(165.8,100,1,"B","T1",1)=""
^ONCO(165.8,100,1,"B","T1a",2)=""
^ONCO(165.8,100,1,"B","T1b",3)=""
^ONCO(165.8,100,1,"B","T2",4)=""
^ONCO(165.8,100,1,"B","T2a",5)=""
^ONCO(165.8,100,1,"B","T2b",6)=""
^ONCO(165.8,100,1,"B","T2c",7)=""
^ONCO(165.8,100,1,"B","T3",8)=""
^ONCO(165.8,100,1,"B","T3a",9)=""
^ONCO(165.8,100,1,"B","T3b",10)=""
^ONCO(165.8,100,2,0)="^165.83IA^5^5"
^ONCO(165.8,100,2,1,0)="NX"
^ONCO(165.8,100,2,1,1)="Histopathology Dutch grades 3-4 or NCI LN4;"
^ONCO(165.8,100,2,2,0)="N0"
^ONCO(165.8,100,2,2,1)="No clinical or pathological lymph node involvement"
^ONCO(165.8,100,2,3,0)="N1"
^ONCO(165.8,100,2,3,1)="Involvement of one peripheral node region that drains an area of current or prior skin involvement"
^ONCO(165.8,100,2,4,0)="N2"
^ONCO(165.8,100,2,4,1)="Involvement of two or more peripheral node regions or involvement of any lymph node region that does not drain an area of current or prior skin involvement"
^ONCO(165.8,100,2,5,0)="N3"
^ONCO(165.8,100,2,5,1)="Involvement of central nodes"
^ONCO(165.8,100,2,"B","N0",2)=""
^ONCO(165.8,100,2,"B","N1",3)=""
^ONCO(165.8,100,2,"B","N2",4)=""
^ONCO(165.8,100,2,"B","N3",5)=""
^ONCO(165.8,100,2,"B","NX",1)=""
^ONCO(165.8,100,3,0)="^165.84IA^3^3"
^ONCO(165.8,100,3,1,0)="cM0"
^ONCO(165.8,100,3,1,1)="No evidence of extracutaneous non-lymph node disease"
^ONCO(165.8,100,3,2,0)="cM1"
^ONCO(165.8,100,3,2,1)="Extracutaneous non-lymph node disease"
^ONCO(165.8,100,3,3,0)="pM1"
^ONCO(165.8,100,3,3,1)="Extracutaneous non-lymph node disease, microscopically proven"
^ONCO(165.8,100,3,"B","cM0",1)=""
^ONCO(165.8,100,3,"B","cM1",2)=""
^ONCO(165.8,100,3,"B","pM1",3)=""
^ONCO(165.8,101,0)="82^Plasma Cell Myeloma and Plasma Cell Disorders"
^ONCO(165.8,102,0)="83^Leukemia: Unspecified or Other Type"
^ONCO(165.8,103,0)="83.1^Leukemia: Acute Myeloid Leukemia"
^ONCO(165.8,104,0)="83.2^Leukemia: Acute Lymphoblastic Leukemia in Children"
^ONCO(165.8,105,0)="83.3^Leukemia: Acute Lymphocytic Leukemia in Adults"
^ONCO(165.8,106,0)="83.4^Leukemia: Chronic Myeloid Leukemia"
^ONCO(165.8,107,0)="13^Larynx: NOS^^6^6"
^ONCO(165.8,107,1,0)="^165.82IA^1^1"
^ONCO(165.8,107,1,1,0)="TX"
^ONCO(165.8,107,1,1,1)="Primary tumor cannot be assessed"
^ONCO(165.8,107,1,"B","TX",1)=""
^ONCO(165.8,"B",6,1)=""
^ONCO(165.8,"B",7,2)=""
^ONCO(165.8,"B",8,3)=""
^ONCO(165.8,"B",9,4)=""
^ONCO(165.8,"B",10,5)=""
^ONCO(165.8,"B",11.1,6)=""
^ONCO(165.8,"B",11.2,7)=""
^ONCO(165.8,"B",12.1,8)=""
^ONCO(165.8,"B",12.2,9)=""
^ONCO(165.8,"B",13,107)=""
^ONCO(165.8,"B",13.1,10)=""
^ONCO(165.8,"B",13.2,11)=""
^ONCO(165.8,"B",13.3,12)=""
^ONCO(165.8,"B",14,13)=""
^ONCO(165.8,"B",15,14)=""
^ONCO(165.8,"B",16.1,15)=""
^ONCO(165.8,"B",16.2,16)=""
^ONCO(165.8,"B",16.3,17)=""
^ONCO(165.8,"B",17,18)=""
^ONCO(165.8,"B",18.1,19)=""
^ONCO(165.8,"B",18.2,20)=""
^ONCO(165.8,"B",19,21)=""
^ONCO(165.8,"B",20,22)=""
^ONCO(165.8,"B",21,23)=""
^ONCO(165.8,"B",22,24)=""
^ONCO(165.8,"B",23,25)=""
^ONCO(165.8,"B",24,26)=""
^ONCO(165.8,"B",25,27)=""
^ONCO(165.8,"B",26,28)=""
^ONCO(165.8,"B",27,29)=""
^ONCO(165.8,"B",28,30)=""
^ONCO(165.8,"B",29,31)=""
^ONCO(165.8,"B",30,32)=""
^ONCO(165.8,"B",31,33)=""
^ONCO(165.8,"B",32,34)=""
^ONCO(165.8,"B",33,35)=""
^ONCO(165.8,"B",34,36)=""
^ONCO(165.8,"B",35,37)=""
^ONCO(165.8,"B",36,38)=""
^ONCO(165.8,"B",37,39)=""
^ONCO(165.8,"B",38.1,40)=""
^ONCO(165.8,"B",38.2,41)=""
^ONCO(165.8,"B",38.3,42)=""
^ONCO(165.8,"B",40,43)=""
^ONCO(165.8,"B",41,44)=""
^ONCO(165.8,"B",42,45)=""
^ONCO(165.8,"B",43.1,46)=""
^ONCO(165.8,"B",43.2,47)=""
^ONCO(165.8,"B",44,48)=""
^ONCO(165.8,"B",45,49)=""
^ONCO(165.8,"B",46,50)=""
^ONCO(165.8,"B",47,51)=""
^ONCO(165.8,"B",48,52)=""
^ONCO(165.8,"B",50,53)=""
^ONCO(165.8,"B",51,54)=""
^ONCO(165.8,"B",52,55)=""
^ONCO(165.8,"B",53,56)=""
^ONCO(165.8,"B",54.1,57)=""
^ONCO(165.8,"B",54.2,58)=""
^ONCO(165.8,"B",55,59)=""
^ONCO(165.8,"B",56,60)=""
^ONCO(165.8,"B",57,61)=""
^ONCO(165.8,"B",58,62)=""
^ONCO(165.8,"B",59,63)=""
^ONCO(165.8,"B",60,64)=""
^ONCO(165.8,"B",61.1,65)=""
^ONCO(165.8,"B",61.2,66)=""
^ONCO(165.8,"B",62.1,67)=""
^ONCO(165.8,"B",62.2,68)=""
^ONCO(165.8,"B",63.1,69)=""
^ONCO(165.8,"B",63.2,70)=""
^ONCO(165.8,"B",63.3,71)=""
^ONCO(165.8,"B",63.4,72)=""
^ONCO(165.8,"B",64,73)=""
^ONCO(165.8,"B",65,74)=""
^ONCO(165.8,"B",66,75)=""
^ONCO(165.8,"B",67.1,76)=""
^ONCO(165.8,"B",67.2,77)=""
^ONCO(165.8,"B",68,78)=""
^ONCO(165.8,"B",69,79)=""
^ONCO(165.8,"B",70,80)=""
^ONCO(165.8,"B",71,81)=""
^ONCO(165.8,"B",72,82)=""
^ONCO(165.8,"B",73.1,83)=""
^ONCO(165.8,"B",73.2,84)=""
^ONCO(165.8,"B",74,85)=""
^ONCO(165.8,"B",75,86)=""
^ONCO(165.8,"B",76,87)=""
^ONCO(165.8,"B",77,88)=""
^ONCO(165.8,"B",79,89)=""
^ONCO(165.8,"B",79.1,90)=""
^ONCO(165.8,"B",79.2,91)=""
^ONCO(165.8,"B",79.3,92)=""
^ONCO(165.8,"B",79.4,93)=""
^ONCO(165.8,"B",79.5,94)=""
^ONCO(165.8,"B",79.6,95)=""
^ONCO(165.8,"B",79.7,96)=""
^ONCO(165.8,"B",80.1,97)=""
^ONCO(165.8,"B",80.2,98)=""
^ONCO(165.8,"B",81.1,99)=""
^ONCO(165.8,"B",81.2,100)=""
^ONCO(165.8,"B",82,101)=""
^ONCO(165.8,"B",83,102)=""
^ONCO(165.8,"B",83.1,103)=""
^ONCO(165.8,"B",83.2,104)=""
^ONCO(165.8,"B",83.3,105)=""
^ONCO(165.8,"B",83.4,106)=""
